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I first became aware of joint replacement registries during my time as a Fellow in Hip and Knee 
Replacement at the Nuffield Orthopaedic Centre in Oxford in 1993.  I was following up 
patients for a cohort study on what was then an emerging problem, how to treat patients with 
fractures around the femoral stem of a hip replacement.  The study examined the causes and 
treatment of a series of 35 patients presenting with these periprosthetic fractures and, according 
to the literature at the time, the study represented the largest number of patients with 
periprosthetic fractures in the world1.  I was therefore amazed when I saw a presentation on 
data from the Swedish Hip Arthroplasty Registry, reporting the outcomes associated with all 
total hip replacements performed in Sweden, and the very large numbers involved compared 
to a study form a single institution.  Although the publication was in Swedish, there was an 
English translation in summary form which I kept.  Regrettably it disappeared somewhere 
during my return to Australia two years later. 
 
I was fortunate to become involved with the Australian Orthopaedic Association National Joint 
Replacement Registry (AOANJRR) in 2004, firstly as a Victorian State member on the 
Governance Committee, and then was honoured to be invited as a Deputy Director of the 
AOANJRR in 2007.  I had previously worked under Professor Stephen Graves, the Director of 
the AOANJRR, who had been the Chairman of Orthopaedics at my hospital.  My first 
publication, based on AOANJRR data, was on a thorough analysis of the ASR Resurfacing and 
total hip replacement system, detailing the high rate of revision compared to other prostheses 
(1)2.  The AOANJRR was the first registry to report these findings and the world wide recall has 
led to significant changes in the way devices are introduced into the market and monitored. 
This spurred my interest in undertaking a PhD to investigate the role of the AOANJRR in the 
change of practice of joint replacement surgery in Australia.  
 
  
                                                     
 
1 This was eventually updated and published with larger numbers and longer follow up in 2009.  Fawzy E, de 
Steiger R, Gundle R et al, The Management of Periprosthetic Fractures - J Arthroplasty 2009 24 6 909-13 
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Total Hip Replacement (THR) and Total Knee Replacement (TKR) are effective operations for 
patients with end stage arthritis who can no longer be adequately treated non-operatively.  It is 
increasingly important that these procedures be closely monitored so that the best results can 
be achieved for patients and optimum use of health resources achieved. 
 
Joint replacement registries collect, analyse and report data on patients undergoing joint 
replacement surgery and can monitor numbers and changes over time, evaluate outcomes and 
identify patient and prostheses factors associated with these outcomes.  
 
The aim of this thesis is to study the impact of the Australian Orthopaedic Association National 
Joint Replacement Registry (AOANJRR) on hip and knee replacement in Australia. It will 
explore whether joint replacement outcomes have improved since the introduction of the 
Registry and critically assess the role of the Registry in this process.  Within this main aim, the 
thesis addresses 4 specific research questions: 
 
1. How are prostheses that are not performing as well as others in their class identified and 
what are the consequences of this? 
2. How does the AOANJRR monitor the impact of new technology such as computer 
navigation for TKR and the consequences of this? 
3. How does the AOANJRR monitor the introduction and impact of new materials with 
specific reference to crosslinked polyethylene for both THR and TKR? 
4. What role has the AOANJRR played in the change of practice, policies and outcomes of 






The thesis involves a systematic investigation using data from the AOANJRR to address the 
research questions. The questions were appropriately defined to retrieve information from the 
Registry for critical examination and analysis.  The basic framework is empirical. The processes 
and analytical methods used to answer specific quantitative research questions are standard 
and currently in place at the Registry.  
 
The research questions were developed to examine data that could specifically be addressed by 
the AOANJRR and with minimal information available from other national registries or other 
sources. These were designed with the aim of determining whether any demonstrated 




The revision rates for hip and knee joint replacements have improved since the inception of the 
Registry. The revision burden for total joint replacement is defined as the proportion of all hip 
and knee replacement procedures that are revisions. In Australia, the revision burden for total 
hip replacement has declined from 13.1% in 2002/2003 (the first year of full Registry national 
data) to 9.8% in 2015/2016.  For knee replacements the revision burden has declined from 9.3% 
in 2002/2003 to 7.4% in 2015/2016.  This equates to a 25% reduction in the burden of revision for 
hip replacement and a 20% reduction for knee replacement over the respective periods.  The 
rate of revision for primary THR has declined from 4.8% at 6 years for the time period 2003-
2006 to 3.6% at 6 years for THR performed between 2011 -2014. A similar reduction is also seen 
for TKR over the same period with a decrease in the rate of revision from 5.1% for procedures 
performed from 2003 -2006 compared to 3.8% for procedures performed from 2011-2014. 
 
The role of the Registry in improving the outcomes of joint replacement is addressed within the 
context of the research questions. The first paper described the process and the evolution over 
time of methods the Registry has developed to identify devices with a higher than anticipated 
rate of revision. As a consequence of reporting these devices, there has been a 67% reduction in 
THRs and a 76% reduction in the use of TKRs that have been so identified in the following 
year. The international consequence of this process is followed up later in the thesis. 
 
TKR has a higher rate of revision for younger patients and methods to reduce this rate of 
revision are important. The use of computer navigation results in an overall reduction in the 





The introduction of crosslinked polyethylene (XLPE) results in a prosthesis specific reduction 
in revisions for both TKR and THR compared to the use of the standard conventional non 
cross-linked polyethylene. For younger patients, <55 years of age, there is a fivefold reduction 
in the rate of revision for THR at 15 years compared to the use of conventional non cross-linked 
polyethylene. The Registry was the first to report a reduction in revision with the use of XLPE 
for hip and knee replacements. This has important implications and may enable younger 
patients to undergo surgery, confident of a reduced need for revision in the long term. 
 
The penultimate chapter outlines the contribution that the Registry has made to the improved 
outcomes of joint replacement in Australia by examining the interaction with multiple 
stakeholders. The chapter illustrates the many ways this has been achieved and uses case 
examples of feedback with resultant change of practice. The interaction of the Registry with the 
Australian Government, Regulatory authorities, Industry, and Medical Insurers outlines the 




There has been a substantial improvement in the outcomes of hip and knee replacement in 
Australia over the past 14 years. This thesis outlines the ways by which this has been achieved 
and outlines the critical role of the Registry in achieving these improved outcomes.  
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Note on References and Published Papers 
 
This Thesis contains several published papers.  All references to the work of others are fully 
cited and, to lessen the confusion, for the purpose of this thesis I have decided to list in the 
bibliography all references for the whole body of work.  This has necessitated converting the 
PDFs of the published papers to a Word format to enable the references to be listed in the 
appropriate order.  There are also several footnotes detailing the sources of data and some of 
these refer directly to Board Reports to the Australian Orthopaedic Association (AOA) and to 
Commercial in Confidence data.  While these cannot be referenced in a publically available 
document, the Chief Executive Officer of the AOA has stated that the AOA Board supports the 




Glossary of Abbreviations 
 
Abbreviation Name 
ACMD Advisory Committee on Medical Devices  
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ASR Articular Surface Replacement 
BMI Body Mass Index 
CAOS Computer Assisted Orthopaedic Surgery 
CI Confidence interval 
CPD Continuous Professional Development 
CPE Conventional polyethylene 
CPR Cumulative Percent Revision 
CR Cruciate Retaining 
CREPS Centre of Research Excellence in Patient Safety  
CT Computerized  Tomography 
EFORT European Federation of Orthopaedics and Traumatology 
FAR Finnish Arthroplasty Register 
FDA Food and Drug Administration US 
HR Hazard Ratios 
HRQOL Health related quality of life 
HTARR Higher Than Anticipated Rates of Revision 
ICOR International Consortium of Orthopaedic Registries 
IDI Image Derived Instrumentation 
IPL International Prosthesis Library 
ISAR International Society of Arthroplasty Registries 





LROI Dutch Arthroplasty Registry  
MARCQI Michigan Arthroplasty Registry Collaborative Quality Initiative 
MHRA Medicines and Healthcare Products Regulatory Agency  
MRI Magnetic Resonance Imaging  
NAR Norwegian Arthroplasty Register 
NARA Nordic Arthroplasty Register Association 
NHMRC National Health and Medical Research Council 
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NZJR New Zealand Joint Registry 
NZOA New Zealand Orthopaedic Association 
OA Osteoarthritis 
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RACS Royal Australasian College of Surgeons 
RCT Randomised Controlled Trial 
SAP Scottish Arthroplasty Project 
SCP Superior Performance Suffix  
SD Standard deviation 
SHAR Swedish Hip Arthroplasty Register 
SKAR Swedish Knee Arthroplasty Register 
TGA Therapeutic Goods Administration 
THA Total Hip Arthroplasty 
THR Total Hip Replacement 





TKR Total Knee Replacement 
UKR Unicompartmental Knee Replacement 
UK United Kingdom 
USA United States of America 
XLPE Cross linked polyethylene  













1.1 - Burden of Hip and Knee Replacement 
 
There is an increasing burden of hip and knee osteoarthritis.  The Global Burden of Disease 
2010 study was a comprehensive effort to measure epidemiological levels and trends of 291 
diseases across 187 countries. The Osteoarthritis (OA) Expert group reported a global 
prevalence of radiographically confirmed knee OA to be 3.8%, and hip OA 0.85%. The 
prevalence varied between regions with knee OA higher in the Asia Pacific area and hip OA in 
North America. Hip and knee OA was ranked as the 11th highest contributor to global disability 
as measured by years lived with disability (YLD), and had risen from the 15th highest 
contributor to YLD in 1990(2).  While non operative management of OA is recommended for 
most patients, surgery may be required when conservative treatments are not successful. Total 
Hip Replacement (THR) and Total Knee Replacement (TKR) are effective operations for those 
patients with end stage arthritis and numerous studies have demonstrated decreased pain, 
improved function and better health related quality of life (HRQOL) following joint 
replacement (3-8).  The success of both hip and knee replacement, along with an ageing 
population, rising rates of obesity (9-11), patient expectations of an active, pain free lifestyle 
and access to health care have all contributed to increasing numbers of these operations being 
performed (12-15). The annualised incidence per 100,000 of all THR has increased from 94.5 in 
2003 to 149.6 in 2016 and for TKR from 110.2 in 2003 to 215.3 in 2016.  It is anticipated that this 
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rate of increase will continue in the foreseeable future (16).  A recent study, using a logistic 
growth model that assumes an upper limit of THR and TKR incidence, predicts an increase in 
volume in Australia of 219% for THR and 142% for TKR from 2014 to 2046 (17).  Other studies 
using data from Norway, Sweden, Finland, Denmark and Australia to estimate the risk of 
undergoing a THR or TKR in an individual’s lifetime, have demonstrated a significant increase 
in the lifetime risk for these procedures in all five countries from 2003 to 2013(18, 19).  As both 
the volume and overall cost of THR and TKR procedures increase, and new technology is 
introduced into the marketplace, it is increasingly important that these procedures be closely 
monitored, so that the best results can be achieved for patients and optimum use of health 
resources achieved (20-22). 
 
Surgeons use multiple sources of information to make decisions about what types of hip and 
knee replacements to use for their patients.  These include personal experience, attendance at 
scientific meetings, published literature, industry sponsored events, peer discussion and, 
increasingly, the use of joint registry data. 
 
Traditionally, publications on implant performance have largely been from single centre sites, 
often from designer surgeons or a developer institution.  The special expertise from centres 
required to design, develop, or perform the trials, means that results may not be applicable to 
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the wider community (23-25). It is in this context that joint replacement registries provide a 
valuable means of ongoing information regarding the outcomes of prostheses and a system of 
continuous quality control (26-28).  Sir John Charnley, the pioneer of THR in the 1960s, 
advocated the need for rigorous follow up and documentation of his low friction arthroplasty 
patients, and even suggested that consideration should be given to establishing a national 
register (29).  
 
Sweden pioneered the implementation of joint replacement registries in the 1970s due to 
concerns from surgeons in their orthopaedic associations about the outcomes of joint 
replacement surgery.  Finland and Norway followed over the next decade. The Australian 
Orthopaedic Association recognised the need to establish a Joint Replacement Registry in 1993.  
The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) 
commenced initial data collection at a state level in 1999 and full nationwide implementation 
commenced in January 2003.  While it was accepted that there were already quality 
international registries, it was not clear if the outcomes could be attributable to the Australian 
population.  This was largely due to the range of different prostheses used in Australia not 
recorded by these registries, differences in methods of fixation of the implants, possible 
dissimilarities in patients and surgeons, and different methods of healthcare delivery.  While 
the AOA believes that the AOANJRR has become an integral part of orthopaedic practice in 
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Australia3, the contribution of the Registry to the practice of joint replacement in Australia has 
not been formally evaluated.  At the commencement of this thesis, the AOANJRR had 10 years 
of data collection and the final chapters were completed with 16 years of data available for 
analysis. 
 
1.2 - Aim and Research Questions 
 
The aim of this thesis is to study the impact of the Australian Orthopaedic Association National 
Joint Replacement Registry (AOANJRR) on hip and knee replacement in Australia. It will 
explore whether joint replacement outcomes have improved since the introduction of the 
Registry and critically assess the role of the Registry in this process. 
 
Within this main aim, the thesis addresses four specific research questions: 
 
1. How are prostheses that are not performing as well as others in their class identified and 
what are the consequences of this? 
                                                     
 
3 Source: Australian Orthopaedic Association Board of Directors, AOANJRR Update, February 2017 
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2. How does the AOANJRR monitor the impact of new technology such as computer 
navigation for TKR and the consequences of this? 
3. How does the AOANJRR monitor the introduction and impact of new materials with 
specific reference to crosslinked polyethylene for both THR and TKR? 
4. What role has the AOANJRR played in the change of practice, policies and outcomes of 
Hip and Knee Replacement in Australia? 
 
A major function of all registries is to report the outcome of joint replacements and this is 
usually performed by the Kaplan-Meier method to estimate survivorship of a prosthesis at a 
particular time point. The AOANJRR presents the data as the cumulative percent revision 
(complement of the survivorship estimate).  The first research question examines the methods 
by which prostheses that have a higher cumulative percent revision than comparable 
prostheses are identified. 
 
Research questions two and three examine some of the technical aspects of joint replacement 
surgery that the Registry has tracked since its inception. Computer navigation involves linking 
a preoperative or intraoperative image of the patient’s anatomy with rigid bodies attached to 
the patient’s bones, a tracking system to monitor the motion of the limb and surgical tools in 
3D space, and a sophisticated computer program that allows accurate measurement of the 
surgical cuts required to implant the prosthesis. Navigation has been adapted from industry 
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and initially used for neurosurgery to image the brain and allow more accurate identification 
and operation of intracranial lesions. It was first used in France to implant a TKR in 1996 and in 
Australia, by the author, in 2001.  
 
The major long term issue with the longevity of joint replacement has been wear of the 
polyethylene bearing surface, traditionally used in the joint articulation.  Wear particles induce 
an inflammatory reaction that results in bone loss and eventual loosening of the prosthesis. 
This may lead to revision surgery, an operation that carries not inconsiderable risk to the 
patient and cost to the community. This problem of wear has been of major concern to younger 
patients who may require joint replacement surgery, but have been denied because of concerns 
about the longer term performance, the inevitable revision surgery and subsequent risks.  The 
Registry was amongst the first in the world to specifically track the introduction of a new 
modification of polyethylene which involved cross–linking molecules with electron 
bombardment and heating the polyethylene to toughen the structure.  Laboratory studies 
demonstrated very low wear rates and the initial early clinical studies, using state of the art 
measurement tools, showed almost no wear when compared to conventional polyethylene. The 




1.3 - Structure of the Thesis 
 
Chapter Two presents a brief history of registries and outlines how the data from the 
AOANJRR is utilized to address the research questions in this thesis. 
 
Chapter Three presents a literature review relevant to the aim of the thesis. 
 
Chapter Four, entitled ‘Joint Registry approach for identification of outlier prostheses’ 
published in ACTA Orthopaedica (August 2013, Vol. 84, (4) 348-352), addresses the first 
research question of how prostheses that are not performing as well as others are identified by 
the Registry. 
 
Chapter Five presents a paper entitled ‘Computer navigation for total knee arthroplasty 
reduces revision rate for patients less than sixty-five years of age’ published in the Journal of 
Bone and Joint Surgery (2015 97(8) 635-642). It addresses the second research question about 
how the AOANJRR monitors the outcomes of new technology. It is the first study to describe a 




Chapter Six includes a paper entitled ‘Lower prosthesis-specific 10 year revision rate with 
cross-linked than with non cross-linked polyethylene in primary total knee arthroplasty’ 
published in Acta Orthopaedica (2015; 86 (6) 721-7). It addresses research question three on the 
impact of new materials with regard to improved bearing surfaces with TKR. It is the first 
published paper to demonstrate reduced rates of revision with specific brands of TKR using 
new cross-linked polyethylene. 
 
Chapter Seven contains a paper entitled ‘The use of Cross Linked Polyethylene for Total Hip 
Arthroplasty markedly reduces revision surgery at 16 years’ (to be published in the Journal of 
Bone and Joint Surgery, May 2018) and further explores research question three with regard to 
THR. 
 
Chapter Eight presents a paper entitled ‘International overview of joint registries and their role 
in outlier prosthesis identification’ (accepted for publication in Bone and Joint Research) and is 
an extension of research question one with regard to involving international registries in 
prosthesis identification and the international influence that the AOANJRR has had following 




Chapter Nine addresses research question four and explores whether outcomes of joint 
replacement have improved since the introduction of the Registry and critically assesses the 
role of the Registry in this process. The chapter discusses the interaction of the Registry with 
multiple stakeholders including surgeons, government and regulatory authorities, industry, 
hospitals, and patients and outlines the contribution that the Registry has made to these 
outcomes. 
 













2.1 - Brief Overview of Registries 
 
The National Committee on Vital and Health Statistics is the statutory body in the USA which 
provides information and advice to the Secretary of Health and Human Services on policy 
related to community and population health.  It describes registries as ‘an organised system for 
the collection, storage, retrieval, analysis and dissemination of information on individual 
persons who have either a particular disease, a condition (e.g. risk factor) that predisposes to 
the occurrence of a health related event, or prior exposure to substances (or circumstances) 
known or suspected to cause adverse health effects’ (30). By their nature registries use an 
observational study design, monitor all forms of treatment and have few, if any, exclusions 
(31). They also evaluate care as is provided irrespective of protocol and are more representative 
of a “real world practice” (32). This enables a registry to provide data on a broad range of 
patients thereby making the results more generalizable.  This is in contrast to clinical trials 
where an experiment with an active intervention intended to change an outcome is studied.  
Generally in clinical trials there are strict inclusion and exclusion criteria and therefore results 
may not be applicable to a whole population (33, 34) and adverse events may not be reported 
adequately (35).  Just as clinical trials are rated in terms of quality, registries are also subject to 
quality measurements (36-38).  This is to ensure that the design, data collection, analysis and 
reporting of the registry minimises bias or errors in inference (39, 40).  Registries need to have 
clear outcomes which are defined as an end result of a particular healthcare interaction (41).  
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These may differ according to the perceptions of different stakeholders, yet all will have the 
objective of improving patient care. 
 
Registries may be used for many purposes but the important factor for patient based registries 
is that they are used for evaluating outcomes (31). This is distinct from geographic population 
registries created for public health incident reporting, or registries that track patients with a 
particular disease. There are important elements that are common to quality clinical registries 
and these include: 
 
 Data are collected in a naturalistic manner such that treatment is determined by the 
caregiver and not by a registry protocol. 
 Data are reflective of clinical care routinely used for patient management. 
 Data are collected in a uniform manner for every patient, with consistent data 
elements and definitions. 
 Data are purpose driven and this is defined before collecting and analysing the data. 
This is distinct from administrative data sets designed for other means, but does not 




The intention of individual registries should be designated from the start and can vary 
according to the type of registry.  There can be more than one objective.  Registries can define 
the natural history of a disease, show the outcome of devices and be used for post market 
surveillance, in particular for monitoring rare events. They can determine effectiveness of 
interventions and can therefore be used for cost-effectiveness studies.  Perhaps the most 
important function of a registry is to monitor quality of care and how outcomes change over 
time.  
 
The first registry to be established in the world is generally considered to be the Leprosy 
Registry of Norway, which was founded in 1856 by royal decree.  The intention of the Registry 
was twofold, in part to quantify the leprosy problem using the Registry as one of the control 
measures and to clarify the aetiology of leprosy using the Registry material for epidemiological 
analyses (42).  This Registry became an important tool in the public health efforts against 
leprosy and used a minimum data set and a central system of registration, very similar to what 
is in use today.  The number of new patients contracting leprosy in Norway dropped rapidly 
with over a tenfold reduction in 30 years. This was thought to be due to the identification and 
registration of new cases by the Leprosy Registry leading to local isolation of patients in 
dedicated leprosy hospitals. G. Armauer Hansen was able to work with patients that the 
Registry had identified to further study the disease and discovered Mycobacterium Leprae in 
1874 (43). Leprosy is still known as Hansen’s disease.  At the first international leprosy 
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congress in Berlin in 1897 the resolution was adopted that ’the system of compulsory 
notification, surveillance and isolation, as performed in Norway, is recommended in all 
nations’ (44). This is the first example of how a registry played an important role in a significant 
public health problem but this was not widely recognised until the registry protocols were 
found in 1970, just before the centenary of the discovery of the leprosy bacillus. Although the 
value of the Leprosy Registry was clearly established, there was a distinct gap of over 100 years 
before the development of any further clinical registries for improvement of patient care. The 
Medical Birth Registry of Norway commenced in 1967 (45) and the Nordic countries soon 
recognised the great potential of this type of research. 
 
2.2 - Joint Replacement Registries 
 
The first national joint replacement registry was initiated by the Swedish Orthopaedic Society 
in 1975 and situated in Lund. The aim was to prospectively monitor knee replacement surgery.  
In the early 1970s knee replacement was relatively uncommon, with little information 
published in the literature.  Swedish orthopaedic surgeons felt it was appropriate to collect and 
analyse information to enable surgeons to make the most appropriate choice of implants and 
operative methods for their patients (46).  The Scandinavian countries subsequently have had a 
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long history of joint registries. The Swedish Hip Arthroplasty register commenced in 1979, the 
Finnish in 1980, the Norwegian in 1984, and the Danish in 1995. 
 
Joint replacement registries collect, analyse and report data on patients undergoing joint 
replacement surgery.  Information includes, but is not limited to, age, date and side of surgery, 
surgeon, type of prosthesis inserted, patient diagnosis, methods of implant fixation, and other 
information associated with the operation.  In general, a minimal data set ensures a greater 
chance of capturing data from a large population.  For joint replacement registries the principal 
outcome measure is time to first revision using Kaplan-Meier estimates of survivorship.  A 
revision procedure reflects a serious problem with the implant itself or method of intervention 
and is an objective measure that can be readily documented. It implies that both surgeon and 
patient have agreed that the problem is of sufficient magnitude to undergo revision surgery.  
Additional information is collected at the time of revision on the type of revision, the reasons 
for revision and further details of prostheses used. The analytical approaches used by the 
registry investigate associations with statistical methods to limit the impact of bias. 
 
Joint registries can be used to monitor joint replacement numbers and changes over time, 
evaluate outcomes and practice variation, identify patient and prostheses factors associated 
with these, record device utilisation and provide information for comparative effectiveness 
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studies (47, 48).  They are also necessary to evaluate rare outcomes. While a minimal data set 
ensures the best chance of successfully collecting information (49), expanding the data 
collection can lead to a more comprehensive assessment. A four level data hierarchy for 
arthroplasty registries has been proposed and, while there is general agreement on Level 1 
data, there are some differences in the elements required in the other three levels (Table 1).  All 
joint registries that are full members of the International Society of Arthroplasty Registries 
(ISAR) collect Level 1 data but there is variation in the amount of data collected on the other 
three levels (50). 
 
In 1993, largely as a result of the Scandinavian experience, the Australian Orthopaedic 
Association recognised the need to establish a Joint Replacement Registry and, after 
consultation with the Commonwealth Department of Health and Ageing, an agreement was 
signed to fund the Australian Orthopaedic Association (AOA) to establish a joint registry. Data 
collection first began on 1st September 1999.  Full national data have been available from 
January 2003.  The method of data collection was based on the Scandinavian process and has 
been refined over time.  Data are submitted by hospitals on specific forms which are completed 
in the operating theatre.  These forms are sent to the Registry office and then entered by 
experienced data entry personnel.  Validation of Registry data is by a sequential multi-tiered 
matching process against State and Territory health department separation record data.  
Following retrieval of unreported records and further checking of unmatched data the Registry 
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is able to obtain an almost complete record of hip and knee replacements performed in 
Australia.  A matching program is run monthly to search for all primary and revision 
arthroplasty procedures recorded in the Registry that involve the same side and joint of the 
same patient, thus enabling each revision to be linked to the primary procedure. Data are also 
matched bi-annually with the Department of Health and Ageing National Death Index to 
obtain information on the date of death. Survivorship is estimated using the Kaplan-Meier 
method and the survival estimate at each time is accompanied by a 95% confidence interval 
based on the method of Greenwood.  The Registry presents the survival information by the 
proportion of prostheses revised by a certain time, rather than surviving (not revised). This is 
termed the cumulative percent revision (CPR) and is the complement of the Kaplan-Meier 
survivorship.  Age and gender adjusted hazard ratios (HR), calculated from Cox proportional 
hazard models, are used to compare the rate of revision between different groups of interest. 
The Kaplan-Meier method overestimates the risk of revision in the presence of competing risks 
and in such circumstances the Registry uses the cumulative incidence function for all 
competing risks.  In this method patients who have already had a revision, or died, are 
excluded from the set of observations at risk of being revised.  Competing risk graphs are most 





An Annual Report is published in mid-September and this is based on data analysis from all 
procedures reported to the Registry up until 31st December the previous year. As a result of the 
increased amount of data and information to be presented by the Registry, not all of this can be 
included in the Annual Report.  Supplementary Reports on a range of specific topics including 
state variation, mortality, demographics and the outcome of revision surgery are available on 
the Australian Orthopaedic Association website.  These reports have increased in both number 
and complexity over the years. In 2017 there were 11 supplementary reports compared to just 
one in 2012.  
 
2.3 - Assessment of the Quality of AOANJRR 
 
The Australian Commission on Safety and Quality in Healthcare (ACSQHC) was established 
by the Council of Australian Governments in 2006 to lead and coordinate national 
improvements in safety and quality in healthcare (51).  Guidelines have been developed by the 
ACSQHC to assist with the quality of clinical registries and these include various criteria 
relating to the purpose, data capture, identification, security and governance issues (51).  It is 
important that the above criteria are met by the AOANJRR so it is recognised as a Quality 
Clinical Registry and, for the purposes of this thesis, it is also important, so that it is deemed an 
appropriate body of data on which to base this research (52).  The AOANJRR is designated as a 
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Federal Quality Assurance Activity under the Commonwealth Health Insurance Act of 1973, 
amended in 1992 to include Quality Assurance Activity. This ensures that the information is 
free from subpoena and allows surgeons to contribute data with confidence that it will not be 
used for purposes other than quality improvement.  This has been tested in the Australian 
Federal Court in June 2016 and upheld (53).  Over time the Registry has developed into a 
quality improvement activity as a result of continuous provision of data and feedback to all the 
stakeholders involved in joint replacement. This process is outlined in detail in Chapter nine. 
 
 
2.4 - Strengths and Limitations of the AOANJRR 
 
As well as the general benefits of joint registries there are some specific strengths to the 
AOANJRR.  The Australian Orthopaedic Association is the data custodian, contribution by 
surgeons is voluntary and almost 100%, and surgeons have a distinct sense of ownership of the 
data.  These factors have played an important role in the development and ongoing running of 
the Registry. The AOANJRR has a robust governance structure which is subject to regular 
review. The day to day management working group consists of a Director and three Deputy 
Directors, all of whom are orthopaedic surgeons and the author is the senior Deputy Director.  
There is also a Registry Manager, statisticians and a data entry manager who meet with the 
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directors on a weekly basis. The Registry reports to an AOANJRR Governance Committee, 
consisting of orthopaedic surgeons representing the Australian state branches and specialist 
societies, and this in turn reports to the AOA Board. This is in contrast to the U.K. National 
Registry, which is owned by the government and initially had only two orthopaedic surgeons 
of a total of twenty on the steering committee.  A survey of consultant surgeons’ views on the 
governance of the UK National Registry reported some concerns that the British Orthopaedic 
Association did not have more control over the data (54).  A possible consequence of less 
stakeholder engagement by surgeons is less engagement with registry findings and potentially 
less likelihood for improved patient outcomes. 
 
The Registry captures almost all hip and knee replacements performed in Australia and is able 
to analyse data based on both prosthesis and patient factors (Table 1). The Registry has an opt 
out consent process, and, since commencement of data collection up till December 31st 2017, 
there have only been 47 patients who have declined participation from a total of 1,353,290 
procedures. It is a true population registry and therefore has wide application and relevance 
and reflects community practice.  The Annual Report is widely read and in 2016 there were 
over 30,000 log-ins to the Report worldwide. As a result of the Report’s clarity and the amount 
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of information presented, tables and figures are frequently used in presentations from leading 
surgeons throughout the world4. 
 
By their very nature, successful joint replacement registries collect a minimal data set with the 
firm end point of revision surgery.  However an unrevised prosthesis does not necessarily have 
a good outcome as measured by clinical or radiological markers or patient reported outcome 
measures (55, 56).  The Swedish, New Zealand and the UK National Registry have all, to a 
variable extent, recorded Patient Reported Outcome Measures (PROMs) for a subset of registry 
data (55, 57-59). The AOANJRR, at present, does not include these patient outcome measures. 
Information that may be pertinent to the outcome of joint replacement, including co-
morbidities and imaging, are not collected by the AOANJRR.  Recently the Registry has 
recorded data on the American Society of Anaesthesiologists (ASA) score, which can be used as 
a surrogate for patient co-morbidity (60), height and weight thereby enabling body mass index 
(BMI) to be calculated; and the surgical approach to THR.  These data may be used to adjust for 
outcomes in the future.  Physicians have previously expressed concerns regarding ownership, 
usage, and reporting of data and the publication of league tables (54, 61). These potentially may 
have a detrimental effect by discouraging surgeons from taking on higher risk patients and 
                                                     
 
4 Personal Communication: Dan Berry, former president, American Academy of Orthopaedic Surgeons and 
current Director, American Joint Registry 
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ranking may not be a true reflection of a surgeon’s skill in delivering a satisfactory outcome 
(62-64). The improvement in outcomes in coronary artery bypass surgery in New York State, 
and paediatric cardiac surgical mortality in Bristol, are compelling examples of improved 
clinical performance as a consequence of feedback of results (65, 66).  While the AOANJRR is 
unable to publically disclose information on individual surgeons under the terms of the Federal 
Quality Assurance Activity it liaises closely with the AOA to provide feedback and advice on 
how best to manage surgeon performance. This process has been increasingly refined and is 

















The aim of this thesis is to study the impact of the AOANJRR on hip and knee replacement in 
Australia, exploring whether joint replacement outcomes have improved since the introduction 
of the Registry and critically assessing the role of the Registry in this process.  A literature 
review was performed interrogating PubMed, Medline, Embase, and Scopus to assess the 
current state of the international literature around the research questions.  The research 
strategy was applied to PubMed and adapted for the other databases. In addition the most 
recent publications of all national registry annual reports were reviewed to assess if 
information was provided within the reports, but not indexed, and to review any relevant 
publications listed in the reports. 
 
The literature review:  
(i) explores whether other joint replacement registries have improved the outcomes of joint 
replacement in their respective countries or regions and the means by which this has 
been achieved; and 
(ii)  examines the literature with respect to the specific research questions.  
 





There are many factors that may lead to registries changing practice and improving outcomes 
for patients. In order to explore whether registries improve outcomes of joint replacement 
several years may be required before change is demonstrable, principally as there is a relatively 
low failure rate of joint replacement surgery. Established national registries with longer follow 
up are therefore more likely to demonstrate change within their respective countries.  However 
smaller, or regional registries can also influence specific areas of practice and influence local 
outcomes.  The Swedish and Norwegian Joint Registries are the longest running and therefore 
are best placed to report on change of practice over a period of time.  
 
In a Presidential Guest Speaker address to the American Academy of Orthopaedic Surgeons, 
Peter Herberts, the founder of Swedish Hip Arthroplasty Register (SHAR), discussed how 
outcome studies have changed THR in Sweden (67). He stated that the aim of the Register is 
twofold:  
 
‘to describe the epidemiology of hip replacement surgery in Sweden, and to identify, by study of 
revisions, risk factors for poor outcome which are related to the patient, to the implant, and to the 
surgical technique.  The primary goal of the register is to widen knowledge of the surgical 





SHAR distributes reports annually or every second year and these are presented at the annual 
scientific association meetings and institution specific data are distributed to each participating 
hospital in the country. Reports on aggregate data are also publically available. 
 
Herberts and Malchau (28) evaluated the outcomes of 158,172 THR performed after the 
introduction of the SHAR in 1979 up till 1997.  They demonstrated a successive decline in the 
cumulative revision incidence for aseptic loosening for patients with osteoarthritis (OA) over 
several time periods. Patients operated on in 1987 were revised for loosening in 3% of cases 
after ten years compared to 9% of those operated on in 1979. They also compared two time 
periods (1979-1986 and 1987-1997) and reported on both cemented and un-cemented implants.  
They demonstrated a reduction in revision for both types of fixation in the latter cohorts and 
attributed the changes to improved prostheses and cement technique. The authors specifically 
stated that the willingness of Swedish surgeons to adopt modern cementing techniques, as a 
result of feedback, contrasted with the UK where only 25% of surgeons used these methods. 
There were poorer outcomes when older cementing techniques were used (68). 
 
They also compared variation in hospital performance and there was a marked reduction in 
inter-hospital differences over several years. They demonstrated that yearly feedback of 
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outcome data impelled most clinics to use safer and well documented implants, which 
contributed to the lower revision rate. The authors stated this change was a good example of 
quality improvement and ‘can be ascribed to many years of information provided by the register’ 
 
The world’s first joint registry, The Swedish Knee Arthroplasty Register (SKAR) was 
established in 1975 and was an early adopter of survivorship analyses for evaluating outcomes 
of arthroplasty (69, 70). The SKAR has identified key areas where it has improved the outcomes 
of knee surgery in Sweden. These include: providing early warnings regarding major problems 
with implants and techniques, collaboration with other researchers to link SKAR with specific 
scientific studies, and provision of information to surgeons and institutions to aid in best 
practice (71).  The information provided by SKAR partly explains why the long term rate of 
revision after TKR in Sweden is very low when compared internationally (72). 
 
There are several examples of the influence of SKAR. A multicenter study of 3,777 
unicompartmental knee replacements compared three types of implants, the PCA, the Marmor 
and the St Georg. The PCA had a much higher rate of revision and was subsequently 
withdrawn from the market (73). Another prosthesis, the Oxford unicompartmental knee 
replacement (UKR), while achieving good results from the developer’s institution, did not 
perform as well in Sweden. This led to the manufacturing company developing an education 
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program for surgeons prior to implanting their device (74). An early study demonstrating the 
value of collaboration involved retrievals of polyethylene liners from revision knee 
replacements which showed a higher risk of deformation and loosening when the polyethylene 
was  6mm in thickness (75).  This led to a recommendation for thicker polyethylene and the 
minimum thickness for polyethylene inserts in modern designs is 9mm. The SKAR also was 
able to show that the use of UKR for patients with rheumatoid arthritis (an intervention 
commonly performed in the early years of knee replacement) was unsuitable and the use of 
UKR for this diagnosis stopped. The SKAR provides comparative institutional information in 
table format demonstrating hospital outcomes in a number of key areas and this information is 
distributed to the heads of departments at each hospital. The SKAR states that ‘it is important to 
inform colleagues about the report to stimulate discussion in order to initiate improvement efforts’ (76).  
Sweden has the lowest rate of TKR revisions in the world. 
 
The success of these joint registries has led the way for Quality Registries in Sweden.  The two 
oldest are the SKAR (1975), and the SHAR (1979), and, since 1990, there have been an 
additional 98 registries certified by the Swedish Association of Local Authorities and Regions 
(77), partly as a result of the improvements demonstrated by the joint registries.  They focus on 
specific disorders, have largely been initiated by physicians, and allow researchers to follow 
patients for life.  As well as the documented improvements in joint replacement outcomes, 
Swedish Quality Registries have contributed to improved outcomes in multiple medical fields 
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including improved survival of childhood cancer (78), a reduction in complications from 
cataract surgery (79), and improving guideline adherence for the treatment of acute myocardial 
infarction (80).  
 
The Norwegian Arthroplasty Register (NAR) commenced in 1987, a little later than the 
Swedish Registries, and there have been many publications from the Registry on aspects of 
joint replacement that have contributed to improved outcomes of surgery. Fevang et al (27) 
used the data from the Norwegian Arthroplasty Register over a 21 year time period 1987-2007 
to demonstrate improved results of total hip replacement.  There were 110,882 THR reported to 
NAR during this time and they divided their analysis of hip replacement into four time 
periods, according to the year of primary surgery.  The earliest time, 1987-1992, was used as the 
reference period. Adjusted Cox regression analyses were performed to compare the risk of 
revision at the different time periods compared to the reference. The sex and mean age of 
patients and proportion of cemented and cementless prostheses remained largely unchanged 
though there were different types of prostheses introduced.  There was a decline in the overall 
number of revisions for any cause throughout the study period similar to the findings from 
SHAR. This was largely due to a reduction in revisions for acetabular and femoral aseptic 
loosening. There was a small increase compared to the initial time period in revision for 
dislocation, which the authors ascribed to a decrease in head size from 32mm to 28mm. There 
was also a small increase in the latter time period for revision for infection which the authors 
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attributed to a number of factors including increased awareness of septic revisions, and patient 
factors such as increased incidence of obesity and diabetes. Information was provided to all 
hospitals in Norway performing THR and there was a general improvement during two time 
periods 1987-1997 and 1998-2007 with the mean survival for the latter period higher than the 
first. 
 
The authors stated that ‘an important cause of the improvement on results seen in our study can be 
attributed to the increasing use of well documented implants with good results’ and that ‘publication of 
registry studies pointing out inferior implants and cements have played an important role in this 
development’.  Publications from the NAR that have contributed to the improved survivorship 
include studies on cement fixation (81-83), studies which have identified certain brands of 
cementless acetabular and femoral components associated with an increased risk of loosening 
(84-87), and reports on the use and duration of antibiotic prophylaxis for THR (88, 89). 
 
The NAR has also published on improved results of TKA. In a study by Dyrhovden et al (90), 
the revision rate of 60,623 primary TKR was evaluated comparing two time periods, 1994 to 
2004 and 2005 to 2015.  There was a similar median term follow up in both time periods. A 
reduced rate of revision for the latter time period was demonstrated and this was due to a 
decline in revisions for aseptic loosening of the femoral component, polyethylene 
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wear/breakage, patella dislocation, and unexplained pain. Similar to NAR’s findings with THR 
there was an increased incidence of revision for infection but this was just seen in the early 
post-operative time period. However, unlike the study by Fevang et al above, the authors did 
not make a direct attribution of the influence of NAR on the reduced rates of revision for TKR. 
 
There are three other Scandinavian joint registries, the Finnish, the Danish Knee and the Danish 
Hip which commenced in 1980, 1995 and 1997 respectively (91-93). While these Registries 
publish regular reports and articles on the results of joint replacement, there is no specific 
information on improved outcomes in their respective countries. With regard to the Finnish 
Arthroplasty Register (FAR), this has in part been due to changes in the administrative 
structure of FAR and issues of ownership of data. In 1993 FAR became part of the National 
Agency for Medicines and, in 2009, the National Institute for Health and Welfare. In 2012 the 
Finnish Arthroplasty Society determined that there was a need to revise the data collection and 
reporting of FAR, and a new advisory board was established. More comprehensive annual 
reports have been published from 2015 and the aim is to report at a hospital level on length of 
stay, early revisions and re-admissions (94). An analysis of 438,733 THR based on the Nordic 
Arthroplasty Register Association database demonstrated a lower 15 year prosthesis survival 
for Finland compared to the other Nordic countries, Sweden, Norway and Denmark (95) A 
number of reasons for this finding were discussed including a younger age group in Finland, 
differences in patient diagnoses and prosthesis variation with a higher use of uncemented and 
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metal on metal bearing surface devices in Finland. The reduced effectiveness of FAR during the 
study time period, compared to the registries from other Nordic countries may also have had a 
bearing on the results5.  
 
The National Joint Registry for England, Wales, Northern Ireland and the Isle of Man is now 
the world’s largest and commenced in April 2003. ‘The aim of the NJR is to provide information to 
all those involved in the management and delivery of joint replacement surgery with regard to surgical 
and implant performance and clinical best practice.’ There have been multiple publications using 
data from the UK Registry, with several of these relating to the higher revision rate of 
prostheses with metal on metal bearing surfaces (96, 97). There has been no specific analyses of 
the UK Registry and its role in the outcome of joint replacement and this may reflect the 
relatively short time that the UK registry has existed compared to the Scandinavian registries. 
However in the 2017 Annual Report (98) there are figures comparing the relative rates of 
revision for prostheses implanted over different years for both THR and TKR. The trend is for 
an improvement in survivorship in the latter years (99).  
 
                                                     
 
5 Personal communication Keijo Makela, Chairman of Advisory Board, FAR 
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The UK Registry also reports on hospital variation using revision surgery from the past five 
years excluding prostheses with metal on metal bearing surfaces ( because they have been 
withdrawn from the market due to a high failure rate) and to reflect more contemporary use of 
implants. Hospital variation is examined with the use of funnel plots with a standardised 
revision ratio plotted against the number of expected revisions. Control limits are set at 
approximately 2 or 3 standard deviations and hospitals with a revision rate above 3 standard 
deviations are termed outliers. In the 2017 Annual Report there were twelve hospitals reporting 
higher than expected rates for knees, and five for hips from a total of 149 National Health 
Service Trusts and Health Boards (98). 
 
The New Zealand Joint Registry (NZJR) published its 18th Annual Report in 2017 and 
commenced data collection a few months prior to the AOANJRR in January 1999 (100, 101). 
There have been no specific studies demonstrating improvements in outcomes as a result of the 
Registry but the annual report highlights with an asterisk prostheses that have revision rates 
significantly higher than the overall rate of 0.73 /100 observed component years (see chapter 8). 
In the latest report the New Zealand Registry makes some recommendations on the best and 
worst combinations for THR suggesting that an all cemented THR, with a ceramic on cross-
linked polyethylene bearing surface and a 32 mm diameter femoral head, performs best and a 





The NZJR has also collected information on Patient Reported Outcome Measures (PROMS) and 
was the first registry to establish that a disease specific joint score (the Oxford Hip and Knee) 
could be predictive of subsequent revision surgery. A statistically significant relationship has 
been confirmed between worse Oxford scores at six months, five, and ten years post-surgery 
and joint revision within two years of the Oxford 12 questionnaire collection date (102, 103). 
The NZJR has also recently linked PROMS to a higher revision rate for first revision joint 
replacements (100). This information is important as it may help reduce regular follow up of 
joint replacement patients to those that had the worst Oxford scores, thereby reducing costs 
and improving access to clinics for new patients. 
 
Kaiser Permanente (KP) is the largest not for profit health care plan in the United States and 
covers approximately 9 million members with over 90% residing in California. In response to 
the increase in volume of implantable medical devices and the associated costs and safety 
issues, KP developed implant registries in 2001 (104). The aim of the registries was to ‘enhance 
patient safety, quality of care and cost-effectiveness for KP’s members’.  As well as standardized 
registry data collection for the specific types of registries the KP registries make use of existing 
administrative databases, the Electronic Health Record, and electronic screening algorithms to 
identify complications and to facilitate adjustment for potential confounders (105).  The KP 
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registry can identify variation in its medical centres and has designated physicians to 
communicate the findings locally. It also has a number of feedback mechanisms to providers 
including risk–adjusted quarterly reports, reports on outlier devices and centres and individual 
surgeon reports documenting both descriptive details and complications.  
 
The THR revision burden has decreased within the KP Healthcare group from 15.4% in 2002 to 
10.1% in 2010 and this is thought to be due to a number of causes including outlier implant 
detection and prosthesis variability, identifying and monitoring product recalls, and 
notification of medical centre variation (48, 106-108).  
 
Regional registries with more comprehensive data collection than the minimal dataset collected 
by national registries can initiate quality improvement activities by identifying variation in 
practice of factors associated with joint replacement (109). Using feedback to surgeons in 
Clinical Quality Assurance meetings, changes in practice can be initiated to improve patient 
outcomes. 
 
The HealthEast Care System was the first community based joint replacement registry to 
commence in the USA and, in 1991, began data collection from surgeons in the greater 
metropolitan area of St Paul, Minnesota (110). The Registry stated that the general goals of a 
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joint registry were similar regardless of whether it was community based or at a national level 
and acknowledged that the majority of primary hip replacements in the United States were 
carried out by low-volume community based surgeons (111). 
 
The HealthEast Joint Registry has been used ‘to generate information of practical use to the 
practicing orthpaedist and can influence surgeon behaviour.  Sharing the results of registry studies with 
the surgeon, as well as furnishing the individual surgeon with information regarding the revision rate of 
his or her primary operations, should only improve each surgeon’s practice in the future’. Examples of 
studies that have led to a change in surgeon behavior within the region include a reduction in 
the use of unicompartmental knee replacement from 23% of all knee replacement surgery in 
1992 to 9.8% in 2004 following a study demonstrating a higher revision rate, especially for 
disease progression (112), and an increase in the use of all cemented TKRs after a study 
demonstrated improved outcomes compared to cementless TKR (113). This study also 
demonstrated economic benefits for using an all polyethylene cemented tibia in the older 
population which could have generated USD 900,000 in savings over the twelve year study 
period. 
 
The Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI) commenced in 
2011 with the aim of improving the quality of care for patients undergoing hip and knee 
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replacement in Michigan (a state in the USA with a similar sized population to Sweden) (114). 
It is part of a Collaborative Quality Initiative program by the insurance provider and includes 
several medical disciplines. Quarterly hospital meetings, led by a clinical champion, are a 
critical part of the model to provide a forum for dissemination and discussion of results. 
Several quality improvement projects have been initiated by MARCQI. There was substantial 
variation in blood transfusion amongst hospitals involved in the Registry. Blood transfusion 
has known risks (115-117) and methods exist to reduce transfusion following joint replacement 
(118, 119). An education program was introduced to raise awareness of the American 
Association of Blood Bank’s guidelines and a quality improvement (QI) program was instituted 
initially at two hospitals. Overall the percentage of patients transfused with a postoperative 
haemoglobin  8g/dL (the target level) decreased 80% after the educational intervention (109). 
The QI was expanded across 28 hospitals involved in MARCQI with regular feedback from 
senior surgeons and data officers in the Registry presenting each hospital’s transfusion risk 
compared to other participating hospitals. This registry based intervention resulted in a 
decrease in the rate of transfusion and elimination of unnecessary transfusions for patients 
undergoing both THR and TKR in the time period following identification (120). 
 
It is notable that both these registries contribute data to the American Joint Registry (AJR) (121) 
which, after many years of planning and regulatory approval, commenced a pilot project in 
2011 (122) and released its first Annual Report in 2017 (123). It will soon have the largest 
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amount of data due to the numbers of joint replacements performed in the USA, but it will be a 
while before analyses, other than descriptive, will be reported. 
 
Larsson et al, in a study using data from 13 disease registries from five countries concluded 
that ‘by making outcome data transparent to both practitioners and the public, well managed registries 
enable medical professionals to engage in continuous learning and share best clinical practices. The 
apparent result: improved health outcomes, often at a lower cost’ (124). 
 
There has been one analysis of the economic benefits of the AOANJRR which was undertaken 
by Monash University and Health Outcomes Australia on behalf of the Australian Commission 
on Safety and Quality in Health Care6. The study examined five clinical quality registries, 
including the AOANJRR, and concluded that registries may improve clinical practice at 
relatively low cost, but that the return on investment varied between the registries, and that full 
national coverage was desirable. The authors estimated that the net benefit of the AOANJRR 
was $53 million over 13 years, with a benefit to cost ratio of 5:1.  The conclusion stated that the 
report ‘will be used to support the development of a national policy context for clinical quality 
registries’. 
                                                     
 
6 Economic evaluation of clinical quality registries. Australian Commission on Safety and Quality in Health Care.  
November 2016.  Final Report.   
58 
 
Examination of the literature with respect to the specific research questions. 
 
As well as an overall view of the contribution of the AOANJRR to the practice of joint 
replacement, I have chosen specific research questions to examine aspects of joint replacement 
where the AOANJRR has collected, monitored and reported on data before other national or 
regional registries or, in most cases, before the publication of any scientific studies.  This was 
firstly to demonstrate the detail of the data that the Registry has captured in order to provide 
more comprehensive analysis of the many factors that may influence joint replacement 






Research Question One: Registry Approach for Identification of Outlier Prostheses 
 
While registries have reported that most prostheses perform well, there are a number of 
prostheses that have rates of revision that are much higher than other prostheses in their class.  
Poorly performing prostheses have, in part, led to the development of the NAR and the UK 
National Registry.   
 
The Norwegian Arthroplasty Registry began in 1987 as an indirect result of problems with the 
first hemiarthroplasty prosthesis developed in Norway, the Christiansen artificial joint (125). 
Tor Christiansen (1917-1981) was a Norwegian general and orthopaedic surgeon who initially 
developed a hemiarthroplasty in the early 1960s for the treatment of fractured neck of femur. In 
1970 he introduced a THA made of a stainless steel stem and femoral head and a cemented cup 
made from polyoxymethylene (trade name Delrin), manufactured by a French company 
Benoist Girard & Co. This was widely used in Scandinavia and Italy. Although there were early 
reports of higher revision rates of the Christiansen THA, it was not until a clinical study from 
the Coastal Hospital in Norway (126), demonstrating inferior results of the Christiansen hip to 
the Charnley, that production and sales of the Christensen THA ceased.  As a result of this 
experience, at the 1983 annual general meeting, the Norwegian Orthopaedic Association 
adopted a proposal for the establishment of a national register to be situated in Haukeland 
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University Hospital in Bergen.  The logo of the NAR is a picture of the asymmetric wear of the 
Christiansen acetabular socket. The NAR publishes on the outcomes of many prostheses but 
does not have a formal method in the Registry Annual Reports to identify underperforming 
devices. 
 
A similar situation arose in the United Kingdom, again indirectly leading to the formation of a 
national joint registry. The Capital Hip (3M) was introduced in 1991 and was based on the well 
performing Charnley prosthesis but differed in manufacturing and design techniques.  Its 
original purpose was to introduce a cheaper prosthesis into the market place based on previous 
long term results.  The Capital Hip had revision rates of 19-21% at five years which was much 
higher than expected (127, 128). The failure of the Capital Hip resulted in a message to all 
Directors of Public Health to ascertain the need for a national register to unite the various 
databases, audits and research that existed (129). The Trent Regional Registry in the UK noted a 
higher rate of revision of the Capital Hip compared to the Charnley before its use was 
discontinued in 1995 (130).  The case for a national joint register in the United Kingdom was 





A major advantage of the observational data that is collected by joint registries is the ability to 
report on comparative performance of prostheses and this may lead to the use of better 
performing devices. However actually highlighting within a publically available report those 
prostheses that do not perform well and detailing the methods by which this is done results in 
a much stronger statement.  At the commencement of this thesis a literature search of all joint 
registries did not reveal any formal reporting or methods by which registries identified 
prostheses that were not performing as well as expected. This is discussed in Chapter 4. A 
repeat literature search at the completion of this thesis demonstrated that two registries, Kaiser 
Permanente and the MARCQI had both formally adopted the AOANJRR approach and the UK 
National Joint Registry and the Dutch Registry are currently using a similar process. 
 
Research Question Two: New Technology and the use of Computer Navigation for TKR. 
 
The number of TKA procedures has increased in Australia by 139.8% from January 2003 till the 
end of December 2016. This trend is consistent with reports from other registries and 
administrative datasets and is greater than the increase in the number of THR performed. 
There are several reasons for this including, initially, an unmet demand, and improved results 
of more modern prostheses compared to those in the 1970s and 1980s making the procedure 
more widely accepted. The rising prevalence of obesity amongst western nations is also 
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strongly correlated with knee arthritis and TKR. Studies from the US, Spain, Norway and 
Australia, using longitudinal data or linked registry data, demonstrate a temporal association 
between increased weight gain and the increased numbers of TKR for both males and females 
(11, 132-134).  
 
The differences with respect to age and the outcome of TKR is markedly dissimilar to that of 
THR and these findings have consistently been reported by the AOANJRR. The revision rate 
for TKR increases with time and at 16 years following initial surgery patients < 55 years of age 
have over an eightfold revision rate compared to patients ≥ 75 years old (135).   
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Cumulative Percent Revision of Primary Total Knee Replacement performed for OA, by Age 
 
Source: AOANJRR Annual Report 2017 Fig KT10 
 
When examining the effect of age, the Registry often groups patients undergoing TKR into 
those < 65 years and those ≥ 65 years of age, and this allows sufficient numbers of procedures 
for analysis. Younger patients ≤ 65 years of age undergoing TKR currently make up 33% of the 
547,407 recorded cases in the 2017 Annual Report. As the rate of revision for patients ≥ 65 years 
is relatively low it is more difficult to demonstrate if an intervention improves outcomes in this 
age group and easier to detect a difference, if one exists, in the younger age group. Because of 
the higher revision rate in younger patients it is therefore important to investigate methods by 
which the rate of revision can be reduced. One such method is the use of computer navigation 
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use of cross-linked polyethylene which has demonstrated lower wear rates in vitro than the 
conventional polyethylene which has been traditionally used in TKR.  
 
Computer navigation for TKR requires a computer with appropriate software and a display 
screen linked to a tracking unit, most commonly an infrared camera. All navigation systems 
monitor the patient’s limb and the surgical instruments in space, registering these objects to the 
computer and finally guiding the surgeon to perform the surgery on a virtual plan. Navigation 
allows the surgeon to obtain accurate mechanical alignment of the prosthesis, to verify the 
position of the components, and adjust accordingly while in the operating theatre (136, 137).  
 
The majority of studies on the use of computer navigation for TKR have demonstrated that 
navigation improves alignment compared to conventional instrumentation (138, 139).  The 
alignment of the lower limb following TKR is generally believed to be important for long term 
success (140-143). Whether this improved alignment leads to a reduction in the long-term rate 
of revision is yet to be determined. Accurate lower limb alignment, along with the ability of 
navigation systems to measure and improve the balance of the TKR may be expected to also 
improve functional patient outcome. The evidence for this is less strong in randomized 
controlled trials of TKA performed with navigation compared to conventional instruments 
(144, 145). Most of the early studies investigating the use of computer navigation for knee 
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arthroplasty have been performed in specialist orthopaedic centres, where the procedures were 
often done by highly experienced surgeons (146-148). Orthopaedic surgeons tend to be early 
adopters of new technology, and it is important to determine the outcome of this technology in 
a broader population.  
 
Previously there has been only one registry study on the use of computer navigation for TKR. 
The Norwegian Arthroplasty Register reported on the short-term outcome of 1,465 computer 
navigated TKR from 2005-2008 (149).  The registration of TKR in NAR began in 1994 but the 
use of computer navigation was not captured until 2005. For the study, the authors restricted 
the population to the three most frequently used navigation systems and the five most 
frequently used TKR inserted with navigation.  There were 1,465 TKR with a mean follow up 
time of 1.4 years in the navigation group and 8,214 TKR with a mean follow up of 1.8 years in 
the conventional group. Cox regression analysis was adjusted for age, sex, prosthesis brand, 
American Society of Anesthesiologists grade (ASA), pre-operative diagnosis, previous knee 
surgery, and fixation method.  There was a higher relative risk of revision in the navigation 
group than the conventional TKR group (RR=1.7 95% CI 1.1-2.5; p=0.02). The results 
demonstrated one particular TKR, the mobile bearing LCS Complete (Depuy, Warsaw), had a 
higher rate of revision for navigation whereas there was no difference for the other four knees.  
The authors stated that the findings may suggest there are brand specific problems when using 
navigation. Computer navigation may also have been used by surgeons for more difficult cases 
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with malalignment or abnormal anatomy (150). While computer navigation has clearly 
demonstrated improved alignment in TKR, any benefit that this provides would be unlikely to 
be realized for several years following the initial procedure. This would most likely be in the 
form of reduced revisions for loosening, or wear related issues, and more likely to be 
demonstrated in younger, more active patients.  
 
The paper on Computer Navigation in Chapter 5 of this thesis was designed to analyse 
prospectively collected Australian data from 2003 with a maximum of nine years follow up and 
to examine the effect of navigation specifically in younger patients <65 years of age undergoing 
TKR, as this group of patients has the highest rate of revision. 
 
Research Question Three: The introduction and impact of cross-linked polyethylene for 
TKR and THR 
 
Both TKR and THR have traditionally used conventional polyethylene as the bearing surface 
for the articulation of the joint. The long term survival of both TKRs and THRs can be affected 
by particles of polyethylene wear which has been associated with osteolysis and loosening of 
the prosthesis (151-153).  Polyethylene wear is multifactorial and can be influenced by 
prosthesis design and sterilization, technical issues such as alignment, and patient-related 
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factors.  In order to reduce the effect of wear and subsequent osteolysis, different types of 
bearing surfaces have been introduced. Cross linked polyethylene (XLPE) is one such new 
material and was developed in 1999. XLPE is a modified form of polyethylene, manufactured 
from conventional polyethylene that has been subjected to radiation doses of 50-100 kGy, and 
either heated above or below its melting point (154-156).  The AOANJRR has identified the use 
of XLPE for THR and TKR since its introduction in Australia in 2000 and 2002 respectively. The 
definition of XLPE was confirmed with industry and crosschecked with the Australian 
Prosthesis Advisory List which records XLPE separately from conventional polyethylene. This 
has enabled a comparison of the two types of polyethylene to be performed. 
 
While laboratory and clinical studies of XLPE have demonstrated less wear in both hip and 
knee replacements (157-161), studies demonstrating an improvement in clinical outcomes and 
reduced rates of revision are scarce.  There have been no published or registry studies prior to 
this thesis that had demonstrated a reduced rate of revision for TKR with XLPE. One study 
from the Kaiser Permanente Registry in the US analysed 62,177 TKR with a median follow up 
time of only 2.8 years (162).  The authors stated that there was no significant reduction in all 




There are differences in the causes of revision for THR compared to TKR that the use of XLPE 
may alter. The commonest cause for revision for THR in the first six years is dislocation. After 
this time period loosening is the most common reason and is related to wear issues similar to 
TKR (135). One of the major contributing factors to dislocation in THR is the size of the femoral 
head and it is thought that a larger femoral head to neck ratio allows for increased motion 
before impingement of the neck on the edge of the socket occurs (163-165). Increasing the 
femoral head size has its limitations with the use of non XLPE as this increases the volumetric 
wear leading to increased particle induced osteolysis. The first widely used THR, the Charnley 
prosthesis, had a femoral head diameter of 22.25mm and, while this was thought to be optimal 
for lubrication and wear reduction (166) there was a higher dislocation rate with this smaller 
head size.  The use of larger head sizes to reduce dislocation has been associated with increased 
wear when used with conventional non XLPE polyethylene (167, 168). The use of XLPE for 
THR might therefore improve survivorship of THR if larger head sizes led to fewer revisions 
for dislocation without the increased wear problems associated with conventional polyethylene 
(169). 
 
As with TKR there are numerous publications on reduced wear with THRs using XLPE but 
there has been little evidence of a reduction in the revision rate as a consequence of its use. The 
Nordic Arthroplasty Register Association (NARA) reported on design specific differences 
between XLPE and conventional polyethylene in total hip replacement (170).  A study from the 
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Kaiser Permanente Total Joint Replacement compared 1815 metal on conventional polyethylene 
THR to 25,008 metal on XLPE and found a higher adjusted all cause rate of revision at 7 years 
in the conventional polyethylene group (171).  
 
A study using pooled data from six joint replacement registries, including the AOANJRR, did 
not demonstrate a reduced risk of revision (172). This study was limited to THRs with 
cementless fixation with a standard 32mm head size, in patients 45 to 64 years of age with a 
short follow up.  The hazard ratio in the adjusted model was in the same direction in favour of 
XLPE, but did not reach significance. The UK National Joint Registry is not able to distinguish 
between conventional and XLPE and reports both types as polyethylene. 
 
Chapter Six on the outcome of XLPE for TKR was designed to analyse prospectively collected 
data from 2003 at 10 years follow up to examine the effect of XLPE on revision rate for TKR 
compared to patients receiving a TKR with conventional polyethylene. As with computer 
navigation, there was specific reference to younger patients < 65 years of age who have the 
highest rate of revision. Chapter Seven on the use of XLPE for THR was designed to analyse 
prospectively collected data at 16 years to examine the effect of XLPE on both the early and 




This literature review has given a broad overview of the aim of this thesis.  In general, the 
registries that have been established the longest have demonstrated improvements in joint 
replacement outcomes in a number of ways by publishing regular reports and scientific papers, 
and by hospital and, to a lesser extent, surgeon feedback. With regards to the specific research 
questions, there is scarce literature available. There were no studies on methods to detect or 
report prosthesis outliers. There was only one Registry study on research question two, with 
small numbers and short follow up, and this did not demonstrate an improvement with the use 
of computer navigation for TKR.  The literature research for question three revealed no 
improvement for the use of XLPE in TKR and minimal prosthesis specific evidence for lower 
revision rates with THR.  Again, these studies had short term follow up and lower numbers 
and highlight the need for studies with large numbers and longer term follow up to 
demonstrate benefits, in the presence of a low revision rate. Research question four was specific 
to Australia but built on the existing knowledge base from older, established registries. 
 
The strength of the review lies not just with the evaluation of the published literature and 
international registry reports but also access to grey literature, attendance at scientific meetings 
and personal communication with international registry scientists to confirm or refute matters. 
A review of theses published mainly in the Scandinavian registries did not reveal topics 
specific to National registries and improvement of joint replacement outcomes  A limitation of 
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this review is that there are also numerous smaller national and regional registries (largely in 
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4.1 - Preface 
 
This chapter contains the first of five articles submitted for publication in peer reviewed journals. 
The article has been published in Acta Orthopaedica, 2013; 84 (4):348-352. 
 
This paper specifically addresses the first research question of ‘How are prostheses that are not 
performing as well as others in their class identified, and what are the consequences of this?’  
Joint replacement registries play a major role in monitoring arthroplasty outcomes by publishing 
data on survivorship of individual prostheses or combinations of prostheses. These outcomes 
may vary for a variety of reasons. Identifying prostheses with a higher rate of revision than other 
prostheses in a similar class is one way of reducing the use of these devices and encouraging best 
practice. The process must be transparent, accountable and have clinical relevance. This paper 
outlines how the Australian Orthopaedic Association National Joint Replacement Registry 
(AOANJRR) has developed a method to report “outlier” prostheses. It is the first registry to 




4.2 - Published Paper 
 
Background and purpose 
 
Joint Replacement Registries play a significant role in monitoring arthroplasty outcomes by 
publishing data on survivorship of individual prostheses or combinations of prostheses. The 
difference in outcomes can be device- or non-device-related, and these factors can be analyzed 
separately. Although registry data indicate that most prostheses have similar outcomes, some 
have a higher than anticipated rate of revision when compared to all other prostheses in their 
class. This report outlines how the Australian Orthopaedic Association National Joint 
Replacement Registry (AOANJRR) has developed a method to report prostheses with a higher 
than expected rate of revision.  
These are referred to as “outlier” prostheses. 
 
Material and methods 
 
Since 2004, the AOANJRR has developed a standardized process for identifying outliers. This is 
based on a 3-stage process consisting of an automated algorithm, an extensive analysis of 
individual prostheses or combinations by registry staff, and finally a meeting involving a panel 
from the Australian Orthopaedic Association Arthroplasty Society. Outlier prostheses are listed 
in the Annual Report as identified but no longer used in Australia (2) those that have been re-
identified and that are still used, and (3) those that are being identified for the first time. 
 
78 prostheses or prosthesis combinations have been identified as being outliers using this 
approach (AOANJRR 2011 Annual Report). In addition, 5 conventional hip prostheses were 
initially identified, but after further analysis no longer met the defined criteria. 1 resurfacing 
hip prosthesis was initially identified, subsequently removed from the list, and then re-
identified the following year when further data were available. All unicompartmental and 
primary total knee prostheses identified as having a higher than expected rate of revision have 




It is important that registries use a transparent and accountable process to identify an outlier 
prosthesis. This paper describes the development, implementation, assessment, and impact of 





Many factors influence the outcome of joint replacement surgery. Arthroplasty registries are 
able to identify differences in outcome based on patient-, surgery-, or prosthesis-specific factors 
(67, 173-175). The principal measure of primary joint replacement surgery is time to first 
revision, generally estimated using the Kaplan-Meier survival method (176). This measure is an 
unambiguous and clear indication of a problem with the primary procedure, where both the 
patient and surgeon have agreed that it is serious enough to require further surgical 
intervention (55, 177). 
 
It is known that prostheses have variable outcomes and, while most perform well, some have 
outcomes well outside what would be regarded as acceptable. This variability in prosthesis 
performance highlights the need for adequate pre-market assessment and vigilant post-market 
surveillance. Joint replacement registries play a critical role in providing quality post-market 
surveillance, as well as helping to understand prosthetic use and improving patient outcomes 
(27, 28, 34, 178). Registries have also been very effective in identifying prostheses or 
combinations of prostheses that are outliers with respect to revision rate, when compared to 
others in the same class (179-181).  
 
It is important that registries use a transparent and accountable process to identify an outlier. 
The AOANJRR was one of the first registries to develop a standardized process for 
identification of such prostheses (182). This process attempts to take into account the extent of 
difference and to determine the possible reasons for that difference. In this paper we describe 
the development, implementation, and assessment of that approach. 
 
Materials and methods 
 
The AOANJRR began a staged implementation on September 1, 1999 and has collected full 
national data since 2002. This registry has developed a standardized 3-stage approach to 
identifying prostheses that have a higher than expected rate of revision. Stage 1 has been 




The first stage is an initial screening test. It is an automated analysis that identifies prostheses 
where the revision rate (per 100 component years) exceeds twice that of all other prostheses in 
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the same class, and the Poisson probability of observing that number of revisions, given the 
rate of the class, is statistically significant (p < 0.05). Additional criteria include that there must 
be at least 10 primary procedures for that prosthesis, or the proportion revised is at least 75% 
and there have been at least 2 revisions. In addition, if a particular class contains a prosthesis 
that represents more than 25% of the group, a second probability analysis is performed in stage 
1. This analysis excludes the prosthesis from the overall rate and the probability is re-estimated 
using only the remaining prostheses. This is to avoid any bias on the revision rate that may 
occur by including a dominant prosthesis. This initial algorithm is based on a well-established 
epidemiological model identifying person-time at risk. This represents the observational 
experience in which disease onsets can be observed (183). Component years are substituted for 
person-years in the Registry model. Individual prostheses are identified but, specifically with 
primary hip replacement, a combination of prostheses may be identified. This occurs when a 
femoral stem and acetabular component are implanted together and the combination has a 
higher than expected rate of revision. Knee replacements are identified as a specific variant of 
the same brand if only the variant of the brand has a higher rate of revision, e.g. Genesis II 




In stage 2, Registry staff—including 3 orthopedic surgeons— review more detailed information 
on all prostheses identified in stage 1. An important part of stage 2 is the analysis examining 
the impact of potential confounders, such as age, primary diagnosis, and reason for revision, 
which are known to influence implant survival (184). This process seeks to identify patient and 
surgeon factors as well as device related factors that may have contributed to the observed 
higher rate of revision. Prostheses may be excluded from further review for a variety of 
reasons, some of which may include inadequate numbers or use in complex primary situations, 
or if they have been combined with prostheses already known to have a higher rate of revision. 
Age and sex-adjusted hazard ratios are calculated using Cox regression models. If the hazard 
ratio of a particular prosthesis—compared to all other prostheses in the same class combined—
is statistically significant, then the prosthesis or prosthesis combination progresses to stage 3. 
Additionally, all prostheses identified in the previous Annual Report are included in stage 2, 
regardless of re-identification in stage 1. The reason for this is to ensure that these previously 






In 2007, a third stage of assessment was added, enabling senior clinicians from the Australian 
Orthopaedic Association Arthroplasty Society to review the detailed analyses of prostheses and 
combinations identified in stage 2. The panel meets with staff from the AOANJRR at a 2-day 
workshop to critically appraise all the information and to determine which prostheses should 
be identified as outliers in the Annual Report. At this stage, the expert panel may request 
Registry technical staff to provide further information or additional statistical analyses. 
At the conclusion of stage 3, the AOANJRR then lists identified prostheses in 1 of 3 groups: (1) 
those that are no longer used in Australia, (2) those that have been re-identified and are still 
used, and (3) those that are being identified for the first time. Summary data for each prosthesis 
or prosthesis combination are provided in the Annual Report, and a full analysis is available in 
the supplementary report section on the AOANJRR website 




Between 2004 and 2011, the AOANJRR identified 78 prostheses or prosthesis combinations 
using its 3-stage approach. These included 42 conventional and 6 resurfacing hip prostheses 
and also 5 unicompartmental and 25 total knee prostheses. In general, once a prosthesis or 
prosthesis combination has been identified, it continues to be identified as an outlier in 
subsequent years. There have been 5 primary conventional hip prostheses or combinations that 
have been used in more than 150 procedures that were initially identified and subsequently 
after 1 year no longer satisfied the defined criteria. 1 resurfacing hip prosthesis was initially 
identified, subsequently removed from the list, and then re-identified the following year when 
further data were available. All unicompartmental and primary total knee prostheses 
previously identified as having a higher than expected rate of revision have been reidentified 
(185).  
 
During preparation of the 2011 Annual Report, the AOANJRR identified 217 prostheses or 
prosthesis combinations in stage 1. Of these, 123 (56.6%) were analyzed in more detail in stage 
2. Those that did not show a statistically significant difference in the rate of revision  
compared to the combination of all other prostheses in the same class were excluded. In stage 
3, there were 95 (44%) prostheses or prosthesis combinations reviewed by the independent 
panel of orthopedic surgeons and 17 were excluded. Reasons for exclusion included identifying 
non-prostheses-related factors such as major differences in primary diagnosis, or where 






Overall, there were 78 prostheses (36%) or prosthesis combinations identified in 2011, and 17 of 
these were newly identified (Table). These prostheses comprise 3.5% of all the different 
primary hip and knee replacements that have been recorded by the Registry. Of the prostheses 
identified, 37 of 78 (47%) are no longer used on the Australian market, and of those prostheses 
that were re-identified and were still used, 18 of 24 (75%) had had reduced use compared to the 
previous year. 14 combinations of acetabular cup and femoral stems have been reported that do 
not feature as individual prostheses, but when combined they have a higher than expected rate 




The approach to identifying “outlier” prostheses varies between arthroplasty registries. The 
Swedish Hip Arthroplasty Register publishes survivorship curves of prostheses and 
combinations but makes no specific comparison (186). The Norwegian Register documents the 
use of prostheses and publishes outcomes in peer-reviewed journals, but does not report 
specific survivorship curves in its annual report (187). The New Zealand Joint Registry (188) 
publishes tables of prosthesis outcomes but does not identify outlying prostheses. The National 
Joint Registry for England and Wales has developed an outlier subcommittee to discuss 
strategy and methodology for analysis of data on each implant that has been highlighted as 
needing evaluation, but these have not been published as yet (189). 
 
The Swedish Knee Arthroplasty Register uses a different approach. A specific knee prosthesis 
is used as a reference to compare the outcome of other prostheses (190). The choice of an index 
prosthesis requires that the prosthesis is used in numbers large enough to allow adequate 
80 
 
comparison. At one point, the AOANJRR compared all unicompartmental knees to the most 
frequently implanted prosthesis, the Oxford 3. This was because at that time it was used in a 
large proportion (35%) of all unicompartmental prostheses (191). Since then, the proportion has 
diminished each year and it became no longer appropriate to use an approach for 
unicompartmental knee replacement that was different to that being used for all other classes 
of prostheses. 
 
The AOANJRR chose to identify outlying prostheses within 2 years of collecting full national 
data, and this paper describes the development and evolution of the method over time. It is a 
transparent and accountable process that culminates in an independent review to determine 
what devices should be identified as outlier prostheses. It is important for surgeons to have 
current information on prosthesis outcomes, to enable them to select the best-performing 
devices for their patients. Registries provide an ideal form of post-market surveillance that is 
readily able to achieve this. Other surveillance measures such as adverse event reporting are 
known to have limitations (192-194). Most importantly, these are very dependent on what is 
reported and there is no provision of information on comparative performance. It is also 
necessary for regulatory authorities and industry to be aware of outlier prostheses as, even 
with internal monitoring, the real number of revisions may not be apparent (179, 195, 196). 
Following a health technology assessment review, and in part based on registry data, the 
Australian government reclassified hip, knee, and shoulder replacements from Class IIB to 
Class III (high-risk medical devices) (197). Since 2007, the Registry approach to identification 
has also been incorporated into the regulatory processes in this country. Following the release 
of the AOANJRR Annual Report, the Therapeutic Goods Administration (TGA), which is the 
Australian regulatory affairs body for medicines and devices, requests further information 
from the industry to justify the continued use of products identified as having a higher than 
expected rate of revision. The response of the industry to the Registry data is then reviewed by 
another specialist orthopedic TGA committee, which makes recommendations about the 
ongoing use of the individual prostheses (198). 
 
The Registry analyses the rate of revision separately for acetabular and femoral components, 
and if there is a higher than anticipated rate, individual components are published in the 
Annual Report. The Registry also analyses all combinations of acetabular and femoral 
components. Occasionally, a combination of prostheses—only when used together—has a 
higher than anticipated rate of revision, and this combination is noted.  
 
A well-performing prosthesis can also be linked to a prosthesis known to have a higher than 
expected revision rate, so that the combination performs less satisfactorily. The Corail/ ASR 
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combination was first reported in 2008 as having a revision rate that was more than twice its 
comparators even though good results had already been reported for the Corail stem (199). 
This was the first time that the ASR acetabular component, which had previously been 
reported with resurfacing (200), was associated with an increased rate of revision in 
conventional hip replacement. In other cases, an individual component is associated with a 
higher than expected revision rate no matter what prosthesis it is implanted with. If a 
prosthesis or combination previously identified no longer meets the criteria, it is not re-
identified subsequently and this is documented in the Annual Report. Registries continually 
monitor changing outcomes, and it is important to note that the report reflects that particular 
time period.  
 
There are both strengths and limitations to the process by which the AOANJRR identifies 
prostheses with higher than anticipated rates of revision. Stage 1 is effective as a screening test 
to flag prostheses but it does not account for changes in revision rate over time. This limitation 
makes it difficult to detect a difference if the higher risk of revision occurs later in the follow-up 
period (201). The introduction of stage 2 enabled further analysis to be performed on a number 
of variables, both device- and non-device-related. Stage 3 has proven to be valuable because it 
broadens the clinical perspective available to the AOANJRR. With the large number of 
prostheses reported to the Registry, it is difficult for the Registry surgeons to have a working 
knowledge of all the devices. The addition of members of the Arthroplasty Society broadens 
the clinical perspective. Surgeons involved in stage 3 have experience of many of the devices 
and add valuable input to the Registry findings. This improves the transparency and 
accountability of the Annual Report by ensuring peer review by the peak arthroplasty body in 
the country.  
 
The Registry compares prostheses to all remaining components in their class, and therefore 
under-reports prostheses with a higher than expected revision rate compared to the situation 
where the Registry only used the better-performing prostheses as the comparator. When a 
prosthesis with a higher than expected revision rate has been identified, it usually continues to 
be identified in subsequent reports. . After identification of the device, the usage usually 
declines—which may have a significant effect on its subsequent outcome, for a variety of 
reasons. Identification may bring the prosthesis to the attention of surgeons not performing 
large enough numbers to be aware that it has a higher rate of revision. They may then change 
their choice of prosthesis. It may also highlight patient selection issues such as resurfacing hip 
arthroplasty having a higher rate of revision in women, patients with smaller-diameter femoral 
heads, and older patients (202). This may result in a change of indication for prosthesis use, 




The Registry is most effective at identifying the performance of recently introduced prostheses, 
but those prostheses with delayed onset of a higher rate of revision are not identified as readily. 
It has become evident that the approach to identification may be too broad, and it is important 
to perform a careful range analysis of prostheses to identify which particular type is 
responsible for the higher than expected rate of revision within that particular group. An early 
example of this process was the Preservation Unicompartmental Knee, which was first 
identified in 2004 (182). In 2006, it became apparent that only the mobile bearing component 
had an increased rate of revision (191). More recent examples of prostheses that were not 
identified on routine screening but that required specific sub-analysis include the LCS/Duofix 
knee and size issues associated with the Spectron femoral stem. The Registry will continue to 
develop further strategies to identify specific prostheses within a broader group, keeping in 
mind that reducing the numbers available for analysis may reduce statistical precision. 
 
The Registry is aware that a single surgeon may be responsible for a prosthesis combination 
that has a higher rate of revision. This situation has occurred twice, and on both occasions 
subsequent use of the combination ceased following publication of the Annual Report. 
 
Identification by registries of prostheses with a higher than expected rate of revision is a 
process that will continue to evolve and develop. This will be enhanced by international 
collaboration between registries, which includes the possibility of using other registries to 
verify or confirm outlier prostheses. In addition, systems could be established to enable data 
pooling, which would allow enhanced analysis to better understand the role of device-related 




Many approaches for systematic reduction of the rate of revision have been described. 
Identification of prostheses with a higher than expected rate of revision is far less widely 
reported. Arthroplasty registries are effective in identifying outliers, and they can determine 
multiple factors that affect outcome—including device- and non-device-related issues. The 
Australian Registry has been successful in doing this and, as a result, many outlier prostheses 
are no longer on the market. Registries and international collaboration between registries will 
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4.3 - Additional Discussion  
 
The Registry has continued to refine and update the process by which implants with a higher 
rate of revision are identified. The publication of these data has become an important method 
by which information on these prostheses is distributed to a national and international 
audience, and the impact of this has been monitored. 
 
The Registry has carefully tracked the use and the ongoing outcome of all prostheses and 
prostheses combinations that have been identified as having a higher than anticipated rate of 
revision (HTARR) in the Annual Reports since this first commenced in 2004.  These devices are 
compared to prostheses within their own joint class and these include Unipolar Modular, 
Bipolar, Total Conventional THR, Resurfacing Hip Replacement Patella/Trochlear, 
Unicompartmental Knee Replacement and Total Knee Replacement.  The Registry has also kept 
data on the number of implants that have been used in the year before identification and again 
the number in the year after identification.  This allows the Registry to determine the influence 
of the identification of prostheses in the Annual Report, as this information can be directly 
attributable to the Registry analysis and reporting. For the examination of the effect of the 
HTARR, process data were used from 2004, (the commencement of identification) up till Dec 
31st 2016. Only primary conventional THR and TKR were studied, as these comprise over 95% 
85 
 
and 88% of all primary hip replacements and knee replacement procedures respectively.  There 
have been a total of 64 types of THR prosthesis and 39 types of TKR prosthesis identified with 
an HTARR since 2004. The Registry has recorded a total number of 47,699 THR and 37,033 TKR 
using a prosthesis or combination with a HTARR from a total of 930,530 hip and knee 
procedures in the database. Over this period 84,702 procedures (9.1%) had one component or 
the combination that had been identified.  This does not imply that all these procedures are 
revised but as a group they have at least twice the rate of revision of all other THR and TKR. 
 
An important metric of the result of the HTARR process is the use of devices after listing in the 
Annual Report as having a higher rate of revision. In the year after identification, 67% of all 
THR prostheses identified had a reduced use, with 23% having no recorded usage. A similar 
effect was seen with TKR with 76% of those identified having a reduced use, with 29% of these 
components having less than four recorded procedures. The Registry has been the first body to 
document these outcomes and this has led to a marked reduction in the number of patients 
exposed to devices with a higher than anticipated rate of revision. Surgeons still have a wide 
choice of devices that they can use for their patients. The Registry also continues to analyse all 
prostheses that we have identified and circumstances may change such that the prosthesis no 
longer fits the category and therefore is no longer identified.  Over the past 11 years, there have 
been 34 prostheses which, following initial identification with an HTARR, are no longer 
identified in subsequent years. There are reasons why this may occur. There may be initial 
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problems with some devices but with larger numbers implanted, longer follow up, and fewer, 
later revisions, these devices no longer meet the criteria for HTARR. Surgeons also may become 
more experienced using these prostheses, leading to improved performance over time. It could 
be argued that a higher revision rate in this situation is not necessarily device related but there 
are ample prostheses available that are technically straightforward to implant. Therefore the 
‘usability’ or ease of implantation of a device is an important feature.  When prostheses no 
longer meet the HTARR criteria a paragraph within the Annual Report is devoted to discussing 
their changed status.  
 
The Registry has developed further methods to identify specific prostheses subsets within a 
family of devices, and clinical experience and feedback have been of benefit. An example of this 
was briefly discussed in Chapter 4 and is now outlined in more detail. The process by which 
the Registry became aware of this outlier highlights how important surgeon feedback is to the 
Registry. The problem with this specific TKR (the LCS/DuoFix TKR, Depuy, Warsaw, In) was 
due to a manufacturing change by the company.  In 2006, following the successful modification 
of the tibial base plate, a layer of hydroxyapatite was added to the porous beaded surface of the 
femoral LCS component. In 2009, a high failure rate of the LCS DuoFix femoral component led 
to a worldwide recall. It was hypothesised that the implant failure was related to retained 
particles used during the manufacturing process which then produced excessive metal 
abrasion and the resulting debris was associated with pain and loosening (203, 204). This 
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prosthesis had not been picked up by the AOANJRR’s usual surveillance methods and was 
first brought to the Registry’s attention by an experienced surgeon who noted complications 
with his patients. A thorough analysis of this particular type of TKR subset revealed a HTARR 
and the LCS/Duofix was identified in the HTARR section in the 2012 Annual Report. The rate 
of revision at 4 years was over fourfold higher than all other TKR but, because this particular 
LCS subset was included in a large number of otherwise well performing LCS components, the 
Registry did not initially flag this in the Stage 1 automated algorithm. 
 
Our identification process now includes a careful analysis by more detailed prosthesis 
identification including catalogue number, and lot numbers if required, and also the methods 
by which implants are fixed to bone. For example, there are TKRs that only have a higher rate 
of revision when they are performed without cement or with a posterior stabilized version.  
These prostheses are then identified with the appropriate characteristics separate from other 
knees with the same family name.  
 
The clinical input of surgeons at the weekend workshop where the final decision about HTARR 
is made has become increasingly valuable. The addition of members of the Arthroplasty 
Society broadens the clinical perspective for the Registry Directors and, with time, surgeons 
have become more confident in interpreting the data presented at the workshop. This has been 
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reflected over time by fewer questions to the statisticians about methodology, more questions 
regarding possible confounders and a far shorter time frame devoted to the HTARR discussion 
at the weekend workshop.  Devices that are flagged in Stage 2 but not listed as HTARR are 
followed carefully in subsequent years and discussed, to enable an ongoing educational 
process. This is also the case with those devices that are no longer identified in Stage 2. 
 
The Registry has refined the process by which prostheses are initially flagged. Hazard ratios 
(HR) are now run on all prostheses or combinations in the Registry with over four recorded 
revisions and those with a significant HR compared to other devices in the same class are then 
more comprehensively analysed. 
 
This paper has been cited 16 times (refer 4.4 Citations).  Studies have cited this paper with 
respect to the method of reporting on metal on metal bearing surfaces or other outlier 
prostheses (205-208). Three papers have cited the study with regards to introducing the same 
concept for identification in their own registries (209-211).  
 
As outlined in Chapter 8, a few registries have followed the AOANJRR’s initiative, though 
most fall short of actually identifying these devices in publically available reports, though they 
may be identified internally. There are reasons for this including the inability to risk adjust 
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before notification and potentially the legal consequence of doing so.  However, patient safety 
should take priority and the Registry has been robust in its defense of the process and 
continues to report these devices in the Annual Report.  The HTARR identification reinforces 
the benefit of having the AOANJRR rather than relying on international registries to provide 
data on devices.  To date, no section of the orthopaedic industry has seriously challenged this 
process, particularly in light of the ASR debacle. 
 
One of the results of this paper has been the formation of a sub-committee of the International 
Society of Arthroplasty Registers (ISAR) to investigate the pooling of data to enable early signal 
detection of prostheses. This will enable a better understanding of the role of device-related 
and non-device-related factors that may contribute to the higher revision rate identified. It will 
also allow registries that may have concerns with a device, but insufficient numbers, to 
contribute data to an international analysis. The sub-committee consists of statisticians and 
clinicians and is investigating new methods for identifying prostheses with potentially higher 
revision rates. A machine learning algorithm has been developed using data from an 
international registry (Kaiser Permanente, California, USA) to address the confounding effect 
of individual device components. This program was then compared to data from the 
AOANJRR to validate the outcome.  As a result of this collaboration a paper has been prepared 
for submission entitled Active Post-Market Surveillance of Orthopaedic Devices in an International 
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Multi-Registry Study, Authors G Cafri, S Graves, A Sedrakyan, J Fan, P Calhoun, R de Steiger, A 
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5.1 - Preface  
 
This chapter contains the second of five articles submitted for publication in peer reviewed 
journals. The article has been published in the Journal of Bone and Joint Surgery 2015 Volume 97A 
(10):635-644, the most widely read orthopaedic journal.  It addresses the second research question 
of this thesis on how the AOANJRR monitors the impact of new technology with reference to 
computer navigation for TKR. 
 
The higher rate of revision in younger patients having a TKR is reported in numerous registries 
and clinical trials.  Methods to address this problem generally focus on new implant 
modifications and these data are recorded by all registries.  The recording and reporting on a 
novel method of inserting a TKR to improve the position of implants has had limited attention 
from registries.  Computer navigation for TKR has improved limb alignment compared to 
conventional, non-navigated TKR and this has been demonstrated in multiple RCTs.  This 
study analysed data from the Australian Orthopaedic Association National Joint Replacement 
Registry to examine the effect of computer navigation on the rate of revision of primary TKR to 




The Additional Discussion reports on extended follow up of the use of navigation in Australia, 
confirming the reduced rate of revision and compares the data to other countries who record 
the use of the technology. It also outlines how the Registry’s experience with the use of 
recording navigation has enabled expanded data collection of new technologies as they come 









Computer navigation for total knee arthroplasty has improved alignment compared with that 
resulting from non-navigated total knee arthroplasty. This study analyzed data from the 
Australian Orthopaedic Association National Joint Replacement Registry to examine the effect 




The cumulative percent revision following all non-navigated and navigated primary total knee 
arthroplasties performed in Australia from January 1, 2003, to December 31, 2012, was 
assessed. In addition, the type of and reason for revision as well as the effect of age, surgeon 
volume, and use of cement for the prosthesis were examined. Kaplan-Meier estimates of 
survivorship were used to describe the time to first revision. Hazard ratios (HRs) from Cox 





Computer navigation was used in 44,573 (14.1% of all) primary total knee arthroplasties, and 
the rate of its use increased from 2.4% in 2003 to 22.8% in 2012. Overall, the cumulative percent 
revision following non-navigated total knee arthroplasty at nine years was 5.2% (95% 
confidence interval [CI] = 5.1 to 5.4) compared with 4.6% (95% CI = 4.2 to 5.1) for computer-
navigated total knee arthroplasty (HR = 1.05 [95% CI = 0.98 to 1.12], p = 0.15). There was a 
significant difference in the rate of revision following non-navigated total knee arthroplasty 
compared with that following navigated total knee arthroplasty for younger patients (HR = 
1.13 [95% CI = 1.03 to 1.25], p = 0.011). Patients less than sixty-five years of age who had 
undergone non-navigated total knee arthroplasty had a cumulative percent revision of 7.8% 
(95% CI = 7.5 to 8.2) at nine years compared with 6.3% (95% CI = 5.5 to 7.3) for those who had 
undergone navigated total knee arthroplasty. Computer navigation led to a significant 
reduction in the rate of revision due to loosening/lysis (HR = 1.38 [95% CI = 1.13 to 1.67], p = 







Computer navigation reduced the overall rate of revision and the rate revision for 
loosening/lysis following total knee arthroplasty in patients less than sixty-five years of age. 
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Total knee arthroplasty is a successful operation for patients with severe arthritis for whom 
non-operative treatment has failed. Many studies have shown good long-term implant 
survivorship (212, 213) although there are age-related differences (214). Prosthetic design, 
surgical technique, surgeon experience, and overall alignment can all have a bearing on the 
success of the procedure. Computer navigation for total knee arthroplasty was first introduced 
in Europe in the 1990s, and there has been a widespread increase in its use throughout the 
world in the last decade. The proposed benefits of computer navigation for total knee 
arthroplasty include improved accuracy of both tibial and femoral component positioning and 
overall mechanical alignment. Most studies comparing computer navigation with standard 
total knee arthroplasty have demonstrated a greater number of patients with coronal 
mechanical axis alignment within 3 degrees of neutral in the navigation group (215-220). 
Whether this improved alignment leads to a reduction in the long-term rate of revision is yet to 
be determined. 
 
Most of the early studies investigating the use of computer navigation for knee arthroplasty 
have been performed in specialist orthopaedic centers, where the procedures were often done 
by highly experienced surgeons (136, 147, 148). Orthopaedic surgeons tend to be early adopters 
of new technology, and it is important to determine the outcome of this technology in a 
broader population. Joint replacement registries collect and report data on patients who have 
undergone joint arthroplasty, and analyses can be performed on device and non-device-related 
characteristics13. Joint replacement registries also provide the ideal platform for monitoring the 
introduction of new technology at a population level. Computer navigation was introduced 
into Australia in 2001, and the Australian Orthopaedic Association National Joint Replacement 
Registry (AOANJRR) began collecting data on its use for knee arthroplasty in 2003. The aim of 
this study was to determine if there was a difference in the rate of revision after navigated total 
knee arthroplasty compared with that after non-navigated total knee arthroplasty. 
 
Materials and Methods 
 
This prospective study was designed to evaluate the rate of revision of computer-navigated 
total knee arthroplasty with use of registry data on the Australian population of patients who 
underwent total knee arthroplasty. The AOANJRR began data collection on September 1, 1999, 
and includes data on almost 100% of the arthroplasty procedures performed in Australia since 
2002.  
 
Registry data are validated against patient-level data provided by each of the state and territory 
health departments in Australia with use of a sequential, multilevel matching process. A 
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matching program is run monthly to search for all primary and revision arthroplasty 
procedures recorded in the Registry that involved the same side and joint of the same patient, 
thus enabling each revision to be linked to the primary procedure. Data are also matched 
biannually with the Department of Health and Aging’s National Death Index to obtain 
information on the date of death. In 2003, an addition to the form for total hip and total knee 
arthroplasty marked “computer assisted” was included, and this enabled information to be 
collected on the use and type of navigation. Data were analyzed for all procedures recorded 
from January 1, 2003, to December 31, 2012. The Registry records the reason for and type of 
revision of total knee arthroplasty and categorizes revision surgery as major or minor. A major 
revision involves the revision of either the tibial or the femoral component, or both. Minor 
revisions are all other revisions—usually patellar resurfacing and tibial insert changes. 
 
The cumulative percent revision was compared between the non-navigated and navigated total 
knee arthroplasties over the same time period, and the impacts of age, sex, reason for revision, 
type of revision, and brand of navigation were assessed. Data were also analyzed according to 
the number of computer-navigated knee arthroplasties performed by the surgeons (ten or 
fewer, eleven to twenty-five, twenty-six to seventy, or more than seventy) to adjust for the 
influence of surgical volume on the rate of revision. The revision rates of prostheses of the same 
type were also compared between the no-navigation and navigation groups to adjust for the 




The AOANJRR uses Kaplan-Meier estimates of survivorship to describe the time to the first 
revision of an arthroplasty, with censoring at the time of death or closure of the database at the 
time of analysis. The unadjusted cumulative percent revision at the end of the first nine years 
after the primary arthroplasty, with an accompanying 95% confidence interval (CI), was 
calculated with use of unadjusted pointwise Greenwood estimates. The unadjusted cumulative 
incidence functions of the reasons for revision of navigated and non-navigated total knee 
arthroplasties were also calculated at the end of the first nine years. The hazard ratio (HR) was 
calculated with use of Cox proportional hazards models, adjusted for age and sex, and was 
used to make statistical comparisons of the revision rates between the groups. The assumption 
of proportional hazards was checked analytically for each model; if the interaction between the 
predictor and the log of the postoperative time was significant in the standard Cox model, then 
a time-varying model was used. For this study, the reported HRs pertain to the entire follow-
up period. All tests were two-tailed at the 5% level of significance. Statistical analysis was 
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Computer navigation was used for 44,573 (14.1% of all) primary total knee arthroplasties 
recorded by the AOANJRR, and 270,545 (85.9%) were recorded as having been performed 
without computer navigation. The use of computer navigation for primary total knee 
arthroplasty increased from 2.4% of all procedures in 2003 to 22.8% in 2012 (Table I). Computer 
navigation was used in 239 of 304 hospitals performing total knee arthroplasty throughout the 
country. The Registry recorded the use of ten different navigation systems, with six systems 
used in more than 100 cases each and the majority of the arthroplasties performed with the aid 
of a Stryker (48.6%) or Brainlab (31.8%) system. The specific system was not recorded for 757 








The cumulative percent revision at nine years after non- navigated total knee arthroplasty was 
5.2% (95% CI = 5.1 to 5.4) compared with 4.6% (95% CI = 4.2 to 5.1) after computer navigated 
total knee arthroplasty (HR = 1.05 [95% CI = 0.98 to 1.12], p = 0.15) (Table II, Fig. 1). There was 
an interaction effect on the rate of revision between the use of navigation and the patient’s age 
(p = 0.0282). There was a significant difference in the rates of revision of non-navigated and 
navigated total knee arthroplasties for patients less than sixty-five years of age. In that group, 
the cumulative percent revision at nine years following non-navigated total knee arthroplasty 
was 7.8% (95% CI = 7.5 to 8.2) compared with 6.3% (95% CI = 5.5 to 7.3) after navigated total 
knee arthroplasty (HR = 1.13 [95% CI = 1.03 to 1.25], p = 0.011). There was no significant 
difference between the rates of revision of non-navigated and navigated total knee 










In patients less than sixty-five years of age, computer navigation led to a significant reduction 
in the rate of revision due to loosening (the most common reason for revision) (Table III), with 
a cumulative percent revision of 1.6% (95% CI = 1.3 to 2.1) at nine years compared with 2.6% 
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(95% CI = 2.4 to 2.8) for those with non-navigated arthroplasty (HR = 1.38 [95% CI = 1.13 to 
1.67], p = 0.001) (Fig. 3). There was no difference between the navigated and non-navigated 








The cumulative percent major revision of non-navigated primary total knee arthroplasty at 
nine years was 2.7% (95% CI = 2.6 to 2.8) compared with 2.1% (95% CI = 1.8 to 2.4) for navigated 
total knee arthroplasty (HR = 1.18 [95% CI = 1.07 to 1.31], p < 0.001) (Fig. 4). There was no 
difference in the rates of minor revision between the arthroplasty groups. There was also no 
difference in the rate of revision between the non-navigated and navigated total knee 
arthroplasties when the rates were compared in each of the four surgeon-volume groups. 
Analysis of prosthetic fixation in patients less than sixty-five years of age showed the benefit of 
navigation to be more apparent in patients who had undergone all-cemented fixation than in 









We believe that this is the first study to demonstrate that the use of computer navigation 
reduced the rate of revision of total knee arthroplasty in younger patients in a population-
based registry. Computer navigation for total knee arthroplasty has widespread acceptance in 
Australia and was used in >22% of all cases in 2012. This study demonstrates that a joint 
registry can be used to monitor the introduction of new technology within an entire 
population. A registry is the ideal vehicle for assessing the performance of new technology as it 
identifies problems and benefits in the “real world.” There were early concerns that the 
introduction of navigation would increase operating times and the use of pin fixation would 
increase the rates of revisions due to infection and fracture. This study showed no difference in 
the percentage of knees revised for those diagnoses between navigated and non-navigated total 
knee arthroplasties, highlighting the Registry’s role and importance in postmarket surveillance. 
While registries can often identify early problems with new technology (221), demonstrating a 
benefit of navigation is more complex, particularly if the benefit is a reduced rate of revision. 
Modern knee prostheses have a low rate of revision. It is therefore likely that, if there is a 
benefit, identifying it requires long-term follow-up and a large sample size. The revision rates 
following total knee arthroplasty vary significantly with age, with younger age groups having 
a higher revision rate (214). Therefore, if navigation has an effect on revision, it will more likely 
be detected in the younger age groups. The majority of total knee arthroplasties are performed 
in older age groups, in which the rate of revision is low and it would be more difficult to 
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demonstrate that navigation reduces the rate of knee revisions, especially those due to wear-
related issues such as loosening or lysis. 
 
It is well established that navigation improves coronal mechanical alignment and reduces 
outliers from what is regarded as acceptable alignment. A systematic review of thirteen 
randomized controlled trials (139) showed a significant odds ratio of 2.32 (95% CI = 1.77 to 3.04, 
p < 0.00001) in favor of computer navigation obtaining satisfactory postoperative alignment—
i.e., a neutral mechanical axis (±3).  
 
Alignment of the total knee prosthesis is believed to be important for long-term success (213, 
222, 223). However, Parratte et al. (224), in a study of 398 patients followed for fifteen years 
after undergoing a total knee arthroplasty, did not show that mechanically well-aligned knees 
had better survivorship than those in which the axis was not within 3 degrees of neutral. 
Bonner et al. (225) found only a weak tendency toward improved survival with restoration of a 
neutral mechanical axis. Despite these studies, it is important not to infer that alignment is not 
important after total knee arthroplasty. However, most studies of computer navigation for total 
knee arthroplasty have not shown the improvement in alignment to have any clinical 
advantage such as superior physical function, range of motion, patient-assessed outcomes, or 
rates of revision (226-234). Three studies have shown improved patient outcomes associated 
with alignment. Choong et al. (235), in a randomized controlled trial comparing conventional 
and navigated total knee arthroplasties, and Huang et al. (144), in a follow-up study of the 
same group, demonstrated that patients with a mechanical axis within 3 degrees of neutral had 
a significantly higher Knee Society score at one and five years. There was also improvement in 
the physical and mental components of the Short Form-12 health score at five years. Hoffart et 
al. (236) also showed an improvement in functional outcomes, with better Knee Society scores 
at five years, for navigated total knee arthroplasty compared with conventional total knee 
arthroplasty. 
 
The strengths of our study include the number of patients involved, the use of population-
based data including all surgeons performing total knee arthroplasty in Australia, and the 
longer-term follow-up. More than 44,000 total knee arthroplasties performed with the aid of 
computer navigation were analyzed, making this the largest study of navigated total knee 
arthroplasties reported, to our knowledge. These type of data can be obtained only from a 
national registry. Most reported trials on the use of computer navigation were from specialized 
centers at which high volumes of knee arthroplasties were performed. It could be argued that 
navigation is best suited for surgeons or centers performing lower volumes of procedures, as 
experienced surgeons may have a limited number of alignment outliers (237, 238). While our 
study showed that surgeons who performed twenty-five or fewer procedures per year had a 




The introduction of registry data collection to capture data on computer navigation for total 
knee arthroplasty coincided with its more widespread use in Australia. Before 2003, only a few 
specialized centers were performing computer navigation, whereas now it has widespread 
community acceptance. Our data include all total knee arthroplasties performed with and 
without navigation and thus include surgeons undertaking their first cases, those who had 
performed a small number of procedures, as well as those who had performed many hundreds 
of navigated total knee arthroplasties. Therefore, this study has strong external validity. There 
is evidence that surgeons can achieve good alignment with the first few navigated total knee 
arthroplasties that they perform (239, 240). While the AOANJRR does not contain information 
on overall alignment, it showed significantly fewer revisions due to loosening/lysis following 
computer-navigated total knee arthroplasties. It may be expected that the effect of improved 
alignment would not be apparent until longer-term follow-up had been completed, when wear 
and loosening may become more important causes of revision. This would likely result in 
fewer major revisions with better alignment, which was shown in our study. Schnurr et al. 
(241) examined the results of 1121 consecutive primary total knee arthroplasties, including the 
last 342 conventional procedures and the first 779 navigated procedures done at their clinic. 
After a duration of follow-up of one to six years, the navigated technique was associated with a 
significantly lower revision rate, which was largely due to a reduced rate of aseptic implant 
loosening. That observation concurs with our findings and with our belief that longer-term 
follow-up is necessary to show the benefits of navigation. In the only other registry study on 
navigation for total knee arthroplasty, which was from Norway (242) and which included 1465 
navigated total knee arthroplasties, the follow-up was short-term (a mean of less than two 
years) and it showed an increased rate of revision following computer-navigated total knee 
arthroplasty but the increase was significant for only one prosthesis. The authors suggested 
that longer-term follow-up in randomized controlled trials and registry studies was important. 
Although our results showed no difference in the rate of revision between navigated and non-
navigated knee arthroplasties in the population as a whole, there was a significant difference in 
the younger age group (less than sixty-five years of age). This group of patients has been 
consistently shown to have a higher rate of revision than older patients, and it may be 
important to consider the use of navigation in this select group. As has been demonstrated in 
multiple studies, improved alignment may well reduce the rate of revision due to loosening 
and lysis. 
 
There are costs associated with the use of computer navigation, including those for the 
computer, camera, software support, and disposable items. All new technology comes at a 
price, and it is important to demonstrate cost-effectiveness. Gøthesen et al. (243), using data 
from the Norwegian registry, employed a Markov model to compare the cost-effectiveness of 
computer-navigated total knee arthroplasty with that of conventional total knee arthroplasty. 
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Sensitivity analysis demonstrated that, for sixty-year-old patients, the ten-year implant survival 
rate needed to rise from 89.8% to 90.6% for institutions performing twenty-five arthroplasties 
per year and from 89.8% to 89.9% for those performing 250 per year for computer navigated 
surgery to be considered cost-effective. Our study supported the cost-effectiveness of 
navigation for patients less than sixty-five years of age, who had a nine-year implant 
survivorship of 93.7% compared with 92.2% for those who underwent non-navigated total knee 
arthroplasty. Cost-effectiveness studies, however, may differ from country to country, 
depending on multiple factors, and would need to be carefully evaluated further. 
 
There are some limitations to this study. Although the AOANJRR is confident that all 
procedures that were reported as navigated were navigated, it is possible that a small number 
of cases were navigated and not recorded as such. This would mean that some total knee 
arthroplasties in the non-navigated group could have been actually implanted with navigation. 
However, with more than 270,000 non-navigated knee arthroplasties in the Registry it is 
unlikely that this would make any difference in the rate of revision. Also, it is possible that 
navigation was abandoned during the procedure but recorded by the Registry as having been 
performed. As the study was based on intention to treat, this does not change the analysis. 
Some of the potential complications of using computer navigation surgery may not be reported 
to the Registry. These include pin track infections and fractures associated with pin insertion. 
Anecdotal reports in the literature have highlighted such concerns (244-246), but clinical 
studies on navigation have not shown them to be major issues (139). Our results demonstrated 
no difference between the percentages of navigated and non-navigated total knee 
arthroplasties revised for infection or fracture. 
 
We also sought to analyze the different systems available for navigation, which were 
dominated in the Australian market by Stryker and Brainlab. The Stryker system was used 
essentially with Stryker implants, whereas Brainlab is a cross-platform design and has been 
used for large numbers for prostheses from several different companies (DePuy, Smith & 
Nephew, and Zimmer). The confounding variables of different knee systems and different 
navigation systems made it difficult to draw any firm conclusions about the benefits of any one 
particular navigation system. 
 
This study showed that the use of computer navigation for total knee arthroplasty reduced the 
overall rate of revision as well as the rate of revision for loosening/lysis in patients less than 
sixty-five years of age and also reduced the rate of major revisions in the entire study 
population. Thus, we concluded that the use of navigation for total knee arthroplasty improves 
implant survivorship in younger patients treated with total knee arthroplasty and may be cost-
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5.3 - Additional Discussion 
 
Computer Navigation for Total Knee Arthroplasty Reduces Revision Rate for Patients Less 
Than Sixty-five Years of Age  
 
One of the novel features of the data captured by the AOANJRR has been the inclusion of the 
methods used to implant devices, as distinct from the standard instrumentation conventionally 
employed. 
 
Computer navigation for Total Knee Replacement (TKR) was first performed in Australia in 
2001 by the thesis candidate. This followed extensive laboratory and cadaver research.  The aim 
of the initial introduction of navigation was to compare its accuracy to the standard of care, 
which was the use of standard instruments to insert a TKR.  There were rapid developments in 
this field, and, over 18 months, navigation progressed from needing pre-operative patient CT 
scans to what is termed ‘image free navigation’, which entailed the registration of the patient to 
the computer system by acquiring a number of anatomical markings on the patient’s bone 
(137).  The initial studies of computer navigation for TKR demonstrated improved alignment 
with the use of navigation compared to conventional technique, but there was no evidence of 
improved outcomes.  For reasons similar to those behind the commencement of the world’s 
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first joint registry (Swedish Knee Arthroplasty Registry) it was felt the best way of looking at 
longer term outcomes was to record all patients who had a TKR with computer navigation in 
the Registry.  The AOANJRR was the first registry in the world to record and report such data 
and, with the preceding paper, the first to demonstrate a reduced rate of revision in younger 
patients having TKR with computer navigation compared to conventional instrumentation.  
The Registry has continued to report annually on the outcomes of computer navigation for 
TKR. 
 
There continues to be an increased use of computer navigation for TKR throughout Australia.  
Initially 2.4% of all procedures in 2003 used computer navigation and this has increased to 
30.8% in 2016 (Fig 5). There are now 96,730 primary TKR procedures performed with 
navigation recorded by the Registry, an increase of 117% over the past four years.  This is due 
to a number of reasons including the use of navigation by younger surgeons who have “grown 
up” with this technology; and the widespread availability in most hospitals, as opposed to 
academic and larger centres when it was initially introduced.  The Registry has continued to 
demonstrate that patients aged less than 65 years have a lower rate of revision when computer 
navigation is used (HR=0.85 (95%CI 0.80,0.91) p<0.001). For all age groups there is now a 
reduction in the rate of revision for navigated knee replacement compared to conventional 
knee replacement for diagnosis of loosening, which is the most common overall reason for 
revision for TKR  (HR=0.73 (95%CI 0.64, 0.83) p<0.001).  The experience of the AOANJRR is in 
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contrast to other registries.  Only two registries record the use of computer navigation for TKR, 
the Norwegian Registry and the National Joint Registry of the United Kingdom.  The 
Norwegian Registry commenced data collection in 2005. In the first year of navigation 7% of all 
TKA used navigation.  By 2008 21% of TKA were performed with the use of navigation but this 
has slowly declined over time.  In 2016 only 10% of TKA were performed with navigation.  This 
is in distinct contrast to the use of navigation in Australia where there has been a steady 
increase over time as documented. The Norwegian Registry has recorded 37,126 TKA 
performed without navigation and 5,591 performed with navigation.  They have not reported 
any difference in the rate of revision with the use of navigation and this may in part explain 
why navigation has not enjoyed a more wide spread use.  In Norway the cumulative percent 
survival of TKA at ten years without navigation is 94.1% (95% CI 93.9%-94.3%) and for TKA 
with navigation the cumulative survival is 94.8% (95% CI 93.8%-95.8%).  There is a much 
smaller number of navigated TKA in Norwegian Register compared to the AOANJRR and 
there is no breakdown by the two specific age groups.  This may partly explain why there is no 
observed difference in rates of revision7.   
 
In the U.K. Registry only 2.3% of TKR have been used with navigation and outcomes are not 
reported. The USA has a low use of navigation for TKR. Using the  American College of 
                                                     
 
7 Personal communication and data from Oysten Gotheson, Norwegian Arthroplasty Registry, 29/8/2017 
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Surgeons National Surgical Quality Improvement Program database, Gholson et al (247) 
identified 108,277 patients undergoing primary TKA between 2010 and 2014, of which 3573 
cases (3.30%) were navigated. Rates of adoption of navigated TKA were determined and 
navigation utilization decreased from 4.96% in 2010 to 3.06% in 2014. There were no significant 
differences in short-term complications, readmission rate, or length of stay between navigated 
and traditional TKA but there was no information on rates of revision from this study. The lack 
of available data on comparative revision rates in the US and UK may influence the uptake of 
this technology. It also may demonstrate that surgeons, for whatever reason, may not believe 
that the Australian data are applicable to their respective countries. 
 
Continued reporting in the AOANJRR of improved outcomes for navigation, particularly in the 
younger age group has potentially contributed to the more widespread use of navigation 
within the Australian community. As proportionally more TKR are performed with navigation 
this may be a factor contributing to the reduced rate of revision overall as demonstrated by the 
15% reduction for patients under 65 yrs. 
 
The experience with recording data for computer navigation has set a precedent for the 
collection of other techniques that have been introduced into the worldwide market place that 
seek to improve outcomes of arthroplasty.  Patient specific or image derived instrumentation is 
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one such technique.  This relies on pre-operative planning with the use of either a 
Computerized Tomography (CT) or Magnetic Resonance Imaging (MRI) to record details of the 
patient’s anatomy.  These data are then used to construct accurate jigs which are then used in 
place of conventional instrumentation to perform the bony cuts required to insert a TKR or 
THR.  The cutting guides take into account anatomical deformities and bony osteophytes and 
the pre-operative planning for bone resection uses a predetermined implant size and position 
based on the images.   
 
The theoretical benefits of the technology are improved alignment of the knee for TKR, better 
positioning of the acetabular component for THR, a reduction in surgical time, a reduction in 
the numbers of conventional instruments required to insert the prosthesis and potentially a 
reduction in costs due to savings in sterilization of instruments.  The drawbacks of these 
techniques include the use of imaging not normally required for standard TKR and the cost of 
3D printing associated with the cutting blocks.  There have been reported technical errors at the 
time of use of the blocks.  Though the techniques have been widely marketed there has been 
little evidence of the benefits compared to conventional TKR or THR. (248-250)  
 
The Registry commenced data collection in 2009 on these specific 3D printed tools for use with 
TKR and coined the term ‘Image Derived Instrumentation’ (IDI) to cover the range of 
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proprietary names that orthopaedic manufacturers have used for their technology.  The 
Registry has recorded 20,931 primary TKR procedures undertaken using IDI on 2009 up till 31st 
December 2016.  In 2016 IDI was used in 10.4% of all primary TKR (135).  There is a lower rate 
of revision in the first three months when IDI is used compared to no IDI.  From three months 
to 1.5 years this is reversed and there is a higher rate of revision.  After 1.5 years there is no 
difference in the rate of revision for primary TKR performed with or without IDI.  The 
difference is age dependent and there is no difference in patents aged less than 65 years. 
However, there is an increased rate of revision for patients aged 65 years or older which is 
evident after three months.  The reason for increased rate of revision in the older population is 
not clear but may be related to poorer fixation of the custom jigs in more osteoporotic bone. As 
with the use of navigation, a longer time maybe required before the appropriate place, if any, is 
found for IDI. 
 
Industry regularly introduces technology, separate from implants, into the marketplace (251, 
252) and the success of the Registry tracking these new technologies has led to closer co-
operation with the manufacturers.  Simple modifications on the Registry data form, along with 
device specific industry labels have contributed to the ability of the Registry to monitor the 
impact of new patient technology. Robotic surgery for both hip and knee replacement is a 
prime example of how industry values the importance of the Registry. Robotic surgery for TKR 
was introduced into Australia by the manufacturing industry leader Stryker in late 2016, and 
119 
 
the author was approached by the company to facilitate the collection of data from all surgeons 
who performed robotic surgery. The Registry now collects data on the two types of robotic 
surgery performed in Australia and the implants that they are used with. The first abstract on 
the early results of robotic knee replacement surgery has been accepted at international 
meetings in 2018. 
 
Future research using these data, especially for navigation, will continue to monitor not only 
whether it is effective, but also if the use of new and more expensive technology is cost-
effective. There has been only a limited analysis of the cost-effectiveness of computer 
navigation at a population level. The study from the Norwegian Arthroplasty Registry 
suggested that the ten-year implant survival rate needed to rise from 89.8% to 90.6% for 
institutions performing twenty-five arthroplasties per year and from 89.8%to 89.9% for those 
performing 250 per year for computer navigated surgery to be considered cost-effective 
compared to the standard of care.  In Australia, for patients <65 of age, the survival rate for 
navigated TKR at ten years is 92.9% compared to 92.1% for non- navigated TKR.(135). As a 
result of this work a project with the Centre for Health Policy, Melbourne University School of 





Paper Five currently has 54 citations (refer 5.4 Citations), the majority acknowledging the study 
as the first investigation to demonstrate the clinical outcome of a reduced revision rate for 
patients undergoing TKR. 
 
Fig 5 The increased use of navigation with primary TKR over time 
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6.1 - Preface  
 
This chapter contains the third of five articles submitted for publication in peer reviewed 
journals. The article has been published in Acta Orthopaedica 2015; 86 (6):721-727.  It is one of two 
papers that address the third research question of this thesis on the introduction and impact of a 
new bearing material, cross- linked polyethylene (XLPE).  It continues the theme of Research 
Question Two on methods to improve the rate of revision for younger patients and documents 
the introduction of a new material that is used with different types of TKR from different 
manufacturers.  The following paper in Chapter Seven examines the impact of this material in 
THR. 
 
While highly crosslinked polyethylene has shown reduced in vitro and in vivo wear, there have 
been few long-term clinical studies on its use in TKR and no studies demonstrating a reduced 
rate of revision compared to conventional polyethylene. This study compared the rate of revision 
of non-crosslinked polyethylene to that of crosslinked polyethylene in patients who underwent 




The Additional Discussion updates the data, which continues to demonstrate reduced rates of 
revision for specific TKR implants, and suggests ongoing analysis and reporting of XLPE for TKR 




6.2 - Published Paper 
 
Background and purpose 
 
While highly crosslinked polyethylene has shown reduced in vivo wear and lower rates of 
revision for total hip arthroplasty, there have been few long-term studies on its use in total 
knee arthroplasty (TKA). We compared the rate of revision of non-crosslinked polyethylene 
to that of crosslinked polyethylene in patients who underwent TKA for osteoarthritis.   
 
Patients and methods 
 
We examined data from the Australian Orthopaedic Association National Joint Replacement 
Registry on 302,214 primary TKA procedures with non-crosslinked polyethylene and 83,890 
procedures with crosslinked polyethylene, all of which were performed for osteoarthritis. The 
survivorship of the different polyethylenes was estimated using the Kaplan-Meier method 




The 10-year cumulative revision rate for non-crosslinked polyethylene was 5.8% (95% CI: 5.7–
6.0) and for crosslinked polyethylene it was 3.5% (95% CI: 3.2–3.8) (> 6.5-year HR = 2.2 (1.5–
3.1); p < 0.001). There was no effect of surgical volume or method of prosthesis fixation on 
outcome. There were 4 different TKA designs that had a minimum of 2,500 procedures in at 
least 1 of the polyethylene groups and a follow-up of ≥ 5 years. 2 of these, the NexGen and the 
Natural Knee II, had a lower rate of revision for crosslinked polyethylene. The Scorpio 





There is a lower rate of revision for crosslinked polyethylene in TKA, and this appears to be 
prosthesis specific and when it occurs is most evident in patients < 65 years of age. The 






Crosslinked polyethylene has shown reduced in vivo wear rates and lower revision rates in 
clinical studies when used for conventional primary total hip arthroplasty (253-257).  
However, it is uncertain whether the same benefit occurs with total knee arthroplasty (TKA). 
Polyethylene wear is multifactorial and can be influenced by prosthesis design, technical 
issues such as alignment, and patient-related factors. The biomechanical environment differs 
in the knee, with polyethylene being subject to deformation, delamination, and potential 
crack propagation. This has led to concerns with the use of crosslinked polyethylene in TKA 
because of reduced strength and fatigue resistance. In vitro studies have shown a decrease in 
wear with increasing radiation dose from 50 to 100k Gy, but toughness decreased with the 
higher radiation dose (157, 258).  Knee simulator models of wear have shown less wear for 
crosslinked polyethylene than for standard compression-moulded polyethylene in both aged 
and unaged forms of the material. Reduced wear was also found in crosslinked polyethylene 
when subjected to diverse wear models with a scratched femoral component or an 
unbalanced knee (159, 161, 259). There have, however, only been a few reports of the clinical 
results of highly crosslinked polyethylene in TKA (260-262). While these studies have shown 
no difference in clinical or radiographic outcomes when comparing crosslinked polyethylene 
with non-crosslinked polyethylene, the longest follow-up was 7 years. Longer-term 
information is lacking. 
 
We compared the rates of revision of non-crosslinked polyethylene and crosslinked 
polyethylene for all patients who underwent TKA for osteoarthritis as reported to the 




The AOANJRR began data collection on September 1, 1999, and it includes data on over 98% 
of the arthroplasty procedures performed in Australia since 2002. Registry data are validated 
against patient-level data provided by each of the state and territory health departments in 
Australia using a sequential, multilevel matching process. A matching program is run on a 
monthly basis to search for all primary and revision arthroplasty procedures recorded in the 
registry that involve the same side and joint of the same patient, thus enabling each revision 
to be linked to the primary procedure. Data are also matched biannually with the National 
Death Index of the Department of Health and Ageing to obtain information on the date of 
death. The registry records the reasons for revision and the type of revision of TKA, and 
categorizes revision surgery as major or minor. A major revision involves revision of either 
the tibial or the femoral component, or both. Minor revisions are all other revisions usually 




Crosslinked polyethylene was defined in the registry database as ultra-high-molecular-weight 
polyethylene that has been irradiated with high-dose (≥ 50 kGy) gamma or electron beam 
radiation, regardless of remelting or annealing. The definition of polyethylene was confirmed 
with industry and crosschecked with the Australian Prosthesis Advisory List, which records 
crosslinked polyethylene separately from conventional polyethylene. Vit E crosslinked 
polyethylene has been recorded separately but included in the crosslinked polyethylene in 
this study, due to short-term follow-up and its use with 1 type of prosthesis. The study 
population was all patients with primary TKAs undergone for osteoarthritis (OA). The 
registry first recorded the use of crosslinked polyethylene in 2001. During the study period, 
there were 302,214 primary TKA procedures performed for OA reported to the registry that 
used non-crosslinked polyethylene and there were 83,890 that used crosslinked polyethylene. 
There was an increase in the use of crosslinked polyethylene, with over 40% of all primary 
TKA procedures performed in 2013 using crosslinked polyethylene (Figure 1). Outcomes 
were determined for all procedures, comparing TKA performed with non-crosslinked 
polyethylene and crosslinked polyethylene and including the effect of age, sex, and reason for 
revision. The types of revision were also analyzed.  
 
In order to account for possible confounders, we also performed a number of sub analyses. 
These included method of fixation, type of tibial bearing, the impact of surgical volume, and 
brand of prosthesis. The effect of the method of fixation (cemented, hybrid, and cementless) 
and tibial bearing surface (fixed-bearing, mobile, and rotating) with crosslinked and non-
crosslinked polyethylene in TKA was examined. Data on the number of TKAs performed 
were analyzed. Surgeons were divided into 4 groups based on the average number of 
procedures per year: ≤ 10, 11–25, 26–70, and > 70 TKAs per year.  
 
A separate analysis was performed on specific prostheses that have both crosslinked and non-
crosslinked polyethylene options. The criteria for inclusion were a minimum of 2,500 







The registry uses Kaplan-Meier estimates of survivorship to describe the time to the first 
revision of an arthroplasty, with censoring at the time of death or closure of the database at 
the time of analysis. The unadjusted cumulative percentage revision (CPR) after the primary 
arthroplasty, with an accompanying 95% confidence interval (CI), was calculated using 
unadjusted pointwise Greenwood estimates. Hazard ratios were calculated using Cox 
proportional-hazards models, adjusting for age and sex, and were used to make statistical 
comparisons of the revision rates between groups. 
 
The assumption of proportional hazards was checked analytically for each model; if the 
interaction between the predictor and the log of the postoperative time was significant in the 
standard Cox model, then a time-varying model was used. Time points were iteratively 
chosen until the assumption of proportionality was met, and the hazard ratios were 
calculated for each selected time period. All tests were 2-tailed at the 5% level of significance. 




The study was approved by the Commonwealth of Australia as a Declaration of Quality 
Assurance Activity under section 124X of the Health Insurance Act, 1973.  All investigations 





The 10-year CPR for non-crosslinked polyethylene was 5.8% (CI: 5.7–6.0) and for crosslinked 
polyethylene it was 3.5% (CI: 3.2–3.8) (HR after 6.5 years = 2.2 (1.5–3.1); p < 0.001) (Figure 2). 
The main reason for the difference in revision rate was a reduction in the rate of revision for 
the wear-related problems of loosening and lysis. The 10-year CPR for loosening/lysis for 
non-crosslinked polyethylene was 1.9% (CI: 1.9–2.0) and for crosslinked polyethylene it was 
0.9% (CI: 0.7–1.0) (HR = 1.8 (1.6–2.0); p < 0.001) (Figure 3). The reasons for revision of TKA for 
both crosslinked polyethylene non-crosslinked polyethylene are listed in Table 1. 
 
The effect of crosslinked polyethylene was more pronounced in the younger age groups. For 
patients less than 65 years of age, the 10-year CPR for non-crosslinked polyethylene was 8.8% 
(CI: 8.5–9.1) and it was 4.9% (CI 4.3–5.5) for crosslinked polyethylene (HR after 2.5 years = 
1.95 (1.7–2.3); p < 0.001) (Figure 4).   
 
The type of fixation had no effect on the outcomes when comparing non-crosslinked 
polyethylene and crosslinked polyethylene. For all cemented TKAs, cementless TKAs and 
hybrid TKAs, the rate of revision was always lower for cross-linked polyethylene. The type of 
tibial bearing was examined, but there was only 1 type of knee prosthesis that had sufficient 
numbers of fixed and mobile bearing surfaces with the 2 types of polyethylene for analysis. 
This was the NexGen Posterior Stabilized TKA, and at 5 years there was no significant 
difference in the rate of revision between the fixed-bearing knee and the rotating mobile knee 
regarding the type of polyethylene. The use of crosslinked polyethylene and non-crosslinked 
polyethylene was evenly spread over all 4 surgical volume groups. For the surgical volume 
groups 11–25, 26–70, and > 70, there was a significant reduction in the rate of revision and for 
crosslinked polyethylene (p < 0.001). There was no difference in the rate of revision in the low-
volume (≤ 10) group, although this was probably due to the smaller numbers of procedures 














4 different TKA designs fulfilled the criteria of a minimum of 2,500 procedures in at least 
1 of the polyethylene groups and a follow-up of 5 or more years. These were the Natural 
Knee II, the Triathlon, the NexGen, and the Scorpio (Table 2). 
 
The Natural Knee II only includes minimally stabilized prostheses, as the posterior-
stabilized option has seldom been used. The registry has 10-year follow-up for both types 
of polyethylene. Crosslinked polyethylene was used in 54% of the procedures, and had a 
lower rate of revision after 3.5 years. The 10-year CPR for non-crosslinked polyethylene 
was 7.4% (CI: 6.3–8.5) as compared to 3.8% (CI: 3.0–4.7) for crosslinked (HR after 3.5 
years = 3.2 (2.1–5.0); p < 0.001). This difference was evident regardless of age; however, 
the difference was greater for those who were less than 65 years old.  
 
The Triathlon knee had a minimum 5-year follow-up for both types of polyethylene, and 
crosslinked polyethylene was used in 72% of the procedures. There was no difference in 
the rates of revision for both minimally and posterior-stabilized Triathlon prostheses 
when comparing non-crosslinked and crosslinked polyethylene (HR = 1.0 (0.9–1.2); p = 
0.9; and HR = 1.3 (0.95–1.7); p = 0.1).  
 
The NexGen knee had 10-year follow-up for both crosslinked and non-crosslinked 
polyethylene for the minimally stabilized prosthesis, and 7-year follow-up for the 
posterior stabilized prosthesis. Crosslinked polyethylene was used in 76% of minimally 
stabilized NexGen CR and CR Flex knees, and had a lower rate of revision after 2.5 years. 
This difference, however, was only evident in those aged less than 65 years. The 10-year 
CPR for patients aged < 65 with non-crosslinked polyethylene was 5.8% (4.6–7.1), as 
compared to 4.3% (3.6–5.1) for crosslinked polyethylene (HR after 1 year = 1.6 (1.2–2.1); p 
= 0.001) (Figure 5). Crosslinked polyethylene was used in 30% of posterior-stabilized 
NexGen LPS and LPS Flex knees. The rates of revision were similar when comparing 
non-crosslinked and crosslinked polyethylene in the posterior-stabilized group.  
 
The Scorpio NRG/Series 7000 knee had 5-year follow-up for non-crosslinked and 
crosslinked polyethylene, and the latter was used in 86% of procedures. There was no 
difference in the rates of revision with minimally and posterior-stabilized Scorpio 
NRG/Series 7000 prostheses when comparing non-crosslinked and crosslinked 











This is the first study to demonstrate a reduced rate of revision for crosslinked 
polyethylene in TKA in a population-based registry. When a new device or material has 
been introduced, post-market surveillance is important and registries are ideally suited to 
determine outcomes—and especially to show whether there are any early problems 
associated with new prostheses. Concerns regarding the mechanical properties of 
crosslinked polyethylene in TKA have not been identified in the results reported from the 
registry. Polyethylene fracture as a reason for revision has only been recorded in 2 cases, 
suggesting that concerns regarding crosslinked polyethylene toughness are presently 
unfounded. 
 
While there is a lower rate of revision for crosslinked polyethylene than for non-
crosslinked polyethylene, this reduction is not evident for all prostheses. While 
crosslinked polyethylene is used frequently in hip arthroplasty, the uptake of crosslinked 
polyethylene for TKA has not been as great, although it accounts for 43% of all tibial 
polyethylene in 2013. At 10 years, there was a reduction in loosening/lysis as a reason for 
revision in the crosslinked polyethylene TKA group.   
 
While TKA has a low rate of revision, there is considerable variation with age—with 
patients younger than 65 having a higher rate of revision (257)). It therefore becomes 
important to examine factors that may reduce this higher rate of revision. This study has 
demonstrated that while there is an overall reduction in the rate of revision for all ages 
when crosslinked polyethylene is used, this is more apparent in the younger age group (< 
65). This may become more pronounced as revision for wear-related issues, such as 
loosening and lysis, increases over time. 
 
In primary TKA, crosslinked polyethylene was used less frequently than non-crosslinked 
polyethylene and there was considerable prostheses difference in its use. While the 
registry has shown a lower rate of revision overall for crosslinked polyethylene, the 
analysis of crosslinked polyethylene may be confounded by well-performing prostheses 
with a higher use of crosslinked polyethylene. Consequently, any observed difference in 
revision rate may be confounded by prosthesis type. This study has demonstrated 
prosthesis variation in the effect that crosslinked polyethylene has on the rate of revision 
following TKA. A lower rate of revision was identified when crosslinked polyethylene 
was used in conjunction with the 2 minimally stabilized TKAs with 10-year follow-up 
(the Natural Knee II and NexGen) in comparison to the use of non-crosslinked 
polyethylene. This difference was most evident in younger patients. No significant 
difference in revision rate was identified for either the minimally stabilized or posterior 





One possible explanation for the variation in CPR differential between non-crosslinked 
and crosslinked polyethylene with different designs may be related to the type of 
crosslinked polyethylene used. The crosslinked polyethylene used in Natural Knee II is 
manufactured by electron beam irradiation of the polyethylene at an elevated 
temperature, to 95 kGy, followed by melting. In NexGen knees, the crosslinked 
polyethylene is made by electron beam irradiation at elevated temperature, to 65 kGy, 
followed by melting. In Triathlon and Scorpio knees, the crosslinked polyethylene is 
made by irradiating the polyethylene to 33 kGy in 3 consecutive steps, with annealing 
(heating to below the melting point) after each irradiation cycle. All 3 types of crosslinked 
polyethylene knees are packaged in air-permeable pouches and are gas sterilized. Thus, 
during shelf storage they are exposed to air until implantation. Radiation generates 
trapped free radicals, which are known to cause oxidation; thus, either melting or 
annealing is used after irradiation to eliminate or reduce the trapped free radicals. 
Independent reports have shown that the annealing results in detectable trapping of free 
radicals, increasing the potential for oxidation during shelf storage and use in vivo. There 
have also been reports showing increased rates of failure due to damage to the 
polyethylene component, mainly caused by oxidation. It is therefore possible that 
radiation-crosslinked and annealed polyethylene components may not necessarily 
perform as well as radiation-crosslinked and melted polyethylene components in 
patients, in comparison to their non-crosslinked polyethylene counterparts, as found in 
the current study. 
 
The first clinical study of crosslinked polyethylene was published by Hodrick et al. 
(2008), and they reported a consecutive series of 200 Natural Knee II systems (Zimmer), 
comparing the first 100 cases to receive crosslinked polyethylene with the previous 100 
cases using non-crosslinked polyethylene. The crosslinked polyethylene group had an 
average age of 67, and was followed for a minimum of 69 months, as compared to an 
average age of 70 and a minimum follow-up of 82 months for the non-crosslinked group. 
In the crosslinked polyethylene group, there were no revisions for tibial wear but 2 
patients had evidence of radiolucencies. In the non-crosslinked group, there were 20 
patients who showed radiolucencies and 3 patients had revisions for tibial loosening and 
wear. The authors commented on some limitations of their study, which included 35 
patients who had been lost to follow-up and lack of retrieval analysis. Our study reports 
on over 3,000 Natural Knee II TKA using crosslinked polyethylene with a 10-year CPR of 
3.8%. 
 
2 other clinical studies have reported on the outcomes of crosslinked polyethylene using 
the NexGen TKA (Zimmer) with Prolong crosslinked polyethylene, which is electron 




et al. (2009) reported on a consecutive series of 113 CR TKAs with non-crosslinked 
polyethylene, and compared them to 89 CR TKAs using Prolong. At 2 years of follow-up, 
the clinical outcome was similar between the 2 groups—with no revisions and no 
evidence of osteolysis or polyethylene failure. Long et al. (2012) reported on a 
consecutive series of 120 TKAs using the NexGen high flex posterior-stabilized knee. 
There were 97 patients who had a full clinical and radiographic evaluation at an average 
of 52 months. There were no cases of radiographic loosening or progressive radiolucent 
lines. Our study involved 35,557 NexGen TKAs with crosslinked polyethylene, and at 10 
years the CPR was 2.8% for the NexGen CR TKA with crosslinked polyethylene. With a 
shorter follow-up of 7 years, we found no difference in the rates of revision of the 
NexGen PS knee for the 2 types of polyethylene.  
 
This study has a number of strengths, including the large number of procedures, the use 
of population-based data, and the longer-term follow-up. Over 83,000 TKAs performed 
for osteoarthritis with the use of crosslinked polyethylene have been analyzed, making 
this the largest study to report on the outcomes of crosslinked polyethylene use in TKA. 
Crosslinked polyethylene is more expensive than conventional polyethylene, so it is 
important to demonstrate some benefit. The reduction in the rate of revision was seen in 
both low volume and high-volume surgeons, and is therefore probably due to the 
crosslinked polyethylene and less likely to be due to surgeon-related factors. 
 
A potential weakness of this study is that when crosslinked polyethylene was 
introduced, for each implant studied the tibial trays were new. This may have led to bias, 
as no crosslinked polyethylene tibial trays may have been kept for a longer time period, 
leading to an extended shelf life before implantation. This could lead to a higher rate of 
revision. We therefore examined the rate of revision of non-crosslinked polyethylene 
before and after the introduction of crosslinked polyethylene for the NexGen and 
Triathlon TKA systems. There was no difference in the rates of revision for non-
crosslinked polyethylene before and after the introduction of crosslinked polyethylene 




A lower rate of revision has been shown for crosslinked polyethylene in TKA, and this 
appears to be prosthesis-specific and confined to minimally stabilized options. When it 
occurs, the lower rate of revision is most evident in patients who are less than 65 years of 
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6.3 - Additional Discussion 
 
The Registry first reported on the effect of XLPE for TKR in 2012.  The overall lower rate of 
revision for XLPE for TKR compared to conventional non XPLE continues to be 
demonstrated by the AOANJRR.  The 2017 Annual Report has information on 163,042 
TKRs with XLPE and the cumulative percent revision at ten years is 5.7% for non XLPE 
compared to 3.7% for XLPE. The major reason for the difference is the reduced revisions 
for loosening and bone lysis, which occurs as a consequence of wear. As has been 
previously outlined in the Literature Review there is a higher rate of revision in younger 
patients and the effect of XLPE is more evident in younger patients. The cumulative 
percent revision at ten years for patients < 65 years of age with a TKR and non XLPE is 
8.4% compared to 5.2% for XLPE, (Hazard Ratio from 6.5 years onwards=2.3, p< 0.001). 
There has been an increased use of XLPE since the original paper and, in 2016 for the first 
time, XLPE was used more frequently (57% of all cases) than non XLPE.  
Not all types of XLPE are performing better than conventional non XLPE and this may be 
due to different manufacturing processes.  Since publication of this chapter there have 
been two further registry based studies which have shown no differences in the overall 
revision rates between XLPE and non XLPE for TKR (263, 264). Possible reasons for the 




variation in prosthesis selection and much smaller numbers available for analysis. 
Importantly these studies confirmed the safety profile of XLPE with no observed failures 
from XLPE component breakage.  
 
The ongoing reporting of a lower overall rate of revision with XLPE in TKR in the 
AOANJRR Annual Report has contributed to the ongoing use of this material by 
Australian surgeons and there is a greater proportion of patients <65 years of age who 
have XLPE with a TKR.  The UK National Joint Registry does not distinguish between the 
types of polyethylene and cannot report on comparative performance. The Swedish Knee 
Arthroplasty Registry and New Zealand Registry do not report on XLPE and other 
registries such as the Norwegian, Dutch, and Finnish only have small numbers of TKRs 
with XLPE.  Continued analysis and reporting of XLPE for TKR by the Registry may 
identify which types of XLPE are performing better and pooling of data with other 
registries will be beneficial. 
 
As a consequence of Paper 6 an international project has been developed to examine data 
from 5 registries that identify XLPE to assess the effect of XLPE in specific TKR groups. 
This will be presented at the Annual Meeting of the International Society of Arthroplasty 
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7.1 - Preface  
 
This chapter contains the fourth of five articles submitted for publication in peer reviewed 
journals. The article has been published by The Journal of Bone and Joint Surgery 2018 Volume 
100-A, (15),1281-1288. It is the second paper to address the third research question of this 
thesis on the introduction and impact of a new bearing material, cross- linked polyethylene 
(XLPE) and was selected as the highlight article of the month. 
 
The long term success of THR is limited by wear of the polyethylene bearing surface. Cross-
linking conventional polyethylene has demonstrated lower wear rates and a reduction in 
bone lysis in both laboratory and clinical studies. The aim of this study was to compare the 
rate of revision at 16 years in patients who had a THR for osteoarthritis, and received either 
cross-linked (XLPE) or conventional non crosslinked polyethylene (CPE). As discussed 
previously, Chapters Five and Six have outlined methods of reducing the rate of revision in 
younger patients with TKR. While the age related revision rates are not as apparent with 
THR the greatest reduction in revision with XLPE compared to CPE is in patients younger 









Total hip arthroplasty (THA) is an effective operation for the management of end-stage hip 
osteoarthritis, but long-term success can be limited by wear of the polyethylene bearing 
surface. Cross-linking conventional polyethylene has resulted in lower wear rates and a 
reduction in bone lysis in both laboratory and clinical studies. The aim of this study was to 
compare the rates of revision between cross-linked polyethylene (XLPE) and conventional 





We performed an observational study of data, from a national registry, on all patients who 
underwent THA for osteoarthritis in Australia from 1999 through December 31, 2016. The 
outcomes of THAs performed with CPE were compared with those of THAs performed 
with XLPE, along with an analysis of the effect of age, sex, femoral head size, the method 
of acetabular and femoral component fixation, and the reason for revision. The principal 
outcome measure was the time to the first revision, determined using Kaplan-Meier 




CPE was used in 41,171 procedures, and XLPE was used in 199,131. The mean ages of the 
men and women treated with CPE were 70.0 years (standard deviation [SD] = 9.9 years) 
and 72.5 years (SD = 9.7 years), respectively, whereas the men and women who received 
XLPE were slightly younger (mean age, 68.6 years [SD = 10.3 years] and 70.7 years [SD = 
9.9 years], respectively. XLPE was associated with a lower rate of revision than CPE at 6 
months, and this difference became more apparent with time. The 16-year cumulative 
percentage of revisions of the primary THAs was 11.7% (95% confidence [CI] = 11.1% to 
12.3%]) in the CPE group and 6.2% (95% CI = 5.7% to 6.7%) in the XLPE group. The hazard 




The use of XLPE has resulted in a significant reduction in the rate of revision at 16 years 




likely to be improved, which may enable younger patients to undergo surgery, confident 
of a reduced need for revision in the long term. 
 
Level of Evidence: 
 








Total hip arthroplasty (THA) is one of the most effective surgical procedures and very 
successful for the management of end-stage hip osteoarthritis. The number of THA 
procedures has been increasing, and this is expected to continue (16, 19, 265-267). The most 
common bearing surface for THA has been conventional non-cross-linked ultra-high 
molecular weight polyethylene (CPE), which has been in use for >50 years. However, the 
biggest problem limiting the life span of THA has been long-term wear, leading to 
osteolysis and aseptic loosening (268). As limiting wear of the bearing surface is critical to 
long-term success, particularly for younger patients, research has led to the development 
of polyethylene with improved wear characteristics. Methods for manufacturing cross-
linked polyethylene (XLPE) differ, but all include radiation doses of 50 to 100 kGy with 
different radiation techniques and thermal treatments. Initial laboratory hip simulator 
trials showed less wear of XLPE compared with CPE (154, 269, 270). A phased clinical 
introduction of this material then commenced with randomized controlled trials (RCTs) 
using radiostereometric analysis, the early results of which demonstrated reduced wear 
with XLPE (271, 272). 
 
Clinical studies of XLPE from different manufacturers have all shown reduced wear 
compared with CPE, confirming the initial laboratory findings (273-276). Examination of 
liners retrieved during surgery for reasons other than wear-related issues has also 
demonstrated reduced wear in vivo (277, 278). A meta-analysis of RCTs comparing XLPE 
with CPE for THA showed a reduction in volumetric and total linear wear of XLPE liners 
along with a reduction in radiographic evidence of osteolysis (279). However, the follow-
up was not long enough to show a difference in the rates of revision surgery, which 
ultimately is most important for the patient. 
 
The aim of this study was to use data from a national joint replacement registry to 
compare the rate of revision at 16 years after THA for osteoarthritis between patients who 
had received XLPE and those treated with CPE. 
 
Materials and Methods 
 
The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) 
began data collection on September 1, 1999, and participation is voluntary. The Registry 
includes data on almost all of the arthroplasty procedures performed in Australia since 
2002, and data are validated against patient-level data provided by each of the state and 
territory health departments in Australia with use of a sequential, multilevel matching 
process. Data are also matched biannually with the Department of Health and Ageing 





XLPE was defined in the Registry database as ultra-high molecular weight polyethylene 
that had been irradiated with high-dose (≥50-kGy) gamma or electron beam radiation, 
regardless of remelting or annealing. This definition was confirmed with industry sources 
and cross-checked with the Australian Prosthesis Advisory List, which records XLPE 
separately from CPE. The Registry first recorded the use of XLPE in 2000. The study 
population consisted of primary THAs undertaken for osteoarthritis and performed with 
either CPE or XLPE. All other bearing surfaces were excluded. 
 
Outcomes were compared between THAs performed with CPE and those done with XLPE, 
and the effect of age, sex, femoral head size, the method of acetabular and femoral 
component fixation and reasons and types of revision were also analyzed. 
 
In order to account for possible confounders in this observational data, we also performed 
a number of subanalyses. These included the type of femoral head material, femoral head 
size, and methods of acetabular and femoral component fixation. We also performed an 
analysis of specific prostheses in order to account for known prosthesis-related outcome 
variation. This analysis was performed on prostheses that had both CPE and XLPE 
options, had been used in a minimum of 800 procedures in both polyethylene groups, and 
had been followed for 8 years. 
 
As polyethylene wear is more likely to have an effect in the longer term in younger 
patients, we performed a separate analysis on patients who underwent THA for 




The Registry uses Kaplan-Meier estimates of survivorship to describe the time to the first 
revision of an arthroplasty, with censoring at the time of death or closure of the database at 
the time of analysis (December 31, 2016). The analytical approach involves high-level 
statistical methodologies to investigate associations to limit the impact of bias. A full 




The Registry recorded the use of CPE for 41,171 procedures and XLPE for 199,131. These 
procedures accounted for 74% of all THAs performed for osteoarthritis. There were 23,813 
women (57.8%) in the CPE group and 110,162 (55.3%) in the XLPE group. The mean age in 
the CPE group was 70.0 years (standard deviation [SD] = 9.9 years) for men and 72.5 years 




mean age of 68.6 years (SD = 10.3 years) for men and 70.7 years (SD = 9.9 years) for women. 
The median follow-up was 9.2 years after the THAs with CPE compared with 4.2 years 
after those with XLPE. The use of XLPE increased over the study period: from 9.2% of all 
primary THAs with polyethylene in 2000 to 97.1% in 2016 (Fig. 1). The use of XLPE was 
also associated with the use of larger femoral heads, with a head size of 32 mm used in 
12% of all THAs done with CPE compared with 75.9% of those done with XLPE. 
 
The rate of revision at 6 months was lower for the patients treated with XLPE than for 
those who received CPE. This difference became more apparent with time, with the 16-
year cumulative percent of revision being 11.7% (95% confidence interval [CI] = 11.1% to 
12.3%) in the CPE group compared with 6.2% (95% CI = 5.7% to 6.7%) in the XLPE group. 
The hazard ratio [HR] at 9 years was 3.02 (p = 0.001) (Fig. 2). The main reason for the 
difference in the revision rate was a reduction in the rate of revisions due to loosening, 
lysis, and dislocation (Fig. 3). The most common reasons for revision of THA in both the 
CPE and the XLPE group are listed in Table I. A revision that could be directly attributable 
to polyethylene wear-related issues (wear of the acetabular insert or lysis) was recorded 
after 332 (0.81%) of the 41,171 THAs with CPE compared with only 102 (0.05%) of the 
199,131 procedures with XLPE. 
 
The CPE and XLPE were combined with 3 different femoral head bearing surfaces—
ceramic, metal, and ceramicized metal—and XLPE was associated with a lower rate of 
revision compared with CPE in all 3 of these subgroups. XLPE was also associated with a 
lower revision rate in the subgroups defined according to the 3 common head sizes (<32, 
32, and >32 mm; Table II) and 3 types of THA fixation (cemented, cementless, and hybrid 
[femur cemented]). 
 
Six brands of acetabular prosthesis were available with both XLPE and CPE bearing 
options, were used in 800 procedures each, and were followed for 8 years. Five were 
associated with a reduced rate of revision at various time points when XLPE had been 
used, whereas the rate of revision of 1 prosthesis (Vitalock; Stryker) during the entire 
follow-up period did not differ significantly according to type of polyethylene used 
(Tables III and IV). Table V lists revision rates for the 10 most commonly used cementless 
prostheses with XLPE with a minimum 7-year follow-up (maximum, 15 years for 2 
models). 
 
According to the Registry, 17,689 primary THAs using either CPE or XLPE had been 
performed for osteoarthritis in younger patients (<55 years of age), and the 15-year 
cumulative percent of revisions in this group was 17.4% (95% CI = 15.5% to 19.5%) for 




7 years, there was a 5-fold increase in the rate of revisions of procedures done with CPE 




To our knowledge, this study of the outcomes of the use of XLPE in THA for patients with 
osteoarthritis represents the longest follow-up of the largest number of procedures 
reported. The use of XLPE makes THA—already one of the most effective operations—
even better. The data confirm the early promise shown by XLPE in RCTs, that is, when 
compared with CPE, an XLPE bearing surface in THA results in a mid-term to longer-term 
reduction in all-cause revision. This is due to a reduced rate of revision due to loosening, 
lysis, and dislocation. The difference is seen both early (due to a reduced rate of revision 
for dislocation) and in the longer term (as a consequence of the reduction in wear-related 
problems). 
 
A major strength of this study is the evaluation of the experience with XLPE in an entire 
national population and therefore has high external validity. Unlike the introduction of 
large-head metal-on-metal bearings, there was a phased introduction of XLPE, with initial 
laboratory testing followed by RCTs and then wider clinical use. This study completes the 
loop of introduction of new technology by reporting the use of XLPE recorded in a 
national registry with long-term follow-up. As a result, patients, surgeons, hospitals, and 
other health-care stakeholders can be confident that the use of XLPE will reduce the rate of 
revision surgery following THA. 
 
Although our data demonstrated a significant reduction in revision overall with the use of 
XLPE, a study using pooled data from 6 registries, including the AOANJRR, did not 
demonstrate a reduced risk of revision (172). That study was limited to cementless fixation 
with a standard 32-mm head in patients 45 to 64 years of age who had a shorter follow-up 
than the patients in our study. The inclusion criteria used in the previous study (172) may 
explain the difference between its results and the data in our study, which included all 
patients in a national registry. The hazard ratio in the adjusted model in the previous 
study was in the same direction as ours, in favor of XLPE, but it did not reach significance. 
The rate of revision of THAs with XLPE in our study (4.4%) was higher than that in a 
recently published RCT by Devane et al. (280) (1.9%) during an equivalent time period (10 
years). However, in the RCT, the THAs were performed by experienced hip surgeons who 
used strict inclusion criteria, whereas our data involved all surgeons in Australia rather 
than just experienced hip surgeons. We therefore believe that our study has strong external 





We were able to adjust for sex, age, method of fixation, and femoral head size, all of which 
have been demonstrated to affect rates of revision of THA. The Registry data showed that 
XLPE was associated with a lower rate of revision overall, but the observed difference 
could have been confounded by prosthesis type, with XLPE being used more often in well-
performing prostheses. To account for known differences in prosthesis-specific revision 
rates, we performed a separate analysis of 6 prostheses that were available with both CPE 
and XLPE options for the same acetabular implant, and this analysis demonstrated lower 
rates of revision in association with XLPE in 5 of these models. As for the 6th model, the 
process for manufacturing the XLPE differs from that used by other companies, and this 
may account for the lack of observable difference between the XLPE and CPE. This has 
been previously noted with regard to the XLPE used by this manufacturer for total knee 
arthroplasty (281). 
 
The Nordic Arthroplasty Register Association (NARA) reported on design-specific 
differences between XLPE and CPE in THA (170). With regard to cemented designs, XLPE 
versions of the ZCA (Zimmer) and Reflection (Smith & Nephew) all-polyethylene cups 
were found to have better survival than the CPE versions. This correlated with our 
analysis of the Reflection cup, but there were not enough XLPE ZCA cups for us to 
compare them with the CPE ZCA cups. With regard to all-cementless cup designs, the 
XLPE shells in the NARA study had better overall survival (with all-cause revisions as the 
end point) than the CPE shells. Only 1 cementless cup, Trilogy (Zimmer), fulfilled the 
inclusion criteria for both types of polyethylene in the NARA study, and the revision rates 
did not differ between the XLPE and CPE versions of that cup. We could not analyze the 
Trilogy cup because there were not enough of them in the CPE group. The NARA 
database confirmed design-specific differences in polyethylene and suggested that their 
results should be confirmed in larger studies with longer follow-up. 
 
There was a reduction in the rate of revision for THA with XLPE after 6 months. This early 
benefit is not directly due to the better wear-related characteristics of XLPE, but it is an 
indirect consequence of them. The reason for this is that the use of larger femoral heads 
reduces the risk of revision due to dislocation, which is one of the most common reasons 
for early revision (282). While the use of a larger femoral head with a CPE cup is known to 
increase the risk of long-term wear, this risk is not evident with XLPE. Thus, the 
introduction of XLPE enabled surgeons to selectively use larger femoral heads, thereby 
reducing revision for dislocation while avoiding the long-term wear problems associated 
with CPE. 
 
The most common reason for long-term failure of THA requiring revision is loosening and 
osteolysis, and periprosthetic osteolysis is largely due to an inflammatory process caused 




osteolysis is not a problem with XLPE (285), there remains some concern about wear-
related issues in the longer term, especially with the use of larger femoral heads. However, 
there have been few reports of osteolysis with the use of XLPE (286-288). A systematic 
review demonstrated an 87% lower risk of osteolysis with XPLE than with CPE (160). In 
our study, only 80 THAs (0.01%) with XLPE were revised because of lysis and 22 (0.004%) 
were revised because of wear of the acetabular insert, suggesting that these are not 
common medium to longer-term clinical problems with XLPE. There was also no evidence 
of increased mechanical failure with XLPE liners, with only 9 revisions for breakage of the 
acetabular insert. 
 
Wear-related and implant-longevity issues are particularly important in younger patients, 
who are generally more active and have a longer expected life span than their older 
counterparts. There are now some longer-term reports of the clinical results of THA with 
XLPE in younger patients (289-291), and these studies demonstrated no revisions for 
polyethylene wear or osteolysis. In light of these findings and our own analysis of 15,502 
THAs with XLPE in younger patients, we believe that the evidence of reduced long-term 
wear with XLPE is now so strong that, when a polyethylene bearing surface is used in 
THA, it should be XLPE, particularly in younger patients. 
 
There are some limitations with this analysis of Registry data. The utilization of XLPE and 
CPE has changed over time. There is the potential for surgeon indication bias, but we 
believe that this would favor XLPE in younger patients. When the analysis was adjusted 
for age, particularly <55 years, the effect of XLPE was more marked. We do not believe that 
trends in surgical techniques, perioperative care, or rehabilitation protocols were 
significant confounding variables in either group. We also do not believe that newer 
implant design changes over this time period would have favored either group (20). 
 
While we adjusted for known risk factors that may have influenced the rate of wear-
related revision of THA, there may be other such factors. We did not have information on 
body mass index (BMI) from the commencement of data collection, although the Registry 
now collects those data. However, there is no evidence that BMI would have a more or less 
detrimental effect on the outcome of THA with XLPE or CPE. We also did not have 
information on activity levels, which have been shown to influence polyethylene wear 
rates (292). Age is often regarded as a surrogate for activity, and we demonstrated the 
most reduction in revision rates in patients who were <55 years old. Evidence from this 
study shows that the XLPE is better than CPE in younger patients and those most likely to 
return to more active pursuits. 
 
The use of XLPE has improved the outcomes of THA at 16 years with no observed 




revisions due to dislocation (because XLPE allows the increased use of larger femoral 
heads) and to wear-related issues. The evidence from our study suggests that longevity of 
THA is likely to be improved beyond 16 years and may enable younger patients to 




Details of the statistical analysis are available with the online version of this article as a 
data supplement at jbjs.org (http://links.lww.com/XXXXXXX). 
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The percentages of primary THAs for osteoarthritis (primary diagnosis) done with the different 









Cumulative percentages of revisions of primary THAs for osteoarthritis (primary diagnosis) by 
polyethylene type, adjusted for age, sex, fixation, and femoral head size. The HR for non-XLPE 
versus XLPE was 0.84 (95% CI = 0.74, 0.94; p = 0.004) at 0 to 3 months, 1.14 (95% CI = 0.96, 1.35; p = 
0.13) at 3 to 9 months, 1.47 (95% CI = 1.32, 1.65; p < 0.0001) at 9 months to 3 years, 1.65 (95% CI = 
1.43, 1.90; p < 0.0001) at 3 to 5 years, 2.04 (95% CI = 1.82, 2.28; p < 0.0001) at 5 to 9 years, and 3.10 








Cumulative percentages of revisions, for different reasons, of primary THAs for osteoarthritis 






Cumulative percentages of revisions of primary THAs for osteoarthritis (primary diagnosis) by 







TABLE I Reasons for Revisions of Primary THAs for Osteoarthritis (Primary Diagnosis) by 
Polyethylene Type 
 Revisions 
 CPE XLPE 




= 41,171)  




THAs (N = 
199,131) 
% of All 
Revisions 
Prosthesis dislocation 601 1.46 21.66 1,404 0.71 24.63 
Infection 360 0.87 12.97 1,275 0.64 22.36 
Fracture 387 0.94 13.95 1,248 0.63 21.89 
Loosening 936 2.27 33.73 1,129 0.57 19.80 
Lysis/wear 332 0.81 11.96 102 0.05 1.79 
Limb length 
discrepancy 
13 0.03 0.47 86 0.04 1.51 
Pain 26 0.06 0.94 86 0.04 1.51 
Other 120 0.29 4.32 371 0.19 6.51 





TABLE II Cumulative Percentages of Revisions of Primary THAs for Osteoarthritis 
(Primary Diagnosis) by Polyethylene Type and Femoral Head Size 





THAs 1 Yr 5 Yr 8 Yr 14 Yr 16 Yr 
CPE       11.7 (11.1, 
12.3) 




32 mm 213 4,642 1.6 (1.3, 2.0) 3.8 (3.2, 4.4) 5.5 (4.7, 6.3) 9.8 (7.6, 
12.8) 
 





XLPE       6.2 (5.7, 6.7) 
<32 mm 1,817 48,001 1.5 (1.4, 1.7) 3.0 (2.8, 3.2) 3.8 (3.7, 4.0) 5.7 (5.4, 6.1) 6.2 (5.7, 6.8) 
32 mm 2,089 84,157 1.5 (1.4, 1.6) 2.7 (2.6, 2.8) 3.5 (3.3, 3.7) 4.6 (4.2, 5.1)  
>32 mm 1,795 66,973 1.7 (1.6, 1.8) 3.1 (3.0, 3.3) 4.0 (3.8, 4.2) 8.5 (6.0, 
11.9) 
 





TABLE III Cumulative Percentages of Revisions of Primary THAs for Osteoarthritis (Primary Diagnosis) by Prosthesis 
and Polyethylene Type 






THAs 5 Yr 8 Yr 12 Yr 13 Yr 14 Yr 15 Yr 
Allofit         
CPE 61 848 3.3 (2.3, 4.7) 5.1 (3.8, 6.9) 8.0 (6.2, 
10.4) 




XLPE 239 7,845 2.5 (2.2, 2.9) 3.7 (3.2, 4.2) 5.0 (4.2, 5.9) 5.7 (4.7, 7.0) 7.2 (5.1, 
10.2) 
 
Duraloc         








XLPE 79 1,716 3.0 (2.2, 3.9) 4.3 (3.4, 5.5) 5.5 (4.3, 6.9) 6.5 (5.0, 8.5) 7.1 (5.3, 9.6)  
Mallory-
Head 
        
CPE 246 4,084 2.7 (2.3, 3.3) 4.0 (3.4, 4.6) 6.2 (5.5, 7.2) 7.1 (6.2, 8.1) 8.2 (7.1, 9.4) 9.5 (8.2, 11.0) 
XLPE 61 2,946 2.3 (1.8, 3.0) 2.4 (1.9, 3.2)     
Reflection 
(cup) 
        








XLPE 27 1,165 2.3 (1.5, 3.4) 2.4 (1.6, 3.6) 2.7 (1.8, 4.2)    
Reflection 
(shell) 
        








XLPE 331 1,919 2.0 (1.8, 2.3) 2.7 (2.4, 3.1) 3.6 (3.2, 4.1) 3.8 (3.3, 4.3) 4.5 (3.7, 5.5) 6.3 (4.0, 9.8) 
Vitalock         
CPE 209 3,569 2.6 (2.1, 3.1) 3.6 (3.0, 4.2) 5.5 (4.8, 6.4) 6.0 (5.2, 6.9) 6.9 (6.0, 7.9) 7.5 (6.5, 8.6) 
XLPE 41 1,050 2.4 (1.6, 3.5) 3.3 (2.3, 4.6) 4.7 (3.5, 6.5) 4.7 (3.5, 6.5)   




TABLE IV Hazard Ratios for Revisions of Primary THAs for Osteoarthritis (Primary 
Diagnosis) by Polyethylene Type (XLPE Vs. CPE) and Acetabular Component 
Acetabular 
Component HR (95%  CI) P Value 
Allofit: 
entire period 
0.68 (0.51, 0.68) 0.012 
Duraloc   
0-5 yr 0.75 (0.54, 1.04) 0.089 
5-9 yr 0.49 (0.31, 0.79) 0.003 
9-9.5 yr 0.18 (0.02, 1.35) 0.096 




0-1 mo 1.22 (0.69, 2.17) 0.497 
1-3 mo 0.61 (0.25, 1.49) 0.280 
3 mo-1.5 yr 1.15 (0.64, 2.04) 0.640 




0-1 yr 1.92 (0.72, 5.26) 0.187 




0-1 yr 0.71 (0.50, 1.02) 0.065 
1-5 yr 0.31 (0.22, 0.43) <0.001 
5-10 yr 0.23 (0.17, 0.30) <0.001 
>10 yr 0.15 (0.09, 0.25) <0.001 
Vitalock: 
entire period 





TABLE V Cumulative Percentages of Revisions of the 10 Most Commonly Used Cementless 
THAs with XLPE 
 No. Cumulative % (95% CI) 
Model 
Revisio
ns Total 7 Yr 9 Yr 10 Yr 13 Yr 14 Yr 15 Yr 
Accolade 
I/Trident (shell) 
280 5,773 4.7 (4.2, 5.4) 5.7 (5.0, 6.4) 6.3 (5.5, 7.2) 7.3 (6.2, 8.5)   
Alloclassic/Allofit 104 3,211 3.2 (2.6, 3.9) 4.1 (3.4, 5.1) 4.1 (3.4, 5.1) 5.3 (3.9, 7.2)   
Anthology/R3 75 3,888 2.3 (1.8, 3.0)      
Corail/Pinnacle 695 24,589 4.0 (3.7, 4.4) 5.1 (4.5, 5.7) 5.4 (4.7, 6.2) 5.6 (4.9, 6.5)   
Polarstem/R3 103 4,381 3.1 (2.5, 3.8)      
Quadra-
H/Versafitcup CC 
104 3,341 4.1 (3.2, 5.1)      
Secur-Fit/Trident 
(shell) 
210 5,628 4.4 (3.8, 5.0) 4.7 (4.0, 5.5) 4.8 (4.1, 5.6) 6.0 (4.8, 7.5) 6.0 (4.8, 7.5) 6.0 (4.8, 7.5) 
Synergy/R3 61 2,713 2.6 (2.0, 3.4)      
Synergy/Reflectio
n (shell) 
148 4,827 2.7 (2.2, 3.2) 3.0 (2.6, 3.6) 3.1 (2.7, 3.7) 3.9 (3.2, 4.7) 3.9 (3.2, 4.7)  
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8.1 - Preface 
 
This chapter contains the fifth and last article submitted for publication in peer reviewed 
journals. The article was first submitted in January 2018 and resubmitted after response to 
reviews in April to Bone and Joint Research Journal.  The first published paper in this thesis, 
‘How are prostheses that are not performing as well as others in their class identified, and 
what are the consequences of this?’ resulted in widespread discussions within the 
international registry community. The paper in Chapter Eight follows on from the first 
research question and describes an overview of how international registries identify 
outliers and suggests solutions to improve post market surveillance of prostheses. At least 
four other large registries have now adopted the method outlined by the AOANJRR 










Total hip and knee replacement are effective operations for the management of end stage 
arthritis. There are increasing numbers of these operations being performed and the rate of 
increase is anticipated to continue into the future (13, 265, 267). There is also a substantial 
rise in the lifetime risk of a person receiving a total hip or knee replacement and this has 
been shown in several countries (18, 19, 293, 294). There are a large number of joint 
replacement prostheses on the market available for use and not all perform the same. Many 
have no published outcomes. Joint replacement registries provide an appropriate way to 
monitor the outcomes of these procedures and can provide comparative data on the rates of 
revision for specific prostheses.  There are many factors that affect revision rates. Non 
device related issues may include patient factors, surgical technique, surgeon experience 
and volume of cases. Device related factors may contribute to the variation in rates of 
revision with individual prostheses. 
 
Prosthesis outcomes have received closer attention following the high rate of revision and 
subsequent recall of the ASR Hip Resurfacing System and ASRXL Acetabular System. Over 
93,000 patients were implanted with these prostheses and the outcome of these was shown 
to be device related, independent of multiple other possible causes of a higher rate of 
revision (1). Concerns regarding the outcomes of the ASR Resurfacing System were first 
identified by the Australian Orthopaedic Association National Joint Replacement Registry 
(AOANJRR) in 2007 (200) and the ASRXL Acetabular System in 2008 (199). These prostheses 
were withdrawn from Australia in 2009 and worldwide in 2010, following confirmation by 
the National Registry of England and Wales (295).  This resulted in tighter regulations 
regarding the introduction and monitoring of new implants (296), demonstrating the 
critical role of registries in post market total joint replacement surveillance. 
 
While many joint replacement registries report comparative revision rates of prostheses it is 
much less common for registries to publicly highlight specific prostheses or prostheses 
combinations that are performing outside of the expected norm. The purpose of this review 
is to determine if joint replacement registries identify prostheses that have a higher than 
expected rate of revision, to describe the current outlier methodologies, discuss the 
consequences of this and recommend ways in which the international registry community 







A detailed search was performed of all Joint Replacement Registries listed on the official 
Websites of the International Society of Arthroplasty Registries (ISAR) (297) and 
Arthroplasty Watch (298). In addition, all links from those registries were also evaluated to 
include smaller regional registries. Available online reports were reviewed to determine if 
individual registries specifically identified prostheses with a higher than expected rate of 
revision and, if so, the method by which this was performed. Those Registries that did not 
have an accessible on line document were contacted to obtain a hard copy version or, if not 
available, personal communication was made to the relevant registry contact to determine 
if they identified prostheses but the information was not publically available. The registries 




A total of 47 Registries with websites were identified of which 9 did not have publically 
accessible documents but were contacted by the author. Of those that did there were four, 
the AOANJRR, the New Zealand National Joint Registry, the Swedish Knee Arthroplasty 
Registry, and the National Joint Registry for England, Wales, Northern Ireland and the Isle 
of Man that identified prostheses in their report and the methods by which this was 
performed. There were two Registries that identified prostheses internally without the 
information being publically available. These were the Kaiser Permanente National Total 
Joint Replacement Registry, and the Dutch Arthroplasty Register.  The Scottish 
Arthroplasty Project monitors surgeon outliers and, by association, implants. None of the 
other Registries had a formal method for prosthesis identification. 
 
The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) 
has previously reported on a method for identifying prostheses with a higher than expected 
rate of revision (221).  This involves a three stage process commencing with an automated 
screening test to identify prostheses that have twice the rate of revision per 100 observed 
component years of all other prostheses in the same class.  The second stage involves a 
more detailed analysis of the identified prostheses by the AOANJRR Registry staff. Age and 
gender-adjusted hazard ratios are calculated using Cox regression models. If the hazard 
ratio of a prosthesis, compared to all others in the same class combined, is statistically 
significant, then the prosthesis progresses to stage 3.  In this stage a panel of independent 
orthopaedic specialists from the Australian Orthopaedic Association Arthroplasty Society 
analyse all the data and determine which prostheses will be identified in the Annual Report 
(16).  Prostheses or prosthetic combinations are then listed as ‘Identified and not used’, 
‘Identified and still used’ and ‘Newly Identified’.  Since the introduction of the 




using this approach and this represents 4.3% of the number of prostheses or combinations 
recorded by the Registry.  
 
The New Zealand Joint Registry lists prostheses combinations that have a minimum of 50 
registered primary arthroplasties and they are sorted in order of descending revisions per 
100 observed component years. In the 2016 Report (299) there were 24 hip prostheses 
combinations that have a significantly higher rate of revision than the overall rate of 0.73 
per 100 observed component years.  These are marked with an asterisk in the report.  A 
similar table is presented for individual knee prostheses sorted by descending revisions per 
100 observed component years and there were five prostheses listed as having a 
significantly higher rate of revision than the overall rate of 0.49 per 100 observed 
component years. 
 
The Swedish Knee Arthroplasty Registry (SKAR) reports on factors that influence the 
revision rate of knee replacements. When the implant model is the factor, the Cox 
regression analysis adjusts for differences in gender, age, and diagnosis, and uses the latest 
10 year period for the analysis.  The SKAR for many years used the AGC as the reference 
model with a risk of one to which other implants were compared.  In the 2014 Report the 
reference model was changed to the PFC Sigma-MBT. In the 2016 report (76) there were 
four implants which were recorded as having a significantly higher rate of revision for TKA 
when performed for osteoarthritis and three knees which had a lower risk ratio.  There was 
one unicompartmental knee with a higher risk of revision when compared to the reference 
implant. 
 
The National Joint Registry of England, Wales, Northern Ireland and Isle of Man (300) has 
an Implant Performances Sub-Committee whose brief is to analyse and assess confidential 
data on potential outliers.  This analysis is performed on a Patients Time Incidence Rate 
(PTIR), which is the revision ratio per 100 observed component years, first introduced by 
the AOANJRR.  Notification for an unacceptably high rate of revision is a PTIR of twice the 
group PTIR, allowing for confidence intervals (Level 1 notification).  When this occurs a 
report is filed with the Medicines and Healthcare Products Regulatory Agency (MHRA).  
When the PTIR is 1.5 times the group PTIR a warning letter is sent to the manufacturing 
company (Level 2 notification). There have been 34 prostheses or combinations identified 
by the National Registry since 2009. 
 
The two other registries that internally identify prostheses with a higher than expected rate 
of revision are the Kaiser Permanente National Total Joint Replacement Registry (301), and 
the Dutch Arthroplasty Registry (LROI) (302). One other registry, the Scottish Arthroplasty 




subsequent complications. As outlier status is frequently associated with poor implants 
SAP states that their methods are applicable for indirect implant surveillance (303) (Table 
1).  While many registries report the survivorship or rates of revision of individual 





The main objective of the study was to determine if Joint Replacement Registries identified 
prostheses with higher than expected rate of revision and how this was performed.  Four 
Registries had publicly available information on the devices and the threshold for 
reporting.  Two registries identified devices internally, one by association with surgical 
outliers and none of the other registries had a formal method for prosthesis identification. 
 
Surgeons rely on many sources of information when deciding which prosthesis to use and 
these include, but are not limited to, experience in training, colleague interaction, peer 
reviewed literature, scientific meetings, company sponsored events, and joint replacement 
registries.  A considerable proportion of prostheses available have no readily available 
evidence of clinical effectiveness to support their use (304). Joint replacement registries, 
with their continuous surveillance, provide the best data for the use and outcomes of a 
device in the general population (3, 305, 306). Careful interpretation of this can help guide 
prosthesis selection in the absence of published evidence (34, 307, 308) and identification of 
specific outlier prostheses, as opposed to listing comparative rates of revision, highlights 
prostheses that are not performing as well as others within their class. 
 
A post market surveillance system for medical devices should provide the following 
functions: readily identify underperforming devices, characterize and disseminate 
information about real-world performance, and provide data that can be used to support 
pre-market clearance or approval of new devices (309).  
 
The need for registries to identify outliers along with well performing implants is therefore 
important but there are problems with current approaches. As revision is a relatively rare 
occurrence, some prostheses may be used in low volumes and there may be insufficient 
power to detect differences. There is also a lack of standardization of implants and their 
attributes which may hamper international comparisons. Registries may have different 
prostheses in their databases, limiting the ability to link data. The comparator and the 
threshold for identification also differ. Three registries use twice the rate of revision of all 
other devices in the same class for initial listing, one uses a single prosthesis as the 




both the timing and the best methods to disseminate findings to the relevant stakeholders, 
need to be addressed. 
 
There are several potential solutions to the above issues to further improve identification of 
outlier prostheses and post market surveillance of implants. Registries can consider pooling 
data to increase the numbers available for statistical analysis.  The Nordic Arthroplasty 
Register Association (NARA) was established in 2007 by Sweden, Norway and Denmark to 
improve collaboration and was joined by Finland in 2010.  This enabled a greater number of 
prostheses with a longer term follow-up (1995-2011) to be analysed (310). While there are 
examples of Registries pooling data to examine outcomes of specific prostheses (311) this 
has proven more difficult with regard to outlier identification.  The International 
Consortium of Orthopaedic Registries (ICOR) commenced in 2011 and focused on two 
major goals: research and surveillance for hip and knee implants and worldwide implant 
harmonization.  The consortium involved over 30 orthopaedic registries and has performed 
multinational investigations of total hip replacement bearing surfaces, prosthesis fixation 
and total knee replacement outcomes with respect to mobile and fixed bearings and 
stabilization.  This initiative has demonstrated that registries worldwide can cooperate to 
monitor and improve outcomes of joint replacements (312) 
 
The International Society of Arthroplasty Registers (ISAR) can play a significant role in 
coordinating data to aid in the early identification of outliers. If international registries are 
to compare results, then it is essential that similar data are collected (177) and there is 
harmonization of the device catalogues between registries.  One of the current objectives of 
ISAR is the development of an International Prosthesis Library which can be distributed 
amongst all member registries, thereby allowing comparison of similar devices. There are 
currently 15 registries sharing this catalogue with plans to expand across all member 
registries. This initiative may lead to an improvement in early signal detection by close 
operation and the sharing of data on prostheses that have been potentially flagged by 
individual registries but need larger numbers for accurate analysis. 
 
The most common comparator used is all prostheses in the same class. The threshold for 
identification is not uniform and needs to be standardized. Three registries use twice the 
expected rate of revision compared to all prostheses with the UK National Registry having 
an initial lower threshold of 1.5x.  This may however mask prostheses that are at the higher 
end of the revision scale and a comparison to a group of the best performing implants may 
be more appropriate. Using a single implant as comparator may also present some 
difficulties. Comparing to the most commonly used prosthesis is one method but this may 
not necessarily be the best performing implant in a registry. Also the use of implants 




comparator. The most appropriate methods for outlier identification are currently being 
investigated by a working group from ISAR. 
 
The timing of release of information on outlier prostheses is also an important factor to 
consider. The release of information in an Annual Report may come many months after a 
decision has been made on prostheses with higher than expected rates of revision. Websites 
that provide real time data for surgeons, industry and regulators on the performance of 
prostheses allow closer monitoring of joint replacement rates of revision and may alert 
users to seek further, more detailed reports. The timing of release of outlier prosthesis 
identification requires a consistent approach to be certain of the accuracy of the data, while 
at the same time being aware that a delay in notification may put patients at risk.  
Arthroplasty Watch is a website devoted to timely release of information regarding issues 
with all types of joint replacement.  It was developed as an information project and opened 
in February 2013 with the purpose of collecting data on arthroplasty safety issues from a 
wide range of information sources on the internet and disseminating this in one single, 
publicly accessible site (298).  The sources include arthroplasty registries, reports from 
regulatory authorities, manufacturers and scientific publications but there is no formal 
method for outlier identification. 
 
There is no question that outlier identification plays an important role in improving the 
outcomes of joint replacement. This has been demonstrated by the marked reduction or 
cessation of use for most prostheses identified by the AOANJRR. The consequence of this 
identification has been the reduced exposure of patients to devices with higher than 
expected revision rates. Only a small percentage of devices are identified and this does not 
impact on surgeon choice, as there is ample evidence of many prostheses with long term 
low rates of revision that surgeons can use for their patients.  
 
Another solution to avoid using devices with higher than expected revision rates would be 
to only use prostheses with good long term outcomes. The Orthopaedic Data Evaluation 
Panel (ODEP) was set up as part of the United Kingdom National Health Service to monitor 
data for primary hip replacement.  Prostheses are classified according to level of evidence 
spanning a time period, with the highest rating being a 10A* for prostheses that have a 95% 
survivorship at 10 years (313). To qualify for this rating a hip prosthesis requires a revision 
rate of 5% or less at 10 years in a cohort study of a minimum 500 prostheses and Registry 
data supporting its use. As longer follow up has occurred the time period has extended and 
there now devices with a 13A rating. The AOANJRR also lists THA and TKA with 15 year 
rates of revision which can provide a guide to well performing implants. However if this 
approach is followed it may not allow for innovation. New prostheses can still be 






There are some limitations to this review on registry identification of outlier prostheses. 
Despite a thorough search, there may be small regional registries that have local 
publications not readily available for review. A comprehensive attempt was made to read 
reports or contact all registries identified. Also, registries that were reviewed may not 
publically identify prostheses but may do so internally and communicate results to 
hospitals and surgeons thereby influencing outcomes at a local or regional level. There may 
also be medicolegal issues in countries that may impact on the ability to identify prostheses. 
 
The Australian experience is that early signal detection of prostheses with a higher than 
expected rate of revision can lead to withdrawal of these devices from the marketplace. 
Consistent reporting of outlier prostheses from registries across countries would make it 
less likely that an under-performing prosthesis was due to patient or surgeon factors. 
Further research is needed to determine the optimum methods for identification including 
the threshold, the comparator, and the numbers required for notification of devices. 
Collaboration and co-operation of registries at a global level will enhance this process, thus 





Table 1 Registries with Internal Identification of Prostheses 




Initial threshold is twice revision rate 
per 100 observed component years of 
prostheses and follow up review by 
statisticians and surgeon leaders 




Initial threshold is twice revision rate 
per 100 observed component years of 
prostheses with review by statisticians 
and surgeon leaders 





CUSUM Analysis of complications with 
prediction limit. Approximately 10% of 
surgeons will become outliers for at 
least one complication per year. 









Appendix 1 List of Joint Replacement Registries 
 
 American Joint Replacement Registry * 
http://www.ajrr.net/  
Access date:  25th Nov 2017 
 Australian Orthopaedic Association National Joint Replacement Registry ** 
https://aoanjrr.sahmri.com/  
 Austrian Arthroplasty Register + 
Access Date: 20th May 2017 
 Belgian National Arthroplasty Register*  
http://beneluxa.org/ 
Access date:  20th November 2017 
 Californian Joint Replacement Registry * 
http://staging.caljrr.org/  
Access date:  25th April 2017 
 Canadian Joint Replacement Registry ** 
https://www.cihi.ca/en/joint-replacements  
Access date:  25th April 2017 
 Catalan Arthroplasty Register* 
http://aquas.gencat.cat/ca/projectes/mes_projectes/qualitat_atencio_sanitaria/racat/  
Access date:  6th May 2017 
 Croatian Arthroplasty Register+ 
24th May 2016 
 Czech Rep. Arthroplasty Register * 
http://www.uzis.cz/  
Access date:  6th May 2017 
 Danish Hip Arthroplasty Register ** 
http://danskhoftealloplastikregister.dk/en/dhr/dhr-the-danish-hip-arthroplasty-
register/  
Access date:  17th April 2017 
 Danish Knee Arthroplasty Register * 
https://www.sundhed.dk/content/cms/99/4699_dkr-rapport-2016.pdf  
Access date:  17th April 2017 
 Dutch Arthroplasty Register (LROI) ** 
https://www.lroi.nl/  
Access date:  25th April 2017 
 Egyptian Community Arthroplasty Register + 




 European Arthroplasty Register * 
https://www.efort.org/european-arthroplasty-register-network-ear-n/  
Access date:  25th April 2017 
 Finnish National Arthroplasty Register * 
https://www2.thl.fi/endo/report/#index  
Access date:  17th April 2017 
 FORCE – TJR Registry ** 
https://forceortho.org/  
Access date:  6th May 2017 
 French Arthroplasty Register * 
http://www.sofcot.fr/Pages/Registre-des-protheses-de-hanche  
Access date:  25th April 2017 
 Geneva Arthroplasty Registry + 
2nd June 2016 
 German Arthroplasty Register * 
https://www.eprd.de/de/  
Access date:  25th April 2017 
 Harris Joint Registry + 
20th May 2017 
 Health East Joint Replacement Registry ** 
http://www.healtheast.org/orthopedics/registry.html  
Access date:  6th May 2017 
 Hospital for Special Surgery Hip and Knee Joint Replacement Registry + 
20th May 2017 
 Hungarian Arthroplasty Register * 
http://www.ortopedtarsasag.hu/info.aspx?web_id=&sp=5  
Access date:  6th May 2017 
 Indian Society of Hip and Knee Surgeons * 
http://www.ishks.com/ 
Access date:  6th May 2017 
 Iranian Joint Registry* 
Arch Bone Jt Surg. 2016 Apr; 4(2): 192–196 
Access date 6th May 2017 
 Irish National Orthopaedic Register ** 
https://www.noca.ie/irish-national-orthopaedic-register  
Access date:  6th May 2017 
 Italian Arthroplasty Register Project (RIAP) * 
http://www.iss.it/binary/riap2/cont/20140407Brochure in inglese.pdf  




 Japanese Arthroplasty Register (JAR) * 
http://jsra.info/  
Access date:  6th May 2017 
 Kaiser Permanente National Implant Registries * 
https://national-implantregistries.kaiserpermanente.org/  
Access date:  17th April 2017 
 Lithuanian Arthroplasty Register *+ 
www.lser.lt  
20th May 2017 
 Malawi National Joint Registry + 
20th May 2017 
 Mayo Clinic Total Joint Registry+ 
20th May 2017 
 Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI) * 
http://marcqi.org/  
Access date:  6th May 2017 
 National Joint Registry (NJR) for England and Wales ** 
www.njrcentre.org.uk  
Access date:  17th April 2017 
 New Zealand National Joint Registry ** 
https://nzoa.org.nz/nz-joint-registry  
Access date:  17th April 2017 
 Norwegian Arthroplasty Register ** 
http://nrlweb.ihelse.net/eng/default.htm   
Access date:  17th April 2017 
 Pakistan National Joint Registry ** 
http://www.arthroplasty.org.pk/  
Access date:  6th May 2017 
 Portuguese Arthroplasty Register ** 
http://www.rpa.spot.pt/  
Access date:  6th May 2017 
 RIPO – Register for Orthopaedic Prosthetic Implantation (Emilia-Romagna, Italy) ** 
https://ripo.cineca.it/  
Access date:  6th May 2017 
 Romanian Arthroplasty Register ** 
http://www.rne.ro/rne/?lang=en  
Access date:  6th May 2017 
 Scottish Arthroplasty Project ** 
http://www.arthro.scot.nhs.uk/  




 Slovakian National Arthroplasty Register ** 
http://sar.mfn.sk/.320.html  
Access date:  6th May 2017 
 Slovenian Valdoltra Arthroplasty Register * 
http://www.ob-valdoltra.si/international  
Access date:  6th May 2017 
 South African National Joint Registry + 
13th April 2016 
 Swedish Hip Arthroplasty Register ** 
https://shpr.registercentrum.se/en/default.aspx  
Access date:  17th April 2017 
 Swedish Knee Arthroplasty Register ** 
http://www.myknee.se/en/  
Access date:  17th April 2017 
 Swiss Arthroplasty Register * 
http://www.siris-implant.ch/de/?id=51&L=1  
Access date:  25th April 2017 
 











The Role of the AOANJRR in the Change of 
Practice, Policies and Outcomes of Hip and 





9.1 - Preface 
 
In the previous chapters I have discussed the first three research questions examining specific 
themes within the overall aim and how they have led to lower rates of revision for both THR 
and TKR.  In Chapter Nine, I address the contribution of the Registry to the change of practice 
and policies of joint replacement in Australia by exploring the interaction with the multiple 
stake holders involved. The Chapter is divided into 3 sections:  
 
In the first section I will investigate whether there has been an improvement in the results of 
hip and knee replacement in Australia since the commencement of the Registry.  
 
The second part entitled Stakeholder engagement in registry activity will discuss how the 
Registry has influenced key stakeholders, some of the methods by which this has been 
achieved and critically assess the role that the Registry has played in improving the practice 
of joint replacement in Australia. I will explore the interaction with surgeons, hospitals, 
government and regulatory bodies, industry, medical insurers and patients.  Several case 





In the last section I give a brief overview of some of the Registry’s’ other international 





9.2 - Overview  
 
So far in this thesis I have provided a description of the nature and activities of the 
AOANJRR, and discussed the introduction, monitoring and changes in outcomes of new 
materials and technologies in joint replacement.  I now turn to the role of the Registry in 
effecting change and critically examine the evidence for this.  As I will discuss, in the non-
experimental setting of Registry data, evidence must be accrued from several perspectives 
and due caution exercised in attributing effect to cause. 
 
As with most observational studies it is difficult to approach analyses of these large data 
sets from a causal perspective.  A randomised trial linking cause to effect is supported by 
the randomisation of the treatment groups and strict adherence to the trial protocol.  In 
general, the analytical approach that has been used for this study investigates associations, 
with methodologies to limit the impact of bias. Although it may be possible on occasion to 
make a causal inference, it is rare, if ever, to be definite about this.  It has been estimated 
that to compare the outcomes of two prostheses with a randomised, controlled trial (RCT) it 
would take 4,000 patients followed for ten years in order to detect a 30% difference in the 
revision rate (49).  It would be difficult and expensive to arrange an RCT with the numbers 




follow up and death. Also it would not be uncommon for new prostheses to come onto the 
market before prior RCT’s have been reported. Registries can offer some advantages over 
clinical trials, especially in the case of joint replacement surgery, where one of the main 
outcomes of interest, revision surgery, has a low occurrence.  Well conducted observational 
studies can enable understanding of the practices, new developments and longer term 
effects of different exposures with the ability to evaluate large numbers of patients and 
evaluate multiple interventions in various patient populations (47). 
  
A registry can achieve improvement by identifying and reporting variation in practice (best 
and worst). Increased adoption of best practice, whether related to prosthesis use, surgical 
technique, or use of technology, is not necessarily dependent on understanding the reasons 
why one practice is better than another.  The AOANJRR has presented, in a variety of 
formats, data earlier than other available sources of information, data not readily available 
from any source other than the Registry, and these data are generalizable to the Australian 
population with strong external validity.(34)  
 
There are many ways by which a change in joint replacement outcomes may be achieved 
and this can involve multiple stakeholders. These groups include surgeons, hospitals, 




sources of information to make decisions about joint replacement surgery for their patients. 
These include personal experience, attendance at scientific and industry meetings, 
published literature, peer discussion and, increasingly, the use of registry data. 
 
The primary outcome measure of the Registry is the time to first revision of a primary joint 
replacement. It is also a metric that can be verified, easily understood by all stakeholders, 
and allows comparison of different factors associated with joint replacement. There are 
some problems with using revision surgery as an endpoint as revisions can occur long after 
the index procedure and the lack of a revision operation does not always indicate a 
successful procedure.  There may be medical or social reasons that may preclude further 
surgery.  Patients may be too unwell to undergo further operations, they may not present to 
their doctor for care, or they may be offered surgery but choose not to proceed.  It is 
therefore likely that the true failure rate for joint replacement is higher than that measured 
by the Registry.  Revision surgery does provide an unambiguous measure of the need for 
further intervention and confirmation that the primary procedure, for whatever reason, has 
not been successful.  Another metric to determine the outcome of joint replacement surgery 
is Patient Reported Outcome Measures (PROMS) (315, 316).  The New Zealand Joint 
Registry has demonstrated a strong correlation between patients with poorer Oxford Hip 
and Knee Scores (a patient specific outcome measure with worldwide use) and revision 




first revision of a primary procedure is the metric that the AOANJRR uses to compare 
various factors associated with joint replacement and also for international comparative 
studies with other registries.  
 
9.3 - Has the revision rate changed since the inception of the 
AOANJRR? 
 
A reduction in revision rate over time can be viewed as a metric that demonstrates an 
improvement in the practice of joint replacement surgery in Australia. This can be 
measured by a reduction in the overall burden of revision surgery or a decrease in the rate 
of revisions of primary procedures over consecutive time periods since the Registry’s 
inception.  
 
The revision burden is defined as the proportion of all hip and knee replacement 
procedures that are revisions.  This can be calculated from State Health admission and 
discharge data and the Registry has access to these from 1994. In Australia, the revision 
burden for total hip replacement has declined from 13.1% in 2002/2003 (the first year of full 




declined from 9.3% in 2002/2003 to 7.4% in 2015/2016.  This equates to a 25% reduction in 
the burden of revision for hip replacement and a 20% reduction for knee replacement over 
the respective periods and means there were 7,000 fewer hip revisions and 8,400 fewer knee 
revisions performed in 2015/2016 if the proportion of revisions had remained at their 
respective rates before the commencement of full national data collection. There was a 
small increase in hip revision in 2011 as a result of the increased rate of revision of patients 
who had large head metal on metal hip prostheses. These prostheses are no longer 
available, with the Registry having played a major role in their removal, as discussed later.  
Figures 1a and 1b demonstrate the revision burden for hip and knee replacement from 
1994/1995 until the latest available data for 2015/2016. They show a reduction in revisions 
since the commencement of the Registry national data collection and reporting.  There may 
be other reasons that have contributed to the reduction in revision burden though these are 
unlikely to be present in the Australian context. Access to hospital care improved with the 
Australian Government Private Health Insurance Rebate (317), introduced in 2000, but this 
would affect both primary and revision procedures equally.  Improvements in anaesthesia, 
multi-modal pain therapy, and peri-operative care, over this time period make it less likely 






Fig 1a Revision Burden for Hip Replacement 
 
*Y axis is the number of fewer revisions than 1994/1995 if the proportion of hip revisions had remained the 
same as 1994/1995 (14.7%).  
 

































Fig 1b Revision Burden for Knee Replacement 
 
* Y axis is the number of fewer revisions than 1994/1995 if the proportion of knee revisions had remained the 
same as 1994/1995 (10.0%)  
 
  Commencement of full national data collection of AOANJRR. 
 
Source: Figures prepared from Government admission and discharge data held by AOANJRR and 
based on material prepared by AOANJRR for Economic Evaluation of Clinical Quality Registries, 
Australian Commission of Safety and Quality in Health Care November 2016 
 
In contrast to Australian figures, the revision burden has increased for TKR in the 
U.S.A.(318, 319).  Bozic et al utilised data from the Nationwide Inpatient Sample (NIS) to 
evaluate approximately 8,000,000 discharge records from 1051 hospitals in 45 states. The 
database gives a representative sample of all US hospitals and the 45 states covered 96% of 
the population.  From 2006 to 2010 the authors demonstrated an increased revision burden 
































replacement (15.4% to 14.6%) over this time period.  The revisions for TKR were due to 
mechanical loosening, implant failure and joint infection.  Nineteen percent of both TKR 
and THR revisions were performed in patients <55 years of age and the authors stated that 
an increasing proportion of primary TKR performed in younger patients (12, 318) may 
contribute to the revision burden.  While it is difficult to directly compare the reasons for 
revision listed in registry data with administrative datasets based on the use of ICD-9-CM 
diagnosis codes, there is a larger proportion of TKR and THR revised for mechanical and 
implant issues in the NIS dataset than the AOANJRR.  The AOANJRR has also consistently 
reported on the association between a younger age and higher revision rates for TKR, and 
the proportion of primary TKR performed in Australia in patients <55 years of age remains 
small (6.9%) and there has been little change in that proportion since 2003.  It is important 
to note that there was no nationwide joint registry in the U.S.A. over the time period 
reported in this study.  
 
Another method of demonstrating improvement in outcomes of THR and TKR is by 
examining revision rates over consecutive time periods, a method that has been used by the 
Swedish registries. Three consecutive time periods of four years were chosen from the 
commencement of full national data collection: 2003-2006, 2007-2010, and 2011-2014.  This 
allowed for calculation of revision rates up to six years for the latter group. In Australia the 




time period 2003-2006 to 3.6% for THR performed between 2011 -2014. A similar reduction 
is also seen for TKR over the same period with a decrease in the rate of revision from 5.1% 
for procedures performed from 2003 -2006 compared to 3.8% for procedures performed 





Figure 2a Cumulative Percent Revision of All Hip Replacements by Procedure Year  
 
Number at Risk 0 Yr 1 Yr 2 Yrs 3 Yrs 4 Yrs 5 Yrs 6 Yrs 7 Yrs 
2003-2006 99854 91622 87580 83915 80311 76738 73051 69438 
2007-2010 118830 109421 104687 100252 95791 91490 87347 80470 
2011-2014 141004 130230 125409 116001 80106 48981 21704 0 
 
Number at Risk 8 Yrs 9 Yrs 10 Yrs 11 Yrs 12 Yrs 13 Yrs 14 Yrs 15 Yrs 16 Yrs 
2003-2006 65957 62622 59430 54541 37593 22394 9610 0 0 
2007-2010 54775 32728 14057 0 0 0 0 0 0 
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2003-2006 vs 2011-2014
0 - 3Mth: HR=0.86 (0.80, 0.93),p<0.001
3Mth - 6Mth: HR=1.15 (0.99, 1.34),p=0.061
6Mth - 1.5Yr: HR=1.39 (1.26, 1.52),p<0.001
1.5Yr - 3Yr: HR=1.42 (1.28, 1.57),p<0.001
3Yr - 5.5Yr: HR=1.77 (1.61, 1.95),p<0.001
5.5Yr - 6.5Yr: HR=2.99 (2.59, 3.45),p<0.001
6.5Yr+: HR=4.38 (1.10, 17.51),p=0.036
2007-2010 vs 2011-2014
0 - 3Mth: HR=0.88 (0.82, 0.94),p<0.001
3Mth - 1Yr: HR=1.10 (0.99, 1.21),p=0.067
1Yr - 1.5Yr: HR=1.32 (1.16, 1.50),p<0.001
1.5Yr - 3Yr: HR=1.67 (1.52, 1.83),p<0.001
3Yr - 6.5Yr: HR=2.36 (2.16, 2.58),p<0.001
6.5Yr+: HR=3.69 (0.92, 14.73),p=0.064
2007-2010 vs 2003-2006
Entire Period: HR=1.02 (0.98, 1.05),p=0.310







Figure 2b: Cumulative Percent Revision of All Knees by Procedure Year  
 
Number at Risk 0 Yr 1 Yr 2 Yrs 3 Yrs 4 Yrs 5 Yrs 6 Yrs 7 Yrs 
2003-2006 115185 112661 109713 107084 104243 101239 97985 94406 
2007-2010 147750 144916 141667 138567 135391 131925 128221 120968 
2011-2014 184612 181379 177836 169642 120202 75376 34312 0 
 
Number at Risk 8 Yrs 9 Yrs 10 Yrs 11 Yrs 12 Yrs 13 Yrs 14 Yrs 15 Yrs 16 Yrs 
2003-2006 90775 86738 82477 76370 51755 30227 13075 0 0 
2007-2010 83222 50926 22107 0 0 0 0 0 0 
2011-2014 0 0 0 0 0 0 0 0 0 
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9.4 - Stakeholder Engagement in Registry Activity 
 
Provision of information to surgeons 
 
Changing behaviour in a healthcare setting involves complex interactions between 
stakeholders (320).  While it would appear reasonable that audit of outcomes and feedback 
of information might prompt healthcare professionals to change practice, this has not been 
found to be consistently effective (321).  Jamtvedt et al conducted a systematic review of the 
effects of audit and feedback on a variety of randomized controlled trials involving 
healthcare professionals (322, 323). The authors concluded that audit and feedback can be 
effective in improving practice. The effect is likely to be larger if compliance with 
recommended practice is lower and if feedback is more intensive or multifaceted.  
Developing strategies to implement effective change should incorporate multiple 
interventions including education, audit and feedback, multi stakeholder collaboration and 
professional development (324, 325). Using data from registries to improve both short and 
long term outcomes for joint replacement surgery should be a priority (326).  The 
AOANJRR has endeavored to provide accurate information to all stakeholders regularly, 





The Registry has provided this information to surgeons in multiple ways, including the 
published Annual Report, regular Scientific Presentations of Registry data, the provision of 
surgeon specific information through ad hoc reports, and on the AOANJRR Website. The 
Annual Report was first published in 2000 (327) and outlined the aims of the AOANJRR:  
 
 Determine demographic and diagnostic characteristics of patients undergoing joint 
replacement surgery nationally 
 Provide accurate information on the use of different types of prostheses in both 
primary and revision joint replacements 
 Evaluate the effectiveness of different types of joint replacement prostheses and 
surgical techniques at a national level 
 Compare the Australian joint replacement experience to that of other countries 
 Provide confidential data to individual surgeons and hospitals to audit their joint 
surgical techniques to achieve successful outcomes 
 
As with all observational data collections the initial reports were largely demographic in 
nature, giving a thorough snap shot of the practice of hip and knee replacement in 
Australia in the preceding years. The first two aims of the Registry were therefore 




With increasing data and time, comparative analyses and more in depth reporting was first 
published in the 2005 Annual Report, thereby achieving the third aim of the initial Report. 
Opportunities to compare at an international level have been strengthened with the 
development of the International Society of Arthroplasty Registries.  Close co-operation of 
Joint Registries from many countries has allowed benchmarking and development of early 
signal detection of devices, thus fulfilling the fourth aim. The final aim, provision of 
information to surgeons and hospitals, has been an ongoing project of the Registry and will 
be discussed further. 
 
The Annual Report, in its printed version, is distributed to all surgeons performing 
arthroplasty in Australia and, in 2017, was sent to over 1600 surgeons. The Registry 
recorded 1,174 surgeons who had performed at least one procedure in 2016 and the Report 
is also sent to surgeons who have ceased operating, but still have an interest in the field of 
joint replacement.  The Annual Report has also been available on the AOA website since 
2001. The Annual Report is available to trainee surgeons within the AOA accredited 
training scheme.  Lectures on interpretation of AOANJRR data have been embedded in the 






The Annual Reports have had almost 2,000 citations since 2004 (Table 1) and are 
increasingly viewed on the Web (Table 2).  The 2016 Annual Report has been viewed over 




Table 1: Cumulative number of citations 
of AOANJRR publications by year 















Table 2: Number of downloads of 




Annual Report 2000 770 
Annual Report 2001 496 
Annual Report 2002 730 
Annual Report 2003 706 
Annual Report 2004 866 
Annual Report 2005  1013 
Annual Report 2006 983 
Annual Report 2007  1687 
Annual Report 2008 1822 
Annual Report 2009 2364 
Annual Report 2010 2574 
Annual Report 2011 2492 
Annual Report/SR 2012 20733 
Annual Report/SR 2013 31797 
Annual Report/SR 2014 17635 
Annual Report/SR 2015 15597 






Presentations at Scientific Meetings 
 
The Annual Report is released in September of each year and therefore a specific 
limitation of the Report is that data are up to date as of 31st December of the previous 
year.  While the Report provides the most complete synopsis of the Joint Registry 
activity on the whole population, provision of data in more up to date fashion is 
potentially more beneficial to surgeons. 
 
Presentations at Scientific Meetings are a powerful method for the Registry to 
disseminate up to date information. A formal Registry session has been incorporated 
into every AOA Annual Scientific Meeting (AOA ASM) since 2006. More than half of 
all orthopaedic surgeons register for the ASM, and, along with industry 
representatives, the Registry plenary session on a Wednesday morning is one of, if 
not the most, well attended.  Commencing in 2007, the Registry has presented a 
preview of the latest findings to the Annual Meeting of the Arthroplasty Society of 
Australia, approximately 5 months prior to the official Report release. This session 
summarises that year’s Report, highlighting new chapters and any significant 
changes in outcomes.  This has enabled feedback from the peak arthroplasty body in 
the country and a two way exchange of information. Issues that have been discussed 
include adjusting outcomes for surgical volume and complexity, suggestions for new 




with higher revision rates.  The Director and Deputy Directors also present Registry 
data at multiple meetings throughout Australia including State Branch Meetings, 
Continuing Orthopaedic Education Meetings, industry sponsored joint surgery 
meetings, and academic university meetings centred on Registry sciences.  In this 
way up to date data is available for dissemination sometimes many months prior to 
the formal Report being distributed. Following the release of the Annual Report and 
AOANJRR Australian Orthopaedic Association Annual Scientific Meeting 
presentations there is a spike in ad hoc requests from surgeons and an approximately 
100% increase in web site access, which may be attributed to the release of the 
Registry Report. (Fig 3)  
 
Figure 3 – AOANJRR Web Access following Annual Report and Scientific 
Meeting  
 
Source: Google analytics from AOANJRR 2017 
 
Over the past ten years Registry staff have given over 350 scientific presentations at 
state, national, and international conferences. Information from the Registry Annual 




international surgeons and researchers when giving presentations8. The Registry has 
won awards from the American Academy of Orthopaedic Surgeons (AAOS)9 and the 
European Federation of Orthopaedics and Traumatology10 and was recently invited 
to contribute to a major symposium entitled ‘The Benefits of National and Regional 
Arthroplasty Registries’ at the world’s largest orthopaedic meeting, the AAOS, in 
March 2018.  The proceedings from this symposium will be published in 
Instructional Course Lectures 68 (AAOS Press). 
 
Surgeon Ad Hoc Requests 
 
Commencing in 2001 the Registry has allowed surgeons, academic institutions, 
governments and industry to specifically request data from the Registry.  The 
requests are discussed at the Registry Working Group meetings, data analysis is 
performed by the Registry statisticians, and the reports are reviewed by the Registry 
Working Group before release to the stakeholder.  Although requests were few in 
                                                     
 
8 Personal Communication: Dan Berry, former president, American Academy of Orthopaedic 
Surgeons and previous Director, American Joint Registry 
 
9 Best Poster Outcome of Metal on Metal articulation in primary Conventional THA: Analysis of 17,775 
procedures.American Academy of Orthopaedic Surgeons ASM, San Diego USA February 2011 
 
10 Best Poster EFORT Jacques Duparc Award The Outcome of revised Resurfacing Arthroplasty 14th 




the first few years following the commencement of the Registry, there has been a 
steady increase in both the number and complexity of the ad hocs. 
Overall the number of ad hoc requests has risen from 17 in 2001 to 326 in 2017. Fig 4.  
The importance of these and the attribution of the Registry to the improvements of 
joint replacement are discussed with respect to each of the specific stakeholders. A 




Source: Data from AOANJRR Board Report to the AOA. Adelaide, Australia; 2017, updated 
Feb 2018 
 
With regard to surgeon ad hoc requests there has been over a fivefold increase from 
2006 (26) to 2017 (169).  One of the most common requests from surgeons is for the 
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than is provided on the web portal.  Information includes full demographics of the 
surgeon’s practice, reasons and types of revisions, a list of prostheses they use, 
hospitals where they treat their patients and revisions by year of implantation.  On a 
number of occasions surgeons have also provided their own databases for cross 
checking and linkage with the Registry.  Prior to 2008 a surgeon’s individual code 
number was not linked to their name and from June 2008 surgeons were given the 
opportunity to link their data thus enabling them to have a more complete picture of 
their activity from the beginning of Registry data collection. 
 
Feedback from surgeons who have been supplied analyses of their own data from 
the Registry indicates that the process is an important element in the way they 
practice and this process will often motivate change, especially if they are outside the 




Mr. Rowden is a surgeon performing a high volume of knee replacements.  He had 
kept comprehensive records of his knee replacements and had provided his own 
database for cross checking and linkage with the Registry. He submitted an ad hoc 




expected revision rate for total knee replacement. His revision rate for total knee 
replacement was double the national rate (1.6 revisions/100 observed component 
years compared to 0.8  revisions/100 observed component years) This report also 
demonstrated that he had a higher rate of revision for patella femoral pain and a 
higher proportion of revisions were for patella only.  Mr. Rowden did not routinely 
resurface the patella during TKR.  As a result of this information he changed his 
surgery to resurface the patella in all cases. Mr. Rowden then reviewed his results 
regularly. A further ad hoc request analyzing data up till December 31st 2015 
demonstrated a significant improvement in revision rates for total knee replacement, 
reducing from 1.6 to 0.77 revisions/100 observed component years. Figures 5a and 5b 
illustrate this change. Figure 6 demonstrates the cumulative percent revision of TKRs 
performed by Mr. Rowden before and after change, compared to the national rate, 





Fig 5a Cumulative Percent Revision of Primary Total Knee Replacement by Mr. 
Rowden 
 
Source: ad-hoc request number 390 June 2009 based on AOANJRR data up till December 
31st 2008 
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Figure 5b: Cumulative Percent Revision of Primary Total Knee Replacement by 
Mr. R, after routine resurfacing of the patella 
 
Source: ad-hoc request number 2024 September 2016 based on AOANJRR data up till 
December 31st 2015 





Fig 6 Cumulative Percent Revision of Primary Total Knee Replacement by 
Surgeon and Procedure Year 
 
Source: ad-hoc request number 2024 September 2016 based on AOANJRR data up till 
December 31st 2015 
Data provided with kind permission of Mr. Rowden 
 
This improvement in outcomes occurred directly as a result of his surgeon portal 
feedback, practice audit through the Registry and subsequent change of practice. 
 
There are multiple reasons why surgeons may not know the outcomes of all their 
patients and these include, but are not limited to, the following: 
 
 Follow up of patients is time consuming and contacting patients for a follow 




 Patients may be unhappy with their result and they seek other surgeons for 
advice.  Although it is generally accepted practice to provide information 
back to a treating surgeon, it is not uncommon for patients to specifically 
request that no further information is provided to the initial surgeon.  
Therefore the treating surgeon for the initial operation may have no 
knowledge of the outcome of that patient’s procedure.   
 Patients move interstate, may be difficult to contact and also may not wish to 
be involved in follow up studies.  The Registry is able to monitor all revision 
surgery regardless of who performed the surgery or where it was performed, 
although information is only provided back to the treating surgeon of the 
primary procedure if they were involved in the revision procedure.   
 
The Registry has analysed the data on the proportion of surgeons who perform both 
the primary and revision procedure for THR and TKR and the surgery is carried out 
approximately only 65% of the time for both hip and knee procedures by the 
surgeon involved in the primary procedure. The reasons the treating surgeon does 
not perform the revision procedure in over a third of their cases could be due to 
referral by the initial treating surgeon to surgeons who specialize in revision 
surgery, because the patient has moved, or the patient does not wish to be treated by 
their first surgeon. These figures illustrate that a substantial number of procedures 




importance of feedback to enable the treating surgeon to be aware of their patient 
outcomes. Only the Registry can provide this information. 
 
Surgeon Specific Internet Access and Comparative Analysis of Surgeon 
Performance  
 
The AOANJRR developed a web portal for members who had consented to access 
their data and this was launched in April 2009 (328). In the first month after the 
introduction of the Web portal in April 2009, 112 surgeons accessed their site.  This 
information is available to surgeons who have linked their identification number to 
their name, thus enabling the Registry to confirm that the specific procedure 
belonged to that individual surgeon.  The information is provided in table form of all 
classes of both hip and knee replacement performed by the surgeon, including 
numbers of primary procedures, the numbers of procedures that have been revised 
and the revisions per 100 observed component years.  Surgeons can break down 
their activity by class of device and by hospitals in which they performed the 
surgery and there are tables for the type of revision performed and the reason for the 
revision.  The national revision rate per 100 observed component years is also 





Feedback back from surgeons was extremely positive; and refining and improving 
surgeon reporting has been a major focus of the Registry.  An initial workshop was 
held with Registry staff, statisticians  and  AOA Board Members in 2016 with the aim 
of exploring methods by which this could be done that would be easily understood 
by surgeons, and relatively straightforward to implement at a national level.  It was 
decided that the provision of funnel plots used to display variation in revision was 
the best way to providing a visual representation of surgeon performance.  A funnel 
plot is a scatter plot where each point represents a single surgeon’s rate of revision 
with the X axis representing volume of procedures performed (individual 
procedures performed by the surgeon and recorded by the Registry).  The Y axis is a 
measure of performance given by a standardized proportion of the ratio of the 
number of revisions observed to the number of revisions expected, multiplied by the 
overall proportion of revisions. The degree of variation is displayed on the graph 
with both 95% upper confidence limits and 99.97% upper confidence limits, which 
indicate the confidence limits around the overall revision rate for all procedures.  
This overall revision rate is represented by a separate green line and each surgeon is 
recorded in the scatter plot.  The individual surgeon whose data is displayed is then 
represented by a green diamond that demonstrates their performance with respect to 
their peers.  Funnel plots are provided for several options associated with both THR 
and TKR including overall outcomes for all diagnoses and all types for revisions, 
and outcomes for specific revision diagnoses such as prosthesis dislocation, or 




performance, compare themselves to the national average and examine the reasons 
for revision. The provision of the funnel plots along with a detailed analysis as 
provided in a typical ad hoc report, was made available to surgeons in August 2017 
(135).  The report on individual surgeon variation and hospital variation was also 
presented in the 2017 Annual Report.  These detailed surgeon reports and funnel 
plots will be provided on a yearly basis and are expected to increase to biannual 
within the next two years. Figures 7a, 7b, 7c, 7d demonstrate the author’s own 
outcome of THR with a standard Kaplan Meier survival curve and funnel plots 
demonstrating comparative performance. 
 
Figure 7a: Cumulative Percent Revision of Primary Total Conventional Hip 
Replacement performed by the author. (Excluding Large Head (>32mm) Metal on 





Figure 7b: Funnel Plot of Primary Total Conventional Hip Replacement 




Figure 7c: Funnel Plot of Primary Total Conventional Hip Replacement (Excluding 
Large Head (>32mm) Metal on Metal, All Diagnoses, Revision for Prosthesis 
Dislocation within 2 Years) 
 
Source: Surgeon Reports Dec 2017 prepared for all surgeons on comparative outcomes of 




Figure 7d: Funnel Plot of Primary Total Conventional Hip Replacement 
(Excluding Large Head (>32mm) Metal on Metal, All Diagnoses, and Revision for 
Fracture within 2 Years) 
 
 
As a surgeon who regularly reviews and publically presents his own data I am 
pleased with the overall rate of revision of my primary THR compared to the 
population, and, particularly for the low rate of revision for dislocation (one in 16 
years). However the rate of revision for periprosthetic fracture is the same as for the 
population and is the most common reason why my THRs are revised. This is an 
acute event following a fall sometime after a successful procedure.  Only half these 
patients are treated by me as they are often taken to the nearest hospital emergency 
department as distinct from the initial hospital. While I have no revisions for aseptic 
loosening of the femoral prosthesis that I use, this feedback has prompted me to 
examine other types of femoral stems that have good long term results but different 




over. It will also form the basis for a separate publication as my concerns appear to 
be replicated by other registries and surgeons. 
 
Monitoring surgeon use of Registry reports 
 
While it is one thing to provide surgeons with information it is becoming an 
increasingly important part of the Registry to monitor the use of activity and to try 
and determine subsequent benefits.  
 
The AOANJRR has been able to track surgeon activity on online access to the 
Annual Report and surgeon web portal (which are separate activities from ad hoc 
requests) since 2013.  This provides an additional source of information to the hard 
copy version of the Annual Report, distributed to over 1100 surgeons.  These data 
have been available since 2013 and demonstrate over a 100% increase in visits to the 
web portal by surgeons (Fig 8).  In 2013, 193 surgeons (of 980 surgeons who had 
performed at least one joint replacement) had 786 unique visits to the web portal. In 






Fig 8 Unique visits to Website by registered users for surgeons, industry and 
regulators 
 
Source: AOANJRR Internal Reporting Site prepared 2017  
 
There has been increasing use of personal Registry data by surgeons and this reflects 
the increased confidence they have with the ownership, accuracy and analysis of the 
information provided. The Registry is the best source of critical information for 
surgeons and its penetration of the target audience is very high. The provision of 
these data by the Registry is the only way that surgeons can obtain feedback on their 
own outcomes, with the exception of the very small numbers of academic surgeons 
involved in research and follow up studies (329). The use of the Registry as a Quality 
Assurance Activity and the protection from identification means surgeons are now 
readily using the information for self-audit, Continuous Professional Development 
(CPD), and peer presentations. The true challenge for the Australian Orthopaedic 
Association is therefore to engage those surgeons who do not look at Registry data 
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presentation will aid this process.  The AOA has recommended access of a surgeon’s 
individual reports with funnel plot data be counted as a specific requirement of 
ongoing CPD for those surgeons performing joint replacement.  It is encouraging to 
note that, as of March 2018, 387 surgeons of a total of 756 who had performed at least 
one joint replacement in 2016, had downloaded their report11. It will require a few 




One of the major benefits of the Registry is the ability to compare the performance of 
prostheses within an entire population. Post market surveillance is important 
because most prostheses are released into the market with minimal supporting 
clinical data (330).  Surgeons ultimately decide which prostheses they feel are best 
for their patient though the clinical evidence for this choice may be lacking.  
Previous chapters of this thesis have examined the reporting of specific prostheses or 
combinations of prostheses with higher than anticipated rates of revision (HTARR). 
The reporting of outcomes on entire classes of devices by the Registry is another 
major way in which the Registry identifies variation which can lead to the adoption 
of best practice.  There are multiple examples where reporting of data by the 
                                                     
 




Registry appears to be associated with a change of practice that has led to a reduced 
revision burden for hip and knee replacement.  This has been achieved by not only 
reducing the use of certain classes of devices but also reporting the outcome of 
devices with respect to age and gender.  Some prosthesis outcomes are dependent on 
these variables and providing these data enables surgeons to make an informed 
choice.  Some examples of a beneficial change in practice include: 
 
 There was a clear reduction in the use of cementless Moores Hemi-
arthroplasty for fractured neck of femur following the report of an almost 
threefold increase in the rate of revision compared to a cemented Thompson’s 
prosthesis (Annual Report 2003) (331). 
 The use of unicompartmental knee replacement markedly reduced after the 
Registry reported twice the rate of revision compared to total knee 
replacement (Annual Report 2004) (182) and this was particularly evident in 
younger patients. Unicompartmental knee replacements represented 19% of 
knee replacements performed for osteoarthritis in 2003 and this proportion 
has gradually reduced to 5.1% in 2016. The use of unicompartmental knee 
replacement has remained at approximately 15% in some countries (332). 
 A whole class of conventional THR has been classified as ‘Exchangeable Neck 
Prostheses’ by the Registry and the AOANJRR is the only registry to report on 




to adjust leg length and off set with potential greater accuracy. The AOANJRR 
first reported that this class of devices had over twice the rate of revision as 
conventional fixed neck prostheses in the 2010 Annual Report (333). The use 
of primary THAs for OA with exchangeable neck prostheses peaked in 
Australia at 6.6% of all primary THR in 2010.and their use has steadily 
decreased since that time. In 2016 only 1.1% of all procedures for THR used 
an exchangeable neck. The Registry evidence suggests that the continued use 
of femoral components with an exchangeable neck in primary THA 
undertaken for OA can no longer be justified (206).  
 Resurfacing hip replacement is classified as a separate class of primary hip 
replacement and surgeons initially used these devices in all ages and in both 
females and males.  Outcomes analysis by the Registry reported a higher 
failure rate in females and older patients (Annual Report 2007)(200) and when 
femoral head sizes smaller than 50mm diameter were used in both females 
and males (Annual Report 2008)(199).  This led to a change in practice with 
Australian surgeons implanting resurfacing hip replacements largely in males 
under the age of 65.  Continued reporting of resurfacing hip arthroplasty and 
its comparative outcomes compared to conventional hip replacement has led 
a marked reduction in its use in Australia from a peak of 8.9% of primary 





 Continual reporting of the method of femoral fixation for conventional hip 
replacement has demonstrated an increased rate of revision for cementless 
implants in patients over 75 years of age.  This age category is the only age 
group that has a higher proportion of cemented compared to cementless 
femoral stems, reflecting, in part, surgeons responding to ongoing provision 
of data by the Registry. 
 The Registry has identified that the use of patella resurfacing in total knee 
replacement has led to a lower rate of revision over time, particularly with 
posterior stabilized implants.  This has led to increased use of patella 
resurfacing in Australia with more total knee replacements having a 
resurfaced patella than un-resurfaced from 2010 onwards (Annual Report 
2011) (185). 
 
Case example: Large Head Metal on Metal Total Hip Replacement 
 
In 2007 the Registry was the first body to identify a significantly higher rate of 
revision for the ASR Hip Resurfacing System and the following year the ASR XL 
Acetabular System (1). The identification of these particular prostheses was 
associated with a substantial reduction in the use by surgeons and the subsequent 
withdrawal of the prostheses from the Australian market in December 2009. 




Joint Registry of the United Kingdom resulted in the world wide withdrawal of the 
prostheses in August 2010 (96, 199, 200, 334-336). This was a prime example of the 
AOANJRR influencing the global outcome of joint replacement surgery. This also 
demonstrates how a single registry’s data is strengthened by other sources including 
other registries and clinical studies. 
 
The identification of this device led to a closer examination of all prostheses that had 
a large head metal on metal bearing (defined as a femoral head greater or equal to 
32mm diameter).  This class of large head metal on metal devices was introduced 
with little clinical data and was employed to address several factors. These included 
revision of resurfacing hip arthroplasty due to fracture to avoid revising the 
acetabulum, to reduce revision for wear related issues as metal on metal bearings 
had reportedly low wear characteristics, and to use large diameter femoral heads to 
reduce the risk of hip dislocation. The Registry first reported on the outcomes of 
bearing surfaces in THR in the 2008 Annual Report (199). The Registry has tracked 
the use of different bearing surfaces for THR over time but more importantly 
provides a comparative performance of the different surfaces. The 2008 Report 
detailed outcomes on five different combinations, Ceramic on Ceramic, Ceramic on 
Polyethylene, Metal on Metal, Metal on Polyethylene and a small number of cases 




bearing surfaces of all sizes had a higher rate of revision than Metal on Poly at all 
time points at seven years follow up. 
 
In the 2009 Annual Report (337) the Registry examined the effect of bearing surfaces 
for conventional THR with respect to femoral head size. When the head size was 
greater than 28mm Metal on Metal bearing surfaces had the highest rate of revision 
but this was not evident with head sizes of 28mm. The effect of head size was 
analysed in more detail in the 2010 Annual Report (333)  and several variables were 
studied including head size, age and gender. To further evaluate the effect of head 
size with Metal on Metal bearing surface, analysis was undertaken comparing four 
head size groups (≤28, 30-32, 36-40, >40mm).  The two larger head size groups were 
associated with an increased risk of revision compared to the two groups with head 
sizes 32mm or less and the Registry then defined large head Metal on Metal  as head 
sizes greater than 32mm. This naming convention for large head was adopted 
internationally. The higher risk of revision for those prostheses with large head sizes 
became evident after two years. There was also an interaction between age and head 
size.  The risk of revision for large head sizes was higher regardless of age and this 
risk was greater the younger the patient. Females also had a higher rate of revision 
but again only for large head sizes. The reasons for revision of large head Metal on 
Metal were also examined and compared to Metal on Polyethylene. There was a 




on Metal group. In order to determine if the higher revision rate of articulations with 
large head Metal on Metal was prosthesis specific, the Registry analysed all 
prostheses head/acetabular combinations with more than 200 procedures with both 
Metal on Metal or other bearing surfaces.  There were 12 combinations that met these 
criteria and many of these devices contributed to the higher revision rate, lending 
further weight to the argument that the large metal head bearing surface was a 
problem and it was not just the ASR hip. This information was clearly demonstrated 
in the 2010 Annual Report. The use of larger head Metal on Metal bearing surfaces 
peaked in 2009 and then there was a 85.7% reduction in the use of large head Metal 
on Metal in the year after the 2010 Annual Report compared to the peak in 2009 (Fig 
11 and Table 3).  
 
Figure 11. Use of Metal on Metal Total Conventional Hip Replacement by Head 












































Table 3: Metal on Metal Total Conventional Hip Replacement by Head Size 
 ≤32mm >32mm TOTAL 
Procedure 
Year 
N Row% N Row% N Row% 
≤2002 1706 85.2 297 14.8 2003 100.0 
2003 653 60.8 421 39.2 1074 100.0 
2004 647 40.5 952 59.5 1599 100.0 
2005 643 25.1 1915 74.9 2558 100.0 
2006 493 14.8 2828 85.2 3321 100.0 
2007 472 12.8 3222 87.2 3694 100.0 
2008 417 11.3 3280 88.7 3697 100.0 
2009 311 13.0 2077 87.0 2388 100.0 
2010 184 16.2 955 83.8 1139 100.0 
2011 94 24.0 298 76.0 392 100.0 
2012 78 69.6 34 30.4 112 100.0 
2013 41 74.5 14 25.5 55 100.0 
2014 51 91.1 5 8.9 56 100.0 
2015 18 94.7 1 5.3 19 100.0 
2016 8 100.0 . . 8 100.0 
TOTAL 5816 26.3 16299 73.7 22115 100.0 
 
Source: Demographic data prepared from AOANJRR 2017 
 
In Australia there has been no recorded use of large head Metal on Metal since 2015 
when just one was used. 
 
While there were other publications and registry reports of adverse outcomes of 
large head Metal on Metal bearings, (22, 23, 25, 26) the AOANJRR was the first 
Registry to report these findings and, as a consequence, the use of this bearing 








Hospitals are increasingly using Registry reports of their overall joint replacement 
activity. Each hospital performing joint replacement surgery in Australia (currently 
305) receives a hard copy of the report and notification of online access. 
Acknowledgement is also made of the Registry hospital coordinators, who facilitate 
data collection and respond to Registry queries.  Unlike surgeons, industry, 
government and regulators, hospitals do not have registered access to their own 
hospital data but can request this in the form of ad-hoc reports.  In 2001 there were 3 
requests and in 2017 this had increased to 45. There have been a total of 236 ad-hoc 
reports provided to hospitals though some of the larger hospitals have had more 
than one request.  Epworth Healthcare, the largest hospital group in the state of 
Victoria (author’s employer) has used reports for audit and to benchmark against 
other healthcare institutions of equivalent size and similar case complexity. They 
have also chosen to post figures from the Registry reports on the hospital website 
showing the hospital performance (Figs 11a,b) (339). While the results show 
significantly lower rates of revision than the national average for THR, resurfacing 
hip replacement and unicompartmental knee replacement, for TKR the hospital has 
a higher rate. The data have been presented at audit meetings, and the reasons for 
the higher rate have been a combination of prostheses not performing as well as 




by high volume TKR surgeons who did not re surface the patella. There has been a 
change of some prostheses and the high volume surgeons now routinely re surface 
the patella. Further audit meetings have demonstrated an improvement.  
 
Figure 11a Cumulative Percent Revision of Primary THR at Epworth HealthCare  
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Another example of the change in practice as a result of information provided by the 
Registry involves another hospital performing large numbers of joint replacements, 
including a number of devices that had been previously reported by the Registry 
with a HTARR. At the yearly hospital audit meeting all surgeons are asked to 
present the outcomes of their individual joint replacement data as well as the overall 
hospital data. The Director or a Deputy Director of the Registry attends these audits 
and provides interpretation of the data and feedback. As a result of the use of some 
prostheses with a HTARR at the hospital, the hospital board instituted a policy in 
2011 prohibiting the use of any HTARR device reported by the AOANJRR.  As a 
result of this intervention the outcomes of the hospital audit have markedly 
improved as demonstrated by a reduction in the cumulative percent revision before 





Fig 12 Example from One Hospital. Cumulative Percent Revision of Primary Total 
Conventional Hip Replacement by Time of Primary Procedure (All Diagnoses, 
Excluding Large Head (>32mm) Metal/Metal) 
 
Source: data on file AOANJRR 2017, permission granted for use of de-identified information  
 
More recently, Ramsay Healthcare, the largest provider of private hospital beds in 
Australia, has commissioned reports on each of their 35 hospitals that perform joint 
replacement surgery. Multiple public hospitals have also requested data from the 
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Government and Regulatory Authorities 
 
The AOANJRR has worked closely and co-operated with government since its 
inception.  The Registry was initially declared a Federal Quality Assurance Activity 
in March 1999 by the then Federal Minister for Health and Aged Care and the 
Activity status has been renewed in 2001, 2006, 2011 and 2017.  This Quality 
Assurance Legislation is part of the Health Insurance Act of 1973 and was amended 
in 1992 to include Quality Assurance Confidentiality.  The Act operates on the 
underlying assumption that quality assurance activities are in the public interest and 
the Declaration ensures that Registry data are free from subpoena and are held in 
absolute confidentiality.  This prohibits disclosure of information identifying 
individual patients or healthcare providers to any organization including the 
government.  This protection provided by the Quality Assurance Activity assures 
surgeons, hospitals and government that the information supplied to the Registry 
remains confidential and secure. The Registry has received increased funding from 
Government to cover day to day operating costs and this is likely to be as a result of 
the ongoing Quality Assurance activities promoted by the Registry and 
improvement in joint replacement outcomes. 
 
State Health Departments have submitted 107 ad-hoc requests since 2001 and these 




are utilized for public hospital purchasing contracts and to investigate regional 
variation. The author, along with Hospital Directors of Orthopaedic Departments, 
has been a member of the Victorian Department of Health prosthesis review 
committees and has given advice on the clinical interpretation of the Registry data. 
 
The Registry has also worked closely with the Therapeutic Goods Administration 
(TGA) which is part of the Australian Government Department of Health.  The TGA 
is responsible for regulating therapeutic goods across a wide range of medicines, 
vaccines and medical devices.  The manufacturers of medical devices have an 
ongoing responsibility to report adverse outcomes to the TGA.  However, there are 
inherent issues with the accuracy of post market surveillance, as previously 
discussed in Chapter Four (221). The Registry has worked closely with the TGA to 
develop a robust reporting of all hip and knee prostheses implanted in Australia and 
the TGA has had access to its own AOANJRR web portal from 2010. This web portal 
enables staff to view the outcomes of all devices which are reported in outcomes per 
100 observed component years.  The TGA can independently identify devices or 
classes of devices which they believe warrant further investigation, and request an in 
depth ad hoc Report from the industry sponsor responsible for the prostheses.  These 
types of requests have increased in detail and complexity and the Registry Working 
Group has provided clinical input to these reports. The TGA can take regulatory 




(ARTG) when they deem that the safety of the prostheses is not acceptable.  These 
recalls are accompanied by a notification to surgeons and hospitals that have 
implanted the relevant devices and are undertaken in a voluntary fashion. The 
relationships with the TGA have been built over a period of time and reflect the 
increased understanding of the value of the data. 
 
There have been changes to the regulatory framework for approval of new implants 
within the European Union, USA and Australia (340-343). One of the major drivers 
of these changes has been the significantly higher rate of revision of the ASR hip 
resurfacing hip system and ASR XL large head Metal on Metal THR as detailed 
earlier in this chapter. Problems with these devices were first reported by the 
AOANJRR, as were subsequent issues with all large head Metal on Metal THR. In 
August 2013 the TGA released the Regulation Impact Statement: Changes to premarket 
assessment requirements for medical devices (344). This identified the need for an 
increased level of premarket scrutiny for higher risk implantable medical devices 
prior to approval, the need for transparency and for conformity of assessment. The 
report’s conclusion was to improve premarket assessment and subject implantable 
devices to a full TGA conformity assessment.  All prostheses which have a load 
bearing role within the human body are now required to be “up classified” (TGA 
terminology) from Class IIb to Class III. This upgrading has meant that clinical 




Registry has responded to both Industry and the TGA with multiple ad hoc Reports 
on device outcomes(340). Industry have used these ad hoc requests for both the local 
regulators and also to provide information for the European regulators for devices 
that are common to both markets. 
 
The Registry has also had a vital, advisory role to play with the Government’s 
Prostheses List Advisory Committee (PLAC) and Hip and Knee Clinical Advisory 
Groups. The Advisory Committee on Medical Devices (ACDM) provides 
independent medical and scientific advice to the Minister of Health and the TGA on 
the safety, performance and manufacturing of medical devices in Australia and 
Registry reports on orthopaedic devices are a major source of current information 
(345). 
 
The Registry has identified outlier prostheses through the process of Higher Than 
Anticipated Rates of Revision (HTARR).  As a result of this process, a large number 
of devices have been removed from the market (Additional Discussion, Chapter 
Four). However, as well as providing information on these devices that are not 
performing as well as others, the Registry has also had a major role to play in 
providing information for benchmarking of devices.  The Orthopaedic Device and 
Evaluation Panel (ODEP) was established in the United Kingdom in 2002 by the 




benchmark standard for assessing the quality of hip prostheses.  The principal 
benchmark standard was better than 90% survivorship at 10 years (10A) for 
individual acetabular and femoral prostheses. In 2010 the AOANJRR suggested that 
the benchmark for a superior outcome (ODEP 10A*) should be raised from 90% 
survivorship at 10 years to 95% survivorship at 10 years. This was subsequently been 
adopted by ODEP in 2014.  As discussed in the Industry section many companies 
use AOANJRR data for applications to ODEP. 
 
The Registry first published data on the cumulative percent revision of prostheses 
with a 10 year follow up in the 2011 Annual Report This time point was widely 
regarded by the international orthopaedic community as an important milestone in 
assessing the performance of prostheses. With the increasing length of follow up the 
Registry will continue to report on these devices. In the 2017 Annual Report the 
outcomes of over 36 hip prosthesis combinations and 24 knee prosthesis 
combinations with a 15 year follow up are tabled. These data provide information to 
all stakeholders on the longer term outcome of prostheses.  
 
Australia introduced a benchmarking system for both total hip and total knee 
prostheses in 2007.  Those prostheses that are eligible to receive a 10-year benchmark 
are awarded a Superior Performance Suffix (SCP) if they achieve the required 




encourage the continued use of prostheses identified as performing well in the 
longer term.  The Registry has provided data for the recognition of SCP and these 
prostheses are rewarded with an increased premium from Health Insurance Funds 
of up to 20% over the established standard re-imbursement. Once again, the use of 





The relationship between the Registry and Industry has improved over the past 15 
years such that now there is close cooperation with mutual benefit for both parties. 
Initially this was not the case and the Registry was viewed with some suspicion, 
particularly with regard to the early identification of implant failures.  In 2004, 
implants with a HTARR were first identified.  At this stage manufacturing 
companies were given the chance to respond and explain if there might be an 
alternative explanation for why the device was not performing as well as others.  
This explanation was incorporated in the Annual Report without further Registry 
comment, but this practice ceased in 2006 for a number of reasons including a delay 
in company response and also a tendency to apportion blame on anything other than 
the device.  The Registry created a link for companies to log on to their own specific 




Industry can track data on their own website and then request detailed ad hoc reports 
from the Registry if they have evidence that a prosthesis or combinations are not 
performing as well as expected.  This also involves cooperation with the TGA as 
previously explained. The Registry has been able to provide companies with 
accurate data on implant use and revisions of their components.  Prior to this they 
relied on post market surveillance with adverse event report or feedback from sales 
representatives. However, it is quite common for revision procedures to be 
performed by another surgeon with the use of a prosthesis different from that of the 
original company and therefore, without detailed feedback from the Registry, 
industry would be unaware of their true implant revision rate. Several of the 
industry websites now have a direct link to the AOANJRR website though there are 
disclaimers that state there is no organisational affiliation and industry does not 




The 2006 Annual Report identified that the outcome of Hip Resurfacing procedures 
(HR) was related to gender and age, and in the preceding year, HR comprised 8.9% 
of all primary THR.  In 2008 the Registry reported that the size of the femoral head of 
the HR was also related to the outcome, with smaller head sizes (< 50mm) having a 




to a marked change in utilization of these devices by Australian surgeons with male 
patients < 65 years making an increasing proportion of all HR procedures. By 2010 
the proportion of males receiving HR had increased from 71.2% in 2003 to 91%, with 
95% under the age of 65.  The Birmingham Hip Resurfacing (BHR) prosthesis (Smith 
& Nephew) had almost 70% of the hip resurfacing market share at this stage and 
Smith & Nephew reacted to this information. It issued an Instructions for Use 
statement to recommend the use of the BHR in males < 65 years of age and withdrew 
smaller resurfacing femoral heads from the market (before any regulatory authority 
guidelines) (347). This was an example of follow through from an industry 
perspective and reflected a mounting respect for Registry data quality. 
 
The Registry has also worked closely with industry to provide them with reports for 
submission to regulatory authorities, both nationally and internationally, for re-
imbursement. Up until 2017, better performing prostheses in Australia (termed 
superior clinical performance) were awarded a premium price of 10% above the list 
price for implants with less than 5% rate of revision at ten years. Industry used 
reports based on Registry data for applications for superior clinical performance.  
Reports are also used for benchmarking and to obtain device ratings through ODEP 
in the United Kingdom. This promotes the use of devices with good outcomes which 




been 936 requests for ad hoc reports from industry and these comprise 39% of all the 
Registry requests. (Appendix 1). 
 
Over the past 18 months the Registry has worked closely with senior executives of 
the four major industry manufacturers to develop standardized, automated reports. 
This will allow industry unlimited access to their own products, and be available on 
a regular basis as a downloadable file.  All the information required by the 
companies to satisfy regulatory and re-imbursement submissions, and to monitor 
the performance of their implants will be provided. 
 
The AOANJRR Governance sub-committee has recommended to the AOA Board 
that industry can also utilise these reports for a wide range of other activities 
including white papers, advertising, and provision of industry specific reports to 
surgeons and hospitals. The use of above activities using ad hoc reports had 
previously been prohibited and this change reflects the more mature relationship 
between the Registry and Industry. There still strict rules in place for accurate use of 
the data12. Industry has come to respect the scientific veracity of the Registry and the 
close co–operation of both Registry staff and Industry leaders has fostered this. No 
                                                     
 






stakeholders involved in the orthopaedic field wish to see a repeat of the ASR 
failure, with the dramatic health problems suffered by patients and the subsequent 
huge litigation payouts awarded against industry. The ability of Industry to access 
real time reports of devices in an unlimited fashion may help to minimise this from 
ever happening again in future. 
 
While it is pleasing to see the increased cooperation of Industry with the Registry it 
should be recognised that the objectives of companies may differ compared to those 
of the Registry. A commercial entity must satisfy shareholders as well as regulatory 
authorities whereas the Registry primarily serves the Australian public. There are 
strict guidelines in place that stipulate regulations for the members of the Registry 
with regards to commercial influence.  These are incorporated both within 
Government legislation, which forbids any Registry personnel form divulging 
identified information, and with the AOA code of conduct which Registry directors 





Medical Insurance Companies 
 
For the 2015/2016 financial year, 59% of THR and 71% of TKR were performed in 
private hospitals (349) and the trend for more surgery to be performed in private 
hospitals compared to public has been consistent for over 20 years. 
 
Figure 13 Number of Hip and Knee Replacements by Public and Private Sector 
and Year 
 
Source: Data adapted from AOANJRR Supplementary Report, Demographics of Hip, Knee 
and Shoulder Arthroplasty 2017 
 
For companies to be reimbursed, all prostheses inserted in private hospitals have to 
be approved by the Prostheses List Advisory Committee (PLAC), though this is not 
the case for public hospitals, which have separate State Government contracts for re-
imbursement.  The Registry has been represented on the Federal Government 
Department of Health Committee to examine ways to reduce costs associated with 
















































































































































insurers for joint prostheses by 10%. The Registry has strongly encouraged the use of 
well performing devices as a way of also reducing costs. Mindful of the need not to 
stifle innovation, but still adhere to appropriate pre market testing, the Registry has 
been involved in organising the concept of developing clinical trials hosted within 
registries. ‘Registry nested clinical trials’ may support industry and insurers to work 
together to safely introduce new devices into the market (350). 
 
In the introduction to this chapter, I have discussed how revision surgery is the 
metric that the Registry uses to measure the outcome of joint replacement. This 
approach is limited in that it only identifies a subset of patients that have had an 
unsuccessful procedure and the use of PROMs is another method that may be 
employed to achieve further improvement in joint replacement.  PROMs may be a 
valuable tool to aid in the move towards a value based healthcare system with more 
emphasis on patient outcomes. In 2017, Medibank, the largest private health insurer 
in Australia, approached the AOA and the AOANJRR to partner in developing a 
pilot study to investigate the feasibility and effectiveness of collecting national 
PROMs data13.  The AOA PROMs Pilot Project commenced in November 2017 and 
incorporated advice from international experts in the field. Data collection is 
expected to commence in June 2018. This project has been made possible by funding 
                                                     
 
13  Source; Pilot Project on the collection of PROMs and other outcome data within the AOANJRR 




from a variety of medical insurance companies.  The reputation and track record of 
the AOANJRR as a clinical quality registry has been a major reason for the insurers 
to collaborate with the Registry in this important project. This project will have 





Health literacy is defined as the skills and abilities needed to gain access to, 
understand, and use health related information. There is a growing importance of 
providing information to the public to involve them in shared decision making (351), 
though the evidence for the effectiveness of this is mixed (352). The author has been 
involved in research that has examined the use of multimedia with regards to 
surgery and the provision of easily understood information has demonstrated clear 
benefits to patients (353-355). Other studies using decision aids have supported this 
concept (356, 357), and health professionals should take steps to ensure patients have 






The AOANJRR Governance committee has a formal appointment of a patient 
advocate and currently the Registry has a patient champion who regularly speaks at 
public forums.  The widespread newspaper, television, radio and social media 
coverage of the ASR hip revisions involved the Director of the AOANJRR, and 
exposed the Registry findings to a much wider public audience.  Concerns about the 
type of THR and bearing surface became (and still are) regular questions that 
patients ask during consultations.  
 
It is now common practice for patients to refer to the internet for information 
regarding joint replacement.  The Registry provides a publically accessible Lay 
Report annually (358).  This is, by far, the most commonly accessed supplementary 
report provided by the Registry and the 2017 Lay Report was downloaded over 900 
times in the first three months following release14.  The introduction to the Lay 
Report states; 
 
 The Lay summary is provided to ensure that a clear, concise and easily understood 
explanation of the published findings is available to all those who may be interested. 
The Australian Orthopaedic Association (AOA) believes this is especially important 
                                                     
 




because of the high level of community interest in the Registry and the need to ensure 
that reports are accessible to all.  
 
Surgeons are also increasingly using the Registry to interact with patients in 
consultations to provide them with accurate, up to date and unbiased data15. 
Registry data can be used to show each patient the typical outcomes for other 
patients with similar demographic and comorbidity profiles.  An example of one of 
the most commonly used figures is the outcome of TKR with respect to age. 
 
Figure 14 Cumulative Percent Revision of Primary Total Knee Replacement by 
Age  
 
Source: Fig KT10 AOANJRR Annual Report 2017 
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It can be difficult to convey the concept of revision of a joint replacement during a 
consultation with younger patients, particularly when explaining that it is preferable 
to delay TKR and maximise other non-operative methods of treatment for knee 
arthritis for as long as reasonably possible.  Patients younger than 55 years of age 
have a higher rate of revision than older patients and this can be clearly seen and 
understood by patients.  Other figures from the Registry Annual Report that are 
frequently used in surgeon/patient interactions are the benefits of cemented femoral 
stems in older patients, the differences in rates of revision between TKR and 
unicompartmental knees and to demonstrate the likely risk of complications 
following surgery. 
 
Figures based on Registry data are a way to ensure that patients are well-informed 
and have realistic expectations for their procedure outcomes considering their own 
unique circumstances (354). Helping patients become more involved in the shared 







9.5 - International Contribution of the AOANJRR 
 
The Registry is able to use Google analytics to monitor worldwide access to the 
Annual Report.  Australia provides over 50% of all activity followed by the U.S.A., 
United Kingdom and Germany.  The global access by the top 10 countries is shown 
in Figure 9, demonstrating the change from 2013, when data were first collected, to 
2017. Apart from the United Kingdom, access is highest by those countries that do 
not have registries, or registries not long enough established to provide more than 
demographic data.  Recently the Registry has collaborated with Chinese orthopaedic 
surgeons to produce editorial articles summarizing the most recent information from 
the Annual Report with a focus on the application to the Chinese population (360, 




Fig 15 Global Access by Top 10 countries 
 
Source: AOANJRR Internal Reporting Site prepared 2017  
 
Fig 16 World Map of Visits to the AOANJRR Website for 2017
 
Source: Google analytics report prepared by AOANJRR 2017 
 
While the primary aim of the Registry has been to improve the outcomes of joint 
replacement for Australian patients, there are numerous examples of the 

















international influence of the Registry and many of these have been discussed 
throughout the previous chapters.  There are other areas where the AOANJRR has 
made major international contributions and three are discussed below: 
 
1. Implant harmonisation: For international comparative outcomes research in 
joint replacement, it is important that implants have a standard terminology 
and their respective attributes are the same (catalogue and lot numbers) 
throughout the world (49, 362). The Registry Director, Professor S Graves and 
the AOANJRR data management staff and statisticians have made a major 
contribution to hip and knee implant harmonisation with the initial creation 
of an International Prosthesis Library (IPL).  This Library of implants is 
currently in use in 11 registries throughout the world.  An IPL Governance 
Committee has been established as part of the International Society of 
Arthroplasty Registries (ISAR) and, in June 2017, a memorandum of 
understanding was signed on behalf of the Advanced Medical Technology 
Association (AdvaMed) and ISAR.  AdvaMed supports the commitment of 
members of its orthopaedic manufacturing sector to provide ISAR with hip 
and knee arthroplasty attribute data and to update data as appropriate when 
new devices come onto the market.  ISAR has subcontracted with the 
American Joint Registry to implement and manage the IPL and will distribute 




and be important for the early signal detection of devices for post market 
surveillance across international registries.  
 
2. The US Food and Drug Administration (FDA):  Section 510(k) of the Food, 
Drug and Cosmetic Act requires device manufacturers to notify FDA of their 
intent to market a medical device at least 90 days in advance. This is known as 
Premarket Notification, also called PMN or 510(k). This allows FDA to 
determine whether the new device has substantial equivalence to a device 
already in the market (363).  New hip and knee devices are often introduced 
into the US Market under Section 510(k) but historical precedent may not be 
adequate for pre-market assessment. The introduction of large head metal on 
metal THR through this process is a sobering example, and is well described 
in an article in the New England Journal of Medicine (364).  The AOANJRR 
has co-operated closely with the FDA, and allowed access to a secure web 
portal of our Registry database in 2010. This enabled the FDA to access 
another source of information to aid in their assessment and monitoring of 
devices. 
 
3. International Prosthesis Benchmarking: The AOANJRR has pioneered a 
method for identifying implant outliers that has now been adopted by at least 




development of a system to rank the performance of hip and knee prostheses 
and establish a global benchmarking standard.  
 
In conclusion, notwithstanding the limitations of observational data, Chapter 9 
presents abundant evidence that suggests that the AOANJRR has had a substantial 
influence on the practice of orthopaedic surgeons, the processes of government 





9.6 - Appendices 
 
Appendix 1  Ad Hoc Requests Summary 
 





2001 1 3         4 
2002 2 2 2 3     9 
2003   7 2 7 1   17 
2004 2 8 7 11 1   29 
2005 1 15 5 11     32 
2006 3 17 15 26     61 
2007 2 10 23 37   9 81 
2008 3 5 45 39 3 22 117 
2009 2 6 51 47 3 11 120 
2010 4 10 66 50 5 8 143 
2011 15 10 85 76 2 12 200 
2012 21 27 60 105 1 2 216 
2013 12 10 123 98 3 0 246 
2014 11 17 117 107 2 0 254 
2015 15 30 129 123 3 0 300 
2016 9 14 100 129 1 0 253 
2017 4 45 106 169 2 0 326 






Appendix 2 Author Contract Extract with Terms and Conditions in relationship to 
commercial dealings. 
 
9 LIAISON WITH INDUSTRY 
 
9.1  The Deputy Director shall report any liaison with the Orthopaedic prostheses 
industry to the Director and as required through the AOANJRR Committee 
(and where relevant to the AOA CEO) as part of his report to the Director and 
the AOANJRR Committee (as required) and whenever necessary in otherwise 
responsibly carrying out his designated role. 
 
9.2  The Deputy Director must not entertain or engage in any commercial 
undertakings with the orthopaedic prostheses industry nor accept any 
benefits from industry. 
 
9.3  It is noted that the Deputy Director is involved in attracting research grant 
funding for approved human ethic trials. The Deputy Director warrants that 
he is not a beneficiary and that all funds are made available to the Epworth 
Research Foundation. It is also noted that the Deputy Director has declared all 
association with industry to the Commonwealth and is an approved 
Commonwealth Clinical Advisory Group representative on behalf of AOA 9.4 
The Deputy Director must make an annual declaration to the AOA to the 
effect that he has no direct or indirect commercial dealings with industry and 
















The aim of this thesis was to study the impact of the Australian Orthopaedic 
Association National Joint Replacement Registry (AOANJRR) on hip and knee 
replacement in Australia, determine whether joint replacement outcomes had 
improved since the introduction of the Registry, and critically assess the role of the 
Registry in this process. 
 
Chapter one outlined the global burden of hip and knee arthritis, and THR and TKR 
are effective treatments when non operative measures have failed.  Joint registries 
provide an excellent method of monitoring outcomes of these procedures.  Chapter 
two summarised a brief history of registry development, discussed the processes 
involved with the AOANJRR and assessed the quality, strengths and limitations of 
the Registry.  In Chapter three I examined the literature with respect to the aim of 
the thesis and the specific research questions. There is evidence that both national 
and regional joint registries can improve outcomes of joint replacement though these 
do not necessarily extend beyond their respective borders. There has been no formal 
examination of the impact of the AOANJRR apart from an economic assessment of 
the Registry.  As expected, there was minimal literature pertaining to the research 
questions and these questions sought to address specific topics that the Registry 





Chapter four addressed research question one and described the process by which 
the Registry identifies outlier prostheses. The Registry was the first to formalise a 
method for this and it has had a significant national and international impact. As a 
result many implants have been removed from the market, several international 
registries have adopted this method, (Chapter eight) and it has indirectly led to the 
formation of an international working group to investigate early signal detection of 
devices.  This process has also been integrated into the regulatory framework of the 
TGA. 
 
Research question two examined a specific technique of implanting a TKR and the 
resulting paper five was the first to demonstrate that the use of computer navigation 
resulted in a reduced rate of revision for younger patients.  The methods for 
collecting this type of data, as distinct from implant identifiers has enabled the 
Registry to monitor a range of new techniques, including custom designed 
instruments, and robotic surgery. The regular feedback of improved outcomes of 
navigation has led to increasing use of navigation in Australia (not apparent in most 
other countries) and is likely to contribute to the reduced revision burden for TKR. 
 
Research question three examined the impact of XLPE, a modified bearing surface 
designed to reduce wear, on the outcomes of TKR and THR. Papers six and seven 




compared to conventional polyethylene.  Regular analyses of the benefits of XLPE in 
the Annual Reports from 2008 onwards has contributed to the majority of prostheses 
now using XLPE instead of conventional polyethylene. Again Registry data has 
influenced Government policy with a superior performance suffix for XLPE and a 
recent decision from the PLAC to remove all conventional polyethylene from re-
imbursement. 
 
Research question four examined the interaction of the Registry with the multiple 
stakeholders required to implement effective change of practice.  I have 
demonstrated both a reduction in the revision burden for THR and TKR since the 
inception of the registry and a steadily reducing rate of revision over successive time 
periods.  Multiple examples of registry interactions with stakeholders are discussed 
and the argument is presented that all these have contributed to improvements in 
the practice of joint replacement as a result of the Registry. 
Future Research 
Data Linkage 
The Registry has continually endeavoured to meet the aim of improving joint 
replacement practice by increasing the number of analyses, improving feedback to 
all stakeholders and striving to provide the information in as timely a manner as 
possible.  One of the major strengths of the AOANJRR is the use of a minimal dataset 




Australia.  The Registry is aware though, that other sources of information have the 
potential to expand and improve the analysis of our data.  In order to address this 
limitation the AOANJRR applied for, and was awarded in 2017 an NHMRC Grant 
(1148106) with the University of South Australia entitled ‘Enhancing joint replacement 
outcomes through data linkage’.  This will enable the Registry to link to other existing 
health data including the Department of Human Services Medicare Benefits 
Schedule (MBS) and Pharmaceutical Benefits Scheme (PBS) data, Australasian 
Association of Cancer Registries (AACR), state-based hospital data and Australasian 
Rehabilitation Outcomes Centre (AROC) database, and will permit more extensive 
and detailed analysis of the outcomes of THR and TKR. A working group of 
clinicians, statisticians and health services researchers has been formed to investigate 
key factors associated with joint replacement outcomes. These include prosthetic 
joint infection, long term morbidity and mortality associated with joint surgery, 
cancer risk, opioid use, and rehabilitation outcomes. 
Registry Nested Trials 
One of the criticisms by industry directed at joint registries is that they may stifle 
innovation and the introduction of new prostheses.  An area of future research that 
the Registry is currently investigating is implementing Registry nested trials which 
involve imbedding randomised or clinical trials within a Registry framework.  This 
has many potential benefits including, comparing a new device with all other 
devices or just the best devices, an accurate measure of the outcome of the device in 




substantial cost savings for industry in introducing a new device as the 
organizational framework of the Registry can be utilized for the clinical trials. 
Obesity 
Obesity is an increasing problem for the community and can impact on the outcomes 
of joint replacement. The Registry did not commence collecting data on height and 
weight up until 2015 so analysis of outcomes related to BMI was not possible for this 
thesis. Future research will examine the effects of multiple co-morbidities associated 
with joint replacement as outlined above and obesity is one such factor. In the 2018 
AOANJRR Annual Report the Registry reported for the first time the rates of 
revision with respect to the six classes of  BMI, as classified by the World health 
Organisation (365).  For all hip replacements the majority of procedures are 
undertaken in patients who are normal or pre-obese (60.5%). This differs from 
patients undergoing knee replacements where the majority of patients are either pre-
obese or obese class1 (62.3%). The Registry reported increased early rates of revision 
for patients with a higher BMI undergoing hip replacement, with revision for 
infection being the commonest cause for patients with obese class 1 and higher. For 
knee replacement the rate of revision is increased for patients with obese class 3 
compared to a normal BMI, and the rate of infection increases with increasing BMI 
class. The relationship between BMI and joint outcomes will be explored in more 
detail when the Registry has longer follow up to examine whether this higher early 





Patient Reported Outcome Measures 
While the Registry uses cumulative percent revision as a hard end point to 
determine the outcome of the primary procedure, lack of revision does not 
necessarily indicate a successful procedure and the use of Patient Reported Outcome 
Measures (PROMs) provides another aspect of the results of surgery which may help 
to improve outcomes. The Registry has commenced a national pilot project of 
PROMs on patients undergoing hip and knee joint replacement in over 50 hospitals 
in Australia.  This will help the Registry to further understand other measures of 
success or failure which have been discussed as a limitation in Chapter nine.  The 
collection of PROMs will also include an economic benefit and will further explore 
whether PROMs are related to a joint revision. This work has now commenced. 
Health Economic Research 
Health economic analysis is a vital part of any research into medical interventions 
with joint replacement being no exception Now that it is established that the 
outcomes of hip and knee replacement have been improved by the AOANJRR, an 
economic analysis of the Registry warrants further research but was outside the 
scope of this Thesis.  As mentioned in Chapter 5.3 one project is underway to 
analyse the cost effectiveness of computer navigation in association with the Health 






Future research will directly inform the health system and clinical policy and will 
likely result in further improvements for patients undergoing joint replacement 
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